{"name":"Pfizer Inc.","slug":"pfizer","ticker":"PFE","exchange":"NYSE","domain":"pfizer.com","description":"Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.","hq":"New York, NY","founded":1849,"employees":"75000","ceo":"Albert Bourla","sector":"Big Pharma","stockPrice":27.06,"stockChange":-0.04,"stockChangePercent":-0.15,"marketCap":"$153.9B","metrics":{"revenue":90013000000,"revenueGrowth":-1.2,"grossMargin":75.8,"rdSpend":0,"netIncome":7771000000,"cash":1142000000,"dividendYield":6.35,"peRatio":19.9,"fiscalYear":"FY2025"},"revenueBreakdown":[{"name":"Prevnar family","genericName":"prevnar-family","slug":"prevnar-family","revenue":6494000000,"yoyGrowth":0,"percentOfTotal":7.2},{"name":"Prevnar 20","genericName":"pneumococcal 20-valent conjugate vaccine (PCV20)","slug":"prevnar-20","revenue":6400000000,"yoyGrowth":0,"percentOfTotal":7.1},{"name":"Comirnaty","genericName":"BNT162b2 (tozinameran)","slug":"comirnaty","revenue":5400000000,"yoyGrowth":0,"percentOfTotal":6},{"name":"Ibrance","genericName":"Palbociclib","slug":"ibrance","revenue":4500000000,"yoyGrowth":0,"percentOfTotal":5},{"name":"Famtozinameran 12 Years of age and older","genericName":"famtozinameran-12-years-of-age-and-older","slug":"famtozinameran-12-years-of-age-and-older","revenue":4367000000,"yoyGrowth":0,"percentOfTotal":4.9},{"name":"COMIRNATY intramuscular injection","genericName":"comirnaty-intramuscular-injection","slug":"comirnaty-intramuscular-injection","revenue":4367000000,"yoyGrowth":0,"percentOfTotal":4.9},{"name":"Palbociclib in combination with AI","genericName":"palbociclib-in-combination-with-ai","slug":"palbociclib-in-combination-with-ai","revenue":4122000000,"yoyGrowth":0,"percentOfTotal":4.6},{"name":"PF-06863135 + lenalidomide","genericName":"pf-06863135-lenalidomide","slug":"pf-06863135-lenalidomide","revenue":2951000000,"yoyGrowth":0,"percentOfTotal":3.3},{"name":"Nivolumab and Ipilimumab","genericName":"nivolumab-and-ipilimumab","slug":"nivolumab-and-ipilimumab","revenue":2900000000,"yoyGrowth":0,"percentOfTotal":3.2},{"name":"Nivolumab and/or Ipilimumab","genericName":"nivolumab-and-or-ipilimumab","slug":"nivolumab-and-or-ipilimumab","revenue":2900000000,"yoyGrowth":0,"percentOfTotal":3.2},{"name":"Venetoclax; Rituximab","genericName":"venetoclax-rituximab","slug":"venetoclax-rituximab","revenue":2583000000,"yoyGrowth":0,"percentOfTotal":2.9},{"name":"Paxlovid (Copackaged)","genericName":"nirmatrelvir","slug":"nirmatrelvir","revenue":2362000000,"yoyGrowth":0,"percentOfTotal":2.6},{"name":"Talazoparib with enzalutamide","genericName":"talazoparib-with-enzalutamide","slug":"talazoparib-with-enzalutamide","revenue":2194000000,"yoyGrowth":0,"percentOfTotal":2.4},{"name":"talazoparib plus enzalutamide","genericName":"talazoparib-plus-enzalutamide","slug":"talazoparib-plus-enzalutamide","revenue":2194000000,"yoyGrowth":0,"percentOfTotal":2.4},{"name":"Xeljanz","genericName":"tofacitinib","slug":"tofacitinib","revenue":1800000000,"yoyGrowth":0,"percentOfTotal":2},{"name":"Abiraterone Acetate","genericName":"abiraterone","slug":"abiraterone","revenue":1500000000,"yoyGrowth":0,"percentOfTotal":1.7},{"name":"Nurtec Odt","genericName":"Rimegepant Sulfate","slug":"nurtec-odt","revenue":1424000000,"yoyGrowth":0,"percentOfTotal":1.6},{"name":"Immuno-oncology (IO)","genericName":"immuno-oncology-io","slug":"immuno-oncology-io","revenue":1301000000,"yoyGrowth":0,"percentOfTotal":1.4},{"name":"Lorbrena","genericName":"Lorlatinib","slug":"lorbrena","revenue":1100000000,"yoyGrowth":0,"percentOfTotal":1.2},{"name":"Xeljanz","genericName":"Tofacitinib Citrate","slug":"xeljanz","revenue":1087000000,"yoyGrowth":0,"percentOfTotal":1.2},{"name":"In open-label phase: treatment with tofacitinib","genericName":"in-open-label-phase-treatment-with-tofacitinib","slug":"in-open-label-phase-treatment-with-tofacitinib","revenue":1087000000,"yoyGrowth":0,"percentOfTotal":1.2},{"name":"Pristiq","genericName":"Desvenlafaxine Succinate","slug":"pristiq","revenue":1041000000,"yoyGrowth":0,"percentOfTotal":1.2},{"name":"Abrysvo","genericName":"abrysvo","slug":"abrysvo","revenue":1033000000,"yoyGrowth":0,"percentOfTotal":1.1},{"name":"Lipitor","genericName":"atorvastatin","slug":"atorvastatin","revenue":1000000000,"yoyGrowth":0,"percentOfTotal":1.1},{"name":"Premarin","genericName":"Conjugated estrogens","slug":"conjugated-estrogens","revenue":1000000000,"yoyGrowth":0,"percentOfTotal":1.1},{"name":"Axitinib plus Toripalimab","genericName":"axitinib-plus-toripalimab","slug":"axitinib-plus-toripalimab","revenue":923000000,"yoyGrowth":0,"percentOfTotal":1},{"name":"Inlyta","genericName":"axitinib","slug":"axitinib","revenue":923000000,"yoyGrowth":0,"percentOfTotal":1},{"name":"Adcetris","genericName":"brentuximab-vedotin","slug":"brentuximab-vedotin","revenue":900000000,"yoyGrowth":0,"percentOfTotal":1},{"name":"Rimegepant 75mg every other day dosing","genericName":"rimegepant-75mg-every-other-day-dosing","slug":"rimegepant-75mg-every-other-day-dosing","revenue":798000000,"yoyGrowth":0,"percentOfTotal":0.9},{"name":"Chemotherapy","genericName":"chemotherapy","slug":"chemotherapy","revenue":798000000,"yoyGrowth":0,"percentOfTotal":0.9},{"name":"Docetaxel monotherapy","genericName":"docetaxel-monotherapy","slug":"docetaxel-monotherapy","revenue":798000000,"yoyGrowth":0,"percentOfTotal":0.9},{"name":"Lorlatinib with chemotherapy 2","genericName":"lorlatinib-with-chemotherapy-2","slug":"lorlatinib-with-chemotherapy-2","revenue":798000000,"yoyGrowth":0,"percentOfTotal":0.9},{"name":"PF-07104091 monotherapy dose expansion (ovarian)","genericName":"pf-07104091-monotherapy-dose-expansion-ovarian","slug":"pf-07104091-monotherapy-dose-expansion-ovarian","revenue":798000000,"yoyGrowth":0,"percentOfTotal":0.9},{"name":"Ribociclib (Dose #2)","genericName":"ribociclib-dose-2","slug":"ribociclib-dose-2","revenue":787000000,"yoyGrowth":0,"percentOfTotal":0.9},{"name":"Braftovi","genericName":"encorafenib","slug":"encorafenib","revenue":716000000,"yoyGrowth":0,"percentOfTotal":0.8},{"name":"Infliximab [infliximab biosimilar 3]","genericName":"infliximab-infliximab-biosimilar-3","slug":"infliximab-infliximab-biosimilar-3","revenue":646000000,"yoyGrowth":0,"percentOfTotal":0.7},{"name":"Zavicefta, Ceftazidime-Avibactam","genericName":"zavicefta-ceftazidime-avibactam","slug":"zavicefta-ceftazidime-avibactam","revenue":638000000,"yoyGrowth":0,"percentOfTotal":0.7},{"name":"Bosulif","genericName":"Bosutinib Monohydrate","slug":"bosulif","revenue":611000000,"yoyGrowth":0,"percentOfTotal":0.7},{"name":"Bosulif","genericName":"bosutinib","slug":"bosutinib","revenue":611000000,"yoyGrowth":0,"percentOfTotal":0.7},{"name":"Bosutinib capsule","genericName":"bosutinib-capsule","slug":"bosutinib-capsule","revenue":611000000,"yoyGrowth":0,"percentOfTotal":0.7},{"name":"Tukysa","genericName":"tukysa","slug":"tukysa","revenue":463000000,"yoyGrowth":0,"percentOfTotal":0.5},{"name":"Aromasin","genericName":"exemestane","slug":"exemestane","revenue":450000000,"yoyGrowth":0,"percentOfTotal":0.5},{"name":"Omnitrope","genericName":"Somatropin","slug":"genotropin-preservative-free","revenue":446000000,"yoyGrowth":0,"percentOfTotal":0.5},{"name":"somatropin - GH naïve pediatric cohort","genericName":"somatropin-gh-na-ve-pediatric-cohort","slug":"somatropin-gh-na-ve-pediatric-cohort","revenue":446000000,"yoyGrowth":0,"percentOfTotal":0.5},{"name":"somatropin - GH treated cohort","genericName":"somatropin-gh-treated-cohort","slug":"somatropin-gh-treated-cohort","revenue":446000000,"yoyGrowth":0,"percentOfTotal":0.5},{"name":"somatropin - adult cohort","genericName":"somatropin-adult-cohort","slug":"somatropin-adult-cohort","revenue":446000000,"yoyGrowth":0,"percentOfTotal":0.5},{"name":"Radium-223","genericName":"radium-223","slug":"radium-223","revenue":400000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Zithromax","genericName":"Azithromycin","slug":"zithromax","revenue":399000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Zithromax","genericName":"azithromycin","slug":"azithromycin","revenue":399000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Canakinumab Injection","genericName":"canakinumab-injection","slug":"canakinumab-injection","revenue":372000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Taxol","genericName":"nab-paclitaxel","slug":"nab-paclitaxel","revenue":368000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Taxol","genericName":"paclitaxel","slug":"paclitaxel","revenue":368000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Taxol","genericName":"Nabpaclitaxel","slug":"nabpaclitaxel","revenue":368000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Zoloft","genericName":"sertraline","slug":"sertraline","revenue":350000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Isavuconazole","genericName":"isavuconazole","slug":"isavuconazole","revenue":349000000,"yoyGrowth":0,"percentOfTotal":0.4},{"name":"Elrexfio","genericName":"Elranatamab","slug":"elrexfio","revenue":304000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Elrexfio","genericName":"elranatamab","slug":"elranatamab","revenue":304000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Elrexfio","genericName":"elranatamab-bcmm","slug":"elranatamab-bcmm","revenue":304000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Cibinqo","genericName":"abrocitinib","slug":"abrocitinib","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib 100 mg","genericName":"abrocitinib-100-mg","slug":"abrocitinib-100-mg","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib 200 MG Oral Tablet","genericName":"abrocitinib-200-mg-oral-tablet","slug":"abrocitinib-200-mg-oral-tablet","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib 200 mg","genericName":"abrocitinib-200-mg","slug":"abrocitinib-200-mg","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Cibinqo","genericName":"Abrocitinib","slug":"cibinqo","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib Suspension F1","genericName":"abrocitinib-suspension-f1","slug":"abrocitinib-suspension-f1","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib Suspension F2","genericName":"abrocitinib-suspension-f2","slug":"abrocitinib-suspension-f2","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib Suspension F6","genericName":"abrocitinib-suspension-f6","slug":"abrocitinib-suspension-f6","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Abrocitinib tablet","genericName":"abrocitinib-tablet","slug":"abrocitinib-tablet","revenue":284000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Oxbryta","genericName":"Voxelotor","slug":"oxbryta","revenue":250000000,"yoyGrowth":0,"percentOfTotal":0.3},{"name":"Besponsa","genericName":"Inotuzumab Ozogamicin","slug":"besponsa","revenue":200000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Besponsa","genericName":"inotuzumab-ozogamicin","slug":"inotuzumab-ozogamicin","revenue":200000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Besponsa","genericName":"inotuzumab","slug":"inotuzumab","revenue":200000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Talzenna","genericName":"Talazoparib Tosylate","slug":"talzenna","revenue":182000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Talzenna","genericName":"talazoparib","slug":"talazoparib","revenue":182000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Talzenna","genericName":"talazoparib-tosylate","slug":"talazoparib-tosylate","revenue":182000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Daurismo","genericName":"Glasdegib Maleate","slug":"daurismo","revenue":150000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"Daurismo","genericName":"glasdegib","slug":"glasdegib","revenue":150000000,"yoyGrowth":0,"percentOfTotal":0.2},{"name":"tocilizumab or sarilumab","genericName":"tocilizumab-or-sarilumab","slug":"tocilizumab-or-sarilumab","revenue":116000000,"yoyGrowth":0,"percentOfTotal":0.1},{"name":"Mylotarg","genericName":"Gemtuzumab Ozogamicin","slug":"mylotarg","revenue":100000000,"yoyGrowth":0,"percentOfTotal":0.1},{"name":"Mylotarg","genericName":"gemtuzumab-ozogamicin","slug":"gemtuzumab-ozogamicin","revenue":100000000,"yoyGrowth":0,"percentOfTotal":0.1}],"timeline":[{"date":"1939-01-01","label":"Heparin Sodium In Plastic Container first approved","drug":"Heparin Sodium In Plastic Container","drugSlug":"heparin-sodium-25-000-units-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1939-01-01","label":"Heparin Sodium In Plastic Container first approved","drug":"Heparin Sodium In Plastic Container","drugSlug":"heparin-sodium-12-500-units-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1939-01-01","label":"Heparin Sodium In Plastic Container first approved","drug":"Heparin Sodium In Plastic Container","drugSlug":"heparin-sodium-10-000-units-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1939-01-01","label":"Heparin Sodium In Plastic Container first approved","drug":"Heparin Sodium In Plastic Container","drugSlug":"heparin-sodium-preservative-free","type":"approval","sentiment":"positive"},{"date":"1942-01-01","label":"Premarin first approved","drug":"Premarin","drugSlug":"conjugated-estrogens","type":"approval","sentiment":"positive"},{"date":"1942-01-01","label":"Premarin first approved","drug":"Premarin","drugSlug":"prempro","type":"approval","sentiment":"positive"},{"date":"1942-01-01","label":"Meperidine Hydrochloride Preservative Free first approved","drug":"Meperidine Hydrochloride Preservative Free","drugSlug":"demerol","type":"approval","sentiment":"positive"},{"date":"1942-01-01","label":"Premarin first approved","drug":"Premarin","drugSlug":"premphase-14-14","type":"approval","sentiment":"positive"},{"date":"1948-01-01","label":"Lignospan Forte first approved","drug":"Lignospan Forte","drugSlug":"lidocaine-hydrochloride-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1948-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"approval","sentiment":"positive"},{"date":"1950-01-01","label":"Azulfidine En-Tabs first approved","drug":"Azulfidine En-Tabs","drugSlug":"azulfidine-en-tabs","type":"approval","sentiment":"positive"},{"date":"1950-01-01","label":"Levophed first approved","drug":"Levophed","drugSlug":"levophed","type":"approval","sentiment":"positive"},{"date":"1950-01-01","label":"Azulfidine first approved","drug":"Azulfidine","drugSlug":"azulfidine","type":"approval","sentiment":"positive"},{"date":"1952-01-01","label":"Bicillin C-R first approved","drug":"Bicillin C-R","drugSlug":"bicillin-c-r","type":"approval","sentiment":"positive"},{"date":"1952-01-01","label":"Bicillin C-R first approved","drug":"Bicillin C-R","drugSlug":"bicillin-c-r-900-300","type":"approval","sentiment":"positive"},{"date":"1952-01-01","label":"Bicillin C-R first approved","drug":"Bicillin C-R","drugSlug":"bicillin-l-a","type":"approval","sentiment":"positive"},{"date":"1953-01-01","label":"Dilantin first approved","drug":"Dilantin","drugSlug":"dilantin","type":"approval","sentiment":"positive"},{"date":"1956-01-01","label":"Cytomel first approved","drug":"Cytomel","drugSlug":"cytomel","type":"approval","sentiment":"positive"},{"date":"1960-01-01","label":"Aldactone first approved","drug":"Aldactone","drugSlug":"aldactone","type":"approval","sentiment":"positive"},{"date":"1960-01-01","label":"Zarontin first approved","drug":"Zarontin","drugSlug":"zarontin","type":"approval","sentiment":"positive"},{"date":"1961-01-01","label":"Nardil first approved","drug":"Nardil","drugSlug":"nardil","type":"approval","sentiment":"positive"},{"date":"1963-01-01","label":"Oncovin first approved","drug":"Oncovin","drugSlug":"vincristine","type":"approval","sentiment":"positive"},{"date":"1963-01-01","label":"Oncovin first approved","drug":"Oncovin","drugSlug":"vincristine-sulfate-pfs","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Aridol Kit first approved","drug":"Aridol Kit","drugSlug":"mannitol-25","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Benzamycin first approved","drug":"Benzamycin","drugSlug":"erythrocin","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Aridol Kit first approved","drug":"Aridol Kit","drugSlug":"mannitol-5","type":"approval","sentiment":"positive"},{"date":"1964-01-01","label":"Aridol Kit first approved","drug":"Aridol Kit","drugSlug":"mannitol-10","type":"approval","sentiment":"positive"},{"date":"1965-01-01","label":"Sodium Chloride first approved","drug":"Sodium Chloride","drugSlug":"sodium-chloride-0-9-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1965-01-01","label":"Plegisol In Plastic Container first approved","drug":"Plegisol In Plastic Container","drugSlug":"bacteriostatic-sodium-chloride-0-9-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1967-01-01","label":"Mannitol 15% first approved","drug":"Mannitol 15%","drugSlug":"mannitol-15","type":"approval","sentiment":"positive"},{"date":"1971-01-01","label":"Plegisol In Plastic Container first approved","drug":"Plegisol In Plastic Container","drugSlug":"tpn-electrolytes-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1971-01-01","label":"Potassium Acetate first approved","drug":"Potassium Acetate","drugSlug":"potassium-acetate","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Bupivacaine Hydrochloride first approved","drug":"Bupivacaine Hydrochloride","drugSlug":"bupivacaine-hydrochloride-and-epinephrine","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"marcaine-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"marcaine-hydrochloride-w-epinephrine","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"marcaine-hydrochloride-w-epinephrine-preservative-free","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"marcaine-hydrochloride-preservative-free","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1973-01-01","label":"Silvadene first approved","drug":"Silvadene","drugSlug":"silvadene","type":"approval","sentiment":"positive"},{"date":"1976-01-01","label":"Omnitrope first approved","drug":"Omnitrope","drugSlug":"genotropin-preservative-free","type":"approval","sentiment":"positive"},{"date":"1977-01-01","label":"Norpace Cr first approved","drug":"Norpace Cr","drugSlug":"norpace","type":"approval","sentiment":"positive"},{"date":"1977-01-01","label":"Norpace Cr first approved","drug":"Norpace Cr","drugSlug":"norpace-cr","type":"approval","sentiment":"positive"},{"date":"1978-01-01","label":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container first approved","drug":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","drugSlug":"dobutamine-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1981-01-01","label":"Pipracil first approved","drug":"Pipracil","drugSlug":"zosyn-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1981-01-01","label":"Magnesium Sulfate first approved","drug":"Magnesium Sulfate","drugSlug":"magnesium-sulfate-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1981-01-01","label":"Lopid first approved","drug":"Lopid","drugSlug":"lopid","type":"approval","sentiment":"positive"},{"date":"1982-01-01","label":"Amidate first approved","drug":"Amidate","drugSlug":"amidate","type":"approval","sentiment":"positive"},{"date":"1983-01-01","label":"Tracrium Preservative Free first approved","drug":"Tracrium Preservative Free","drugSlug":"atracurium-besylate-preservative-free","type":"approval","sentiment":"positive"},{"date":"1983-01-01","label":"Plasma-Lyte A In Plastic Container first approved","drug":"Plasma-Lyte A In Plastic Container","drugSlug":"sodium-acetate","type":"approval","sentiment":"positive"},{"date":"1983-01-01","label":"Acid Reflux Relief first approved","drug":"Acid Reflux Relief","drugSlug":"sodium-phosphates-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1983-01-01","label":"Atracurium first approved","drug":"Atracurium","drugSlug":"atracurium-besylate","type":"approval","sentiment":"positive"},{"date":"1985-01-01","label":"Naloxone Hydrochloride first approved","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1986-01-01","label":"Cyklokapron first approved","drug":"Cyklokapron","drugSlug":"cyklokapron","type":"approval","sentiment":"positive"},{"date":"1987-01-01","label":"Cipro first approved","drug":"Cipro","drugSlug":"ciprofloxacin-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1987-01-01","label":"Doxorubicin Hydrochloride first approved","drug":"Doxorubicin Hydrochloride","drugSlug":"doxorubicin-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1988-01-01","label":"Cytotec first approved","drug":"Cytotec","drugSlug":"cytotec","type":"approval","sentiment":"positive"},{"date":"1988-01-01","label":"Arthrotec first approved","drug":"Arthrotec","drugSlug":"arthrotec","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Idamycin Pfs first approved","drug":"Idamycin Pfs","drugSlug":"idarubicin-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Synarel first approved","drug":"Synarel","drugSlug":"synarel","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Diflucan first approved","drug":"Diflucan","drugSlug":"fluconazole-in-sodium-chloride-0-9-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Idamycin Pfs first approved","drug":"Idamycin Pfs","drugSlug":"idamycin-pfs","type":"approval","sentiment":"positive"},{"date":"1991-01-01","label":"Nipent first approved","drug":"Nipent","drugSlug":"nipent","type":"approval","sentiment":"positive"},{"date":"1991-11-01","label":"Zithromax first approved","drug":"Zithromax","drugSlug":"azithromycin","type":"approval","sentiment":"positive"},{"date":"1991-12-30","label":"Zoloft first approved","drug":"Zoloft","drugSlug":"sertraline","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Taxol first approved","drug":"Taxol","drugSlug":"nab-paclitaxel","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Taxol first approved","drug":"Taxol","drugSlug":"paclitaxel","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Taxol first approved","drug":"Taxol","drugSlug":"nabpaclitaxel","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Norvasc first approved","drug":"Norvasc","drugSlug":"norvasc","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Lidocaine Hydrochloride Preservative Free first approved","drug":"Lidocaine Hydrochloride Preservative Free","drugSlug":"lidocaine-hydrochloride-preservative-free","type":"approval","sentiment":"positive"},{"date":"1993-01-01","label":"Neurontin first approved","drug":"Neurontin","drugSlug":"neurontin","type":"approval","sentiment":"positive"},{"date":"1993-01-01","label":"Potassium Phosphates first approved","drug":"Potassium Phosphates","drugSlug":"potassium-phosphates","type":"approval","sentiment":"positive"},{"date":"1993-01-01","label":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container first approved","drug":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","drugSlug":"dobutamine-hydrochloride-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1993-01-01","label":"Effexor first approved","drug":"Effexor","drugSlug":"effexor-xr","type":"approval","sentiment":"positive"},{"date":"1994-01-01","label":"Fragmin first approved","drug":"Fragmin","drugSlug":"fragmin","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Merrem first approved","drug":"Merrem","drugSlug":"meropenem","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Camptosar first approved","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Estring first approved","drug":"Estring","drugSlug":"estring","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Levaquin first approved","drug":"Levaquin","drugSlug":"levofloxacin-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Lipitor first approved","drug":"Lipitor","drugSlug":"lipitor","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Magnesium Sulfate In Dextrose 5% In Plastic Container first approved","drug":"Magnesium Sulfate In Dextrose 5% In Plastic Container","drugSlug":"magnesium-sulfate-in-dextrose-5-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"1996-12-17","label":"Lipitor first approved","drug":"Lipitor","drugSlug":"atorvastatin","type":"approval","sentiment":"positive"},{"date":"1998-01-01","label":"Viagra first approved","drug":"Viagra","drugSlug":"viagra","type":"approval","sentiment":"positive"},{"date":"1999-01-01","label":"Aromasin first approved","drug":"Aromasin","drugSlug":"exemestane","type":"approval","sentiment":"positive"},{"date":"2000-01-01","label":"Mylotarg first approved","drug":"Mylotarg","drugSlug":"mylotarg","type":"approval","sentiment":"positive"},{"date":"2000-01-01","label":"Mylotarg first approved","drug":"Mylotarg","drugSlug":"gemtuzumab-ozogamicin","type":"approval","sentiment":"positive"},{"date":"2000-01-01","label":"Pantoprazole Sodium first approved","drug":"Pantoprazole Sodium","drugSlug":"protonix-iv","type":"approval","sentiment":"positive"},{"date":"2000-01-01","label":"Zyvox first approved","drug":"Zyvox","drugSlug":"linezolid","type":"approval","sentiment":"positive"},{"date":"2001-01-01","label":"Levoxyl first approved","drug":"Levoxyl","drugSlug":"levoxyl","type":"approval","sentiment":"positive"},{"date":"2002-01-01","label":"Milrinone Lactate first approved","drug":"Milrinone Lactate","drugSlug":"milrinone-lactate","type":"approval","sentiment":"positive"},{"date":"2004-01-01","label":"Caduet first approved","drug":"Caduet","drugSlug":"caduet","type":"approval","sentiment":"positive"},{"date":"2004-01-01","label":"Lyrica first approved","drug":"Lyrica","drugSlug":"lyrica","type":"approval","sentiment":"positive"},{"date":"2005-01-01","label":"Zithromax first approved","drug":"Zithromax","drugSlug":"zithromax","type":"approval","sentiment":"positive"},{"date":"2005-01-01","label":"Revatio first approved","drug":"Revatio","drugSlug":"revatio","type":"approval","sentiment":"positive"},{"date":"2006-01-01","label":"Chantix first approved","drug":"Chantix","drugSlug":"chantix","type":"approval","sentiment":"positive"},{"date":"2007-01-01","label":"Paroxetine first approved","drug":"Paroxetine","drugSlug":"paroxetine","type":"approval","sentiment":"positive"},{"date":"2008-01-01","label":"Pristiq first approved","drug":"Pristiq","drugSlug":"pristiq","type":"approval","sentiment":"positive"},{"date":"2011-01-01","label":"Abiraterone Acetate first approved","drug":"Abiraterone Acetate","drugSlug":"abiraterone","type":"approval","sentiment":"positive"},{"date":"2011-01-01","label":"Adcetris first approved","drug":"Adcetris","drugSlug":"brentuximab-vedotin","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Xeljanz first approved","drug":"Xeljanz","drugSlug":"tofacitinib","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Xeljanz first approved","drug":"Xeljanz","drugSlug":"xeljanz","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Inlyta first approved","drug":"Inlyta","drugSlug":"axitinib","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Bosulif first approved","drug":"Bosulif","drugSlug":"bosulif","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Bosulif first approved","drug":"Bosulif","drugSlug":"bosutinib","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Elelyso first approved","drug":"Elelyso","drugSlug":"elelyso","type":"approval","sentiment":"positive"},{"date":"2013-01-01","label":"Duavee first approved","drug":"Duavee","drugSlug":"duavee","type":"approval","sentiment":"positive"},{"date":"2015-01-01","label":"Ibrance first approved","drug":"Ibrance","drugSlug":"ibrance","type":"approval","sentiment":"positive"},{"date":"2017-01-01","label":"Besponsa first approved","drug":"Besponsa","drugSlug":"besponsa","type":"approval","sentiment":"positive"},{"date":"2017-01-01","label":"Besponsa first approved","drug":"Besponsa","drugSlug":"inotuzumab-ozogamicin","type":"approval","sentiment":"positive"},{"date":"2017-01-01","label":"Besponsa first approved","drug":"Besponsa","drugSlug":"inotuzumab","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Lorbrena first approved","drug":"Lorbrena","drugSlug":"lorbrena","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Braftovi first approved","drug":"Braftovi","drugSlug":"encorafenib","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Talzenna first approved","drug":"Talzenna","drugSlug":"talzenna","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Talzenna first approved","drug":"Talzenna","drugSlug":"talazoparib","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Talzenna first approved","drug":"Talzenna","drugSlug":"talazoparib-tosylate","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Daurismo first approved","drug":"Daurismo","drugSlug":"daurismo","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Daurismo first approved","drug":"Daurismo","drugSlug":"glasdegib","type":"approval","sentiment":"positive"},{"date":"2019-01-01","label":"Oxbryta first approved","drug":"Oxbryta","drugSlug":"oxbryta","type":"approval","sentiment":"positive"},{"date":"2019-01-01","label":"Bacteriostatic Water For Injection In Plastic Container first approved","drug":"Bacteriostatic Water For Injection In Plastic Container","drugSlug":"bacteriostatic-water-for-injection-in-plastic-container","type":"approval","sentiment":"positive"},{"date":"2019-01-01","label":"Sterile Water first approved","drug":"Sterile Water","drugSlug":"sterile-water-for-injection","type":"approval","sentiment":"positive"},{"date":"2020-01-01","label":"Nurtec Odt first approved","drug":"Nurtec Odt","drugSlug":"nurtec-odt","type":"approval","sentiment":"positive"},{"date":"2020-01-01","label":"Tukysa first approved","drug":"Tukysa","drugSlug":"tukysa","type":"approval","sentiment":"positive"},{"date":"2021-06-08","label":"Prevnar 20 first approved","drug":"Prevnar 20","drugSlug":"prevnar-20","type":"approval","sentiment":"positive"},{"date":"2022-01-01","label":"Cibinqo first approved","drug":"Cibinqo","drugSlug":"abrocitinib","type":"approval","sentiment":"positive"},{"date":"2022-01-01","label":"Cibinqo first approved","drug":"Cibinqo","drugSlug":"cibinqo","type":"approval","sentiment":"positive"},{"date":"2022-01-01","label":"Regadenoson first approved","drug":"Regadenoson","drugSlug":"regadenoson","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Paxlovid (Copackaged) first approved","drug":"Paxlovid (Copackaged)","drugSlug":"nirmatrelvir","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Elrexfio first approved","drug":"Elrexfio","drugSlug":"elrexfio","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Elrexfio first approved","drug":"Elrexfio","drugSlug":"elranatamab","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Elrexfio first approved","drug":"Elrexfio","drugSlug":"elranatamab-bcmm","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Etrasimod first approved","drug":"Etrasimod","drugSlug":"etrasimod","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Ngenla first approved","drug":"Ngenla","drugSlug":"ngenla","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Velsipity first approved","drug":"Velsipity","drugSlug":"velsipity","type":"approval","sentiment":"positive"},{"date":"2023-01-01","label":"Litfulo first approved","drug":"Litfulo","drugSlug":"litfulo","type":"approval","sentiment":"positive"},{"date":"2024-01-01","label":"Hympavzi first approved","drug":"Hympavzi","drugSlug":"hympavzi","type":"approval","sentiment":"positive"},{"date":"2026-06-01","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-25","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-08-13","label":"Taxol patent expiry (Method of Use)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2026-08-21","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2026-08-21","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2026-08-21","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-11-02","label":"Lyrica patent expiry (Method of Use)","drug":"Lyrica","drugSlug":"lyrica","type":"patent_expiry","sentiment":"negative"},{"date":"2026-11-02","label":"Lyrica patent expiry (Formulation)","drug":"Lyrica","drugSlug":"lyrica","type":"patent_expiry","sentiment":"negative"},{"date":"2026-11-02","label":"Lyrica patent expiry (Formulation)","drug":"Lyrica","drugSlug":"lyrica","type":"patent_expiry","sentiment":"negative"},{"date":"2026-12-12","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2026-12-12","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2026-12-31","label":"Elrexfio PHASE2 readout","drug":"Elrexfio","drugSlug":"elranatamab-bcmm","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-06","label":"Camptosar patent expiry (Compound)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-02-13","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2027-02-20","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2027-02-27","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2027-02-27","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-05-02","label":"Lyrica patent expiry (Compound)","drug":"Lyrica","drugSlug":"lyrica","type":"patent_expiry","sentiment":"negative"},{"date":"2027-05-02","label":"Lyrica patent expiry (Compound)","drug":"Lyrica","drugSlug":"lyrica","type":"patent_expiry","sentiment":"negative"},{"date":"2027-05-02","label":"Lyrica patent expiry (Compound)","drug":"Lyrica","drugSlug":"lyrica","type":"patent_expiry","sentiment":"negative"},{"date":"2027-05-23","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-03-12","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2028-03-12","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2028-07-10","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2028-07-10","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2028-07-10","label":"Estring patent expiry (Compound)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2028-08-12","label":"Duramorph Pf patent expiry (Formulation)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2028-08-12","label":"Duramorph Pf patent expiry (Formulation)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2028-08-29","label":"Camptosar patent expiry (Compound)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2028-10-30","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2028-11-25","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2028-11-25","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2028-12-31","label":"Lorbrena PHASE3 readout","drug":"Lorbrena","drugSlug":"lorbrena","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-04-10","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2029-04-10","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2029-11-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2029-11-02","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2030-07-04","label":"Estring patent expiry (Compound)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2031-02-28","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-02-28","label":"Naloxone Hydrochloride patent expiry (Method of Use)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-02-28","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-02-28","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-02-28","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-24","label":"Naloxone Hydrochloride patent expiry (Method of Use)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-05-24","label":"Naloxone Hydrochloride patent expiry (Method of Use)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2031-08-06","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2032-02-04","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2032-03-04","label":"Taxol patent expiry (Method of Use)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2032-03-04","label":"Taxol patent expiry (Method of Use)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2032-03-30","label":"Corticosteroids Phase 3 readout (Muscular Dystrophies, Limb-Girdle)","drug":"Corticosteroids","drugSlug":"corticosteroids","type":"phase3_readout","sentiment":"neutral"},{"date":"2032-05-11","label":"Naloxone Hydrochloride patent expiry (Method of Use)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2032-05-11","label":"Naloxone Hydrochloride patent expiry (Method of Use)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2032-05-11","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2032-08-29","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2032-08-29","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2032-09-04","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2032-09-04","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2032-10-03","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2032-11-21","label":"Estring patent expiry (Formulation)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2033-01-09","label":"Bupivacaine Hydrochloride patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride","drugSlug":"bupivacaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2033-04-01","label":"Prevnar 20 patent expiry (Composition of matter)","drug":"Prevnar 20","drugSlug":"prevnar-20","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-06-12","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-07-01","label":"Duramorph Pf patent expiry (Formulation)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-07-01","label":"Duramorph Pf patent expiry (Formulation)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2033-12-16","label":"Revatio patent expiry (Formulation)","drug":"Revatio","drugSlug":"revatio","type":"patent_expiry","sentiment":"negative"},{"date":"2034-01-12","label":"Taxol patent expiry (Method of Use)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2034-02-02","label":"Estring patent expiry (Method of Use)","drug":"Estring","drugSlug":"estring","type":"patent_expiry","sentiment":"negative"},{"date":"2034-03-12","label":"Duramorph Pf patent expiry (Method of Use)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2034-03-12","label":"Duramorph Pf patent expiry (Formulation)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2034-03-12","label":"Duramorph Pf patent expiry (Formulation)","drug":"Duramorph Pf","drugSlug":"morphine-sulfate","type":"patent_expiry","sentiment":"negative"},{"date":"2034-07-12","label":"Taxol patent expiry (Compound)","drug":"Taxol","drugSlug":"paclitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2034-07-18","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-26","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2035-02-26","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2035-02-26","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2035-02-26","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2035-02-27","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-13","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-13","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-13","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-13","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2035-03-20","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2035-08-01","label":"Prevnar 20 patent expiry (Method of use)","drug":"Prevnar 20","drugSlug":"prevnar-20","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Formulation)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Method of Use)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Formulation)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2035-10-19","label":"Chantix patent expiry (Formulation)","drug":"Chantix","drugSlug":"chantix","type":"patent_expiry","sentiment":"negative"},{"date":"2036-07-20","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2036-08-19","label":"Ibrance patent expiry (Formulation)","drug":"Ibrance","drugSlug":"ibrance","type":"patent_expiry","sentiment":"negative"},{"date":"2036-08-19","label":"Palbociclib patent expiry (Formulation)","drug":"Palbociclib","drugSlug":"palbociclib","type":"patent_expiry","sentiment":"negative"},{"date":"2036-08-19","label":"Camptosar patent expiry (Method of Use)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2036-10-15","label":"Camptosar patent expiry (Formulation)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2036-10-15","label":"Camptosar patent expiry (Formulation)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2036-10-15","label":"Camptosar patent expiry (Formulation)","drug":"Camptosar","drugSlug":"irinotecan-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2036-10-20","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2037-02-19","label":"Ibrance patent expiry (Compound)","drug":"Ibrance","drugSlug":"ibrance","type":"patent_expiry","sentiment":"negative"},{"date":"2037-02-19","label":"Palbociclib patent expiry (Compound)","drug":"Palbociclib","drugSlug":"palbociclib","type":"patent_expiry","sentiment":"negative"},{"date":"2037-02-28","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2037-02-28","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2037-06-07","label":"Lipitor patent expiry (Formulation)","drug":"Lipitor","drugSlug":"lipitor","type":"patent_expiry","sentiment":"negative"},{"date":"2037-06-07","label":"Lipitor patent expiry (Formulation)","drug":"Lipitor","drugSlug":"lipitor","type":"patent_expiry","sentiment":"negative"},{"date":"2037-06-07","label":"Lipitor patent expiry (Formulation)","drug":"Lipitor","drugSlug":"lipitor","type":"patent_expiry","sentiment":"negative"},{"date":"2037-10-12","label":"Oxbryta patent expiry (Formulation)","drug":"Oxbryta","drugSlug":"oxbryta","type":"patent_expiry","sentiment":"negative"},{"date":"2037-12-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2037-12-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2037-12-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-01-30","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2038-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2038-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2038-03-23","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2038-03-23","label":"Levoxyl patent expiry (Formulation)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2039-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-02-06","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-03-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-03-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-03-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-03-21","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2039-04-26","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2039-05-24","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2039-09-17","label":"Levoxyl patent expiry (Method of Use)","drug":"Levoxyl","drugSlug":"levoxyl","type":"patent_expiry","sentiment":"negative"},{"date":"2041-02-05","label":"Naloxone Hydrochloride patent expiry (Method of Use)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2041-03-08","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2041-03-08","label":"Levophed patent expiry (Formulation)","drug":"Levophed","drugSlug":"levophed","type":"patent_expiry","sentiment":"negative"},{"date":"2041-06-14","label":"Naloxone Hydrochloride patent expiry (Formulation)","drug":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2045-01-17","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Ibrance patent cliff ($2.5B at risk)","drug":"Ibrance","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Xeljanz patent cliff ($2.5B at risk)","drug":"Xeljanz","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"Prevnar 20 patent cliff ($1.5B at risk)","drug":"Prevnar 20","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":30659000000,"percentOfTotal":34.1,"drugCount":64,"colorKey":"cardiovascular","drugs":[{"name":"Ibrance","genericName":"Palbociclib","slug":"ibrance","indication":"Hormone receptor positive malignant neoplasm of breast","status":"marketed","revenue":4500000000},{"name":"Palbociclib in combination with AI","genericName":"palbociclib-in-combination-with-ai","slug":"palbociclib-in-combination-with-ai","indication":"Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HER2-negative) advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women with estrogen receptor-positive (ER+), HER2-negative breast cancer","status":"marketed","revenue":4122000000},{"name":"PF-06863135 + lenalidomide","genericName":"pf-06863135-lenalidomide","slug":"pf-06863135-lenalidomide","indication":"Relapsed or refractory multiple myeloma in combination with dexamethasone","status":"marketed","revenue":2951000000},{"name":"Venetoclax; Rituximab","genericName":"venetoclax-rituximab","slug":"venetoclax-rituximab","indication":"Treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies.","status":"marketed","revenue":2583000000},{"name":"Talazoparib with enzalutamide","genericName":"talazoparib-with-enzalutamide","slug":"talazoparib-with-enzalutamide","indication":"Metastatic castration-resistant prostate cancer (mCRPC) with BRCA1, BRCA2, or ATM gene mutations","status":"marketed","revenue":2194000000},{"name":"Abiraterone Acetate","genericName":"abiraterone","slug":"abiraterone","indication":"Metastatic castration-resistant prostate cancer (mCRPC)","status":"marketed","revenue":1500000000},{"name":"Immuno-oncology (IO)","genericName":"immuno-oncology-io","slug":"immuno-oncology-io","indication":"Melanoma","status":"marketed","revenue":1301000000},{"name":"Lorbrena","genericName":"Lorlatinib","slug":"lorbrena","indication":"ALK fusion gene-positive non-small-cell lung cancer","status":"marketed","revenue":1100000000},{"name":"Inlyta","genericName":"axitinib","slug":"axitinib","indication":"Renal cell carcinoma","status":"marketed","revenue":923000000},{"name":"Adcetris","genericName":"brentuximab-vedotin","slug":"brentuximab-vedotin","indication":"Anaplastic large T-cell systemic malignant lymphoma","status":"marketed","revenue":900000000},{"name":"Lorlatinib with chemotherapy 2","genericName":"lorlatinib-with-chemotherapy-2","slug":"lorlatinib-with-chemotherapy-2","indication":"Anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) with brain metastases","status":"marketed","revenue":798000000},{"name":"PF-07104091 monotherapy dose expansion (ovarian)","genericName":"pf-07104091-monotherapy-dose-expansion-ovarian","slug":"pf-07104091-monotherapy-dose-expansion-ovarian","indication":"Advanced ovarian cancer","status":"marketed","revenue":798000000},{"name":"Ribociclib (Dose #2)","genericName":"ribociclib-dose-2","slug":"ribociclib-dose-2","indication":"Hormone receptor positive malignant neoplasm of breast","status":"marketed","revenue":787000000},{"name":"Braftovi","genericName":"encorafenib","slug":"encorafenib","indication":"BRAF mutation-positive colorectal cancer","status":"marketed","revenue":716000000},{"name":"Bosulif","genericName":"Bosutinib Monohydrate","slug":"bosulif","indication":"Blastic phase chronic myeloid leukemia","status":"marketed","revenue":611000000},{"name":"Tukysa","genericName":"tukysa","slug":"tukysa","indication":"Metastatic human epidermal growth factor 2 positive carcinoma of breast","status":"marketed","revenue":463000000},{"name":"Aromasin","genericName":"exemestane","slug":"exemestane","indication":"Advanced Breast Cancer Progression Post-Antiestrogen Therapy","status":"marketed","revenue":450000000},{"name":"Radium-223","genericName":"radium-223","slug":"radium-223","indication":"Castration-Resistant Prostate Cancer, Bone Metastases","status":"marketed","revenue":400000000},{"name":"Taxol","genericName":"nab-paclitaxel","slug":"nab-paclitaxel","indication":"Carcinoma of breast","status":"marketed","revenue":368000000},{"name":"Taxol","genericName":"paclitaxel","slug":"paclitaxel","indication":"Carcinoma of breast","status":"marketed","revenue":368000000},{"name":"Taxol","genericName":"Nabpaclitaxel","slug":"nabpaclitaxel","indication":"Carcinoma of breast","status":"discontinued","revenue":368000000},{"name":"Elrexfio","genericName":"Elranatamab","slug":"elrexfio","indication":"Relapsed or refractory multiple myeloma","status":"marketed","revenue":304000000},{"name":"Elrexfio","genericName":"elranatamab","slug":"elranatamab","indication":"Relapsed or refractory multiple myeloma","status":"marketed","revenue":304000000},{"name":"Elrexfio","genericName":"elranatamab-bcmm","slug":"elranatamab-bcmm","indication":"Relapsed or refractory multiple myeloma","status":"marketed","revenue":304000000},{"name":"Besponsa","genericName":"Inotuzumab Ozogamicin","slug":"besponsa","indication":"Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients","status":"marketed","revenue":200000000},{"name":"Besponsa","genericName":"inotuzumab-ozogamicin","slug":"inotuzumab-ozogamicin","indication":"Pre B-cell acute lymphoblastic leukemia","status":"marketed","revenue":200000000},{"name":"Besponsa","genericName":"inotuzumab","slug":"inotuzumab","indication":"Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients","status":"marketed","revenue":200000000},{"name":"Talzenna","genericName":"Talazoparib Tosylate","slug":"talzenna","indication":"Breast Cancer","status":"marketed","revenue":182000000},{"name":"Talzenna","genericName":"talazoparib","slug":"talazoparib","indication":"Germline BRCA-mutated, HER2-negative metastatic breast cancer","status":"marketed","revenue":182000000},{"name":"Talzenna","genericName":"talazoparib-tosylate","slug":"talazoparib-tosylate","indication":"Germline BRCA-mutated, HER2-negative metastatic breast cancer","status":"marketed","revenue":182000000},{"name":"Daurismo","genericName":"Glasdegib Maleate","slug":"daurismo","indication":"Acute myeloid leukemia, disease","status":"marketed","revenue":150000000},{"name":"Daurismo","genericName":"glasdegib","slug":"glasdegib","indication":"Acute myeloid leukemia, disease","status":"marketed","revenue":150000000},{"name":"Mylotarg","genericName":"Gemtuzumab Ozogamicin","slug":"mylotarg","indication":"Acute myeloid leukemia, disease","status":"marketed","revenue":100000000},{"name":"Bacteriostatic Water For Injection In Plastic Container","genericName":"Sterile Water For Injection","slug":"bacteriostatic-water-for-injection-in-plastic-container","indication":"Parenteral drug products that have not been mixed with other medicinal ingredients","status":"marketed"},{"name":"Idamycin Pfs","genericName":"Idarubicin Hydrochloride","slug":"idarubicin-hydrochloride","indication":"Acute myeloid leukemia, disease","status":"marketed"},{"name":"Sutent","genericName":"Sunitinib Malate","slug":"sutent","indication":"Gastrointestinal stromal tumor","status":"marketed"},{"name":"Inlyta","genericName":"Axitinib","slug":"inlyta","indication":"Renal cell carcinoma","status":"marketed"},{"name":"Menest","genericName":"Estrogens, Esterified","slug":"menest","indication":"Treatment of moderate to severe vasomotor symptoms associated with the menopause","status":"marketed"},{"name":"Synarel","genericName":"Nafarelin Acetate","slug":"synarel","indication":"Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes","status":"marketed"},{"name":"Allr3","genericName":"allr3","slug":"allr3","indication":"Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least two prior therapies","status":"marketed"},{"name":"Arthrotec","genericName":"Diclofenac Sodium","slug":"arthrotec","indication":"Actinic keratosis","status":"marketed"},{"name":"Levoxyl","genericName":"Levothyroxine Sodium","slug":"levoxyl","indication":"Primary hypothyroidism - replacement therapy","status":"marketed"},{"name":"MET097 Injection","genericName":"met097-injection","slug":"met097-injection","indication":"Treatment of certain types of cancer, such as non-small cell lung cancer, melanoma, and renal cell carcinoma","status":"marketed"},{"name":"Neurontin","genericName":"Gabapentin","slug":"neurontin","indication":"Postherpetic neuralgia","status":"marketed"},{"name":"Palbociclib","genericName":"palbociclib","slug":"palbociclib","indication":"Treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy","status":"marketed"},{"name":"Vitamin K antagonist (VKA)","genericName":"vitamin-k-antagonist-vka","slug":"vitamin-k-antagonist-vka","indication":"Prophylaxis and treatment of venous thrombosis and thromboembolism","status":"preclinical"},{"name":"(Part C) MET097","genericName":"part-c-met097","slug":"part-c-met097","indication":"Treatment of Acute Myeloid Leukemia (AML)","status":"marketed"},{"name":"Camptosar","genericName":"Irinotecan Hydrochloride","slug":"irinotecan-hydrochloride","indication":"Adenocarcinoma of pancreas","status":"marketed"},{"name":"Disitamab vedotin","genericName":"disitamab-vedotin","slug":"disitamab-vedotin","indication":"Locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma","status":"marketed"},{"name":"Doxorubicin Hydrochloride","genericName":"Doxorubicin Hydrochloride","slug":"doxorubicin-hydrochloride","indication":"Adjuvant chemotherapy for women with axillary lymph node involvement following resection of primary breast cancer","status":"marketed"},{"name":"Estring","genericName":"Estradiol","slug":"estring","indication":"Acne vulgaris","status":"marketed"},{"name":"Fragmin","genericName":"Dalteparin Sodium","slug":"fragmin","indication":"Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave MI","status":"marketed"},{"name":"Idamycin Pfs","genericName":"Idarubicin Hydrochloride","slug":"idamycin-pfs","indication":"Acute myeloid leukemia, disease","status":"marketed"},{"name":"Met097","genericName":"met097","slug":"met097","indication":"Treatment of adult patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation","status":"marketed"},{"name":"Nipent","genericName":"Pentostatin","slug":"nipent","indication":"Untreated hairy cell leukemia with active disease","status":"marketed"},{"name":"Oncovin","genericName":"vincristine","slug":"vincristine","indication":"Acute lymphoid leukemia","status":"marketed"},{"name":"Oncovin","genericName":"Vincristine Sulfate","slug":"vincristine-sulfate-pfs","indication":"Acute leukemia","status":"marketed"},{"name":"PF-06882961 (Cohort 3)","genericName":"pf-06882961-cohort-3","slug":"pf-06882961-cohort-3","indication":"Non-small cell lung cancer","status":"marketed"},{"name":"PF-06882961 (Cohorts 1 and 2)","genericName":"pf-06882961-cohorts-1-and-2","slug":"pf-06882961-cohorts-1-and-2","indication":"Treatment of follicular lymphoma","status":"marketed"},{"name":"Pf-04171327","genericName":"pf-04171327","slug":"pf-04171327","indication":"Multiple Myeloma","status":"marketed"},{"name":"Pf-06823859","genericName":"pf-06823859","slug":"pf-06823859","indication":"Non-Small Cell Lung Cancer (NSCLC) with high PD-L1 expression (Tumor Proportion Score (TPS) ≥ 50%) as monotherapy (pembrolizumab in combination with pemetrexed and platinum (pemetrexed + platinum) in patients with a PD-L1 TPS ≥ 1% as determined by an FDA-approved test.","status":"marketed"},{"name":"Pf-06865571","genericName":"pf-06865571","slug":"pf-06865571","indication":"Non-Small Cell Lung Cancer (NSCLC) with high PD-L1 expression (≥ 50%) as a monotherapy in adults","status":"marketed"},{"name":"Pf-06882961","genericName":"pf-06882961","slug":"pf-06882961","indication":"Non-small cell lung cancer","status":"marketed"},{"name":"Pf-07264660","genericName":"pf-07264660","slug":"pf-07264660","indication":"Multiple Myeloma","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":22469000000,"percentOfTotal":25,"drugCount":29,"colorKey":"oncology","drugs":[{"name":"Prevnar family","genericName":"prevnar-family","slug":"prevnar-family","indication":"Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F in children 2 through 5 years of age","status":"marketed","revenue":6494000000},{"name":"Prevnar 20","genericName":"pneumococcal 20-valent conjugate vaccine (PCV20)","slug":"prevnar-20","indication":"Prevention of invasive pneumococcal disease in adults (18+)","status":"marketed","revenue":6400000000},{"name":"COMIRNATY intramuscular injection","genericName":"comirnaty-intramuscular-injection","slug":"comirnaty-intramuscular-injection","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed","revenue":4367000000},{"name":"Xeljanz","genericName":"tofacitinib","slug":"tofacitinib","indication":"Juvenile idiopathic arthritis, extended oligoarthritis","status":"marketed","revenue":1800000000},{"name":"Xeljanz","genericName":"Tofacitinib Citrate","slug":"xeljanz","indication":"Juvenile idiopathic arthritis, extended oligoarthritis","status":"marketed","revenue":1087000000},{"name":"In open-label phase: treatment with tofacitinib","genericName":"in-open-label-phase-treatment-with-tofacitinib","slug":"in-open-label-phase-treatment-with-tofacitinib","indication":"Rheumatoid Arthritis","status":"marketed","revenue":1087000000},{"name":"Infliximab [infliximab biosimilar 3]","genericName":"infliximab-infliximab-biosimilar-3","slug":"infliximab-infliximab-biosimilar-3","indication":"Moderate to severe Crohn's disease","status":"marketed","revenue":646000000},{"name":"Canakinumab Injection","genericName":"canakinumab-injection","slug":"canakinumab-injection","indication":"Prophylaxis of gouty arthritis attacks in adults","status":"marketed","revenue":372000000},{"name":"tocilizumab or sarilumab","genericName":"tocilizumab-or-sarilumab","slug":"tocilizumab-or-sarilumab","indication":"Rheumatoid Arthritis","status":"marketed","revenue":116000000},{"name":"Mylotarg","genericName":"gemtuzumab-ozogamicin","slug":"gemtuzumab-ozogamicin","indication":"Newly-diagnosed CD33-positive AML","status":"marketed","revenue":100000000},{"name":"Xeljanz","genericName":"Tofacitinib Citrate","slug":"xeljanz-xr","indication":"Juvenile idiopathic arthritis, extended oligoarthritis","status":"marketed"},{"name":"Azulfidine En-Tabs","genericName":"Sulfasalazine","slug":"azulfidine-en-tabs","indication":"Juvenile rheumatoid arthritis","status":"marketed"},{"name":"Cytotec","genericName":"Misoprostol","slug":"cytotec","indication":"Osteoarthritis in Patients at High Ulcer Risk","status":"marketed"},{"name":"Pfizer-BioNTech COVID-19 mRNA vaccine","genericName":"Pfizer-BioNTech COVID-19 mRNA vaccine","slug":"pfizer-biontech-covid-19-mrna-vaccine","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed"},{"name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","genericName":"bnt162b6-bivalent-original-omi-ba-4-ba-5","slug":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication":"COVID-19 prevention in individuals 12 years of age and older","status":"marketed"},{"name":"Benzamycin","genericName":"Erythromycin Lactobionate","slug":"erythrocin","indication":"Acne vulgaris","status":"marketed"},{"name":"Etrasimod","genericName":"etrasimod","slug":"etrasimod","indication":"Moderate to severe ulcerative colitis","status":"marketed"},{"name":"Induction- PF-06480605 150 mg SC Q4W","genericName":"induction-pf-06480605-150-mg-sc-q4w","slug":"induction-pf-06480605-150-mg-sc-q4w","indication":"Moderate to Severe Atopic Dermatitis","status":"marketed"},{"name":"Velsipity","genericName":"Etrasimod Arginine","slug":"velsipity","indication":"Moderate to severe ulcerative colitis","status":"marketed"},{"name":"Advanced therapy only without dietary intervention","genericName":"advanced-therapy-only-without-dietary-intervention","slug":"advanced-therapy-only-without-dietary-intervention","indication":"Autologous Cultured Chondrocytes for Cartilage Repair","status":"marketed"},{"name":"Azulfidine","genericName":"Sulfasalazine","slug":"azulfidine","indication":"Treatment of mild to moderate ulcerative colitis","status":"marketed"},{"name":"BNT162b2 (Omi XBB.1.5)","genericName":"bnt162b2-omi-xbb-1-5","slug":"bnt162b2-omi-xbb-1-5","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed"},{"name":"Chronic- PF-06480605 150 mg SC Q4W","genericName":"chronic-pf-06480605-150-mg-sc-q4w","slug":"chronic-pf-06480605-150-mg-sc-q4w","indication":"Moderate to severe atopic dermatitis","status":"marketed"},{"name":"Chronic- PF-06480605 450 mg SC Q4W","genericName":"chronic-pf-06480605-450-mg-sc-q4w","slug":"chronic-pf-06480605-450-mg-sc-q4w","indication":"Moderate to severe atopic dermatitis","status":"marketed"},{"name":"Chronic- PF-06480605 50 mg SC Q4W","genericName":"chronic-pf-06480605-50-mg-sc-q4w","slug":"chronic-pf-06480605-50-mg-sc-q4w","indication":"Moderate to severe atopic dermatitis","status":"marketed"},{"name":"Hospital-Based Vaccination Pathway","genericName":"hospital-based-vaccination-pathway","slug":"hospital-based-vaccination-pathway","indication":"Pneumococcal disease","status":"marketed"},{"name":"Induction- PF-06480605 450 mg SC Q4W","genericName":"induction-pf-06480605-450-mg-sc-q4w","slug":"induction-pf-06480605-450-mg-sc-q4w","indication":"Moderate to severe plaque psoriasis","status":"marketed"},{"name":"Intra-articular corticosteroid injections","genericName":"intra-articular-corticosteroid-injections","slug":"intra-articular-corticosteroid-injections","indication":"Osteoarthritis of the knee","status":"marketed"},{"name":"PF-07038124","genericName":"pf-07038124","slug":"pf-07038124","indication":"Atopic Dermatitis","status":"discontinued"}]},{"name":"Other","slug":"other","revenue":15455000000,"percentOfTotal":17.2,"drugCount":72,"colorKey":"neuroscience","drugs":[{"name":"Nivolumab and Ipilimumab","genericName":"nivolumab-and-ipilimumab","slug":"nivolumab-and-ipilimumab","indication":"Other","status":"marketed","revenue":2900000000},{"name":"Nivolumab and/or Ipilimumab","genericName":"nivolumab-and-or-ipilimumab","slug":"nivolumab-and-or-ipilimumab","indication":"Other","status":"marketed","revenue":2900000000},{"name":"talazoparib plus enzalutamide","genericName":"talazoparib-plus-enzalutamide","slug":"talazoparib-plus-enzalutamide","indication":"Other","status":"phase_3","revenue":2194000000},{"name":"Abrysvo","genericName":"abrysvo","slug":"abrysvo","indication":"Prevention of rabies in individuals who have been bitten or otherwise exposed to rabies or have been at risk of rabies exposure and have been vaccinated with a cell culture vaccine or an inactivated rabies vaccine.","status":"marketed","revenue":1033000000},{"name":"Premarin","genericName":"Conjugated estrogens","slug":"conjugated-estrogens","indication":"Dyspareunia","status":"marketed","revenue":1000000000},{"name":"Axitinib plus Toripalimab","genericName":"axitinib-plus-toripalimab","slug":"axitinib-plus-toripalimab","indication":"Other","status":"phase_3","revenue":923000000},{"name":"Chemotherapy","genericName":"chemotherapy","slug":"chemotherapy","indication":"Other","status":"marketed","revenue":798000000},{"name":"Docetaxel monotherapy","genericName":"docetaxel-monotherapy","slug":"docetaxel-monotherapy","indication":"Other","status":"phase_3","revenue":798000000},{"name":"Bosulif","genericName":"bosutinib","slug":"bosutinib","indication":"Chronic Phase Ph+ CML","status":"marketed","revenue":611000000},{"name":"Bosutinib capsule","genericName":"bosutinib-capsule","slug":"bosutinib-capsule","indication":"Other","status":"marketed","revenue":611000000},{"name":"Omnitrope","genericName":"Somatropin","slug":"genotropin-preservative-free","indication":"Growth retardation","status":"marketed","revenue":446000000},{"name":"somatropin - GH naïve pediatric cohort","genericName":"somatropin-gh-na-ve-pediatric-cohort","slug":"somatropin-gh-na-ve-pediatric-cohort","indication":"Other","status":"marketed","revenue":446000000},{"name":"somatropin - GH treated cohort","genericName":"somatropin-gh-treated-cohort","slug":"somatropin-gh-treated-cohort","indication":"Other","status":"marketed","revenue":446000000},{"name":"Isavuconazole","genericName":"isavuconazole","slug":"isavuconazole","indication":"Other","status":"marketed","revenue":349000000},{"name":"Premarin","genericName":"Estrogens, Conjugated","slug":"premarin","indication":"Dyspareunia","status":"marketed"},{"name":"Norpace Cr","genericName":"Disopyramide Phosphate","slug":"norpace","indication":"Documented ventricular arrhythmias","status":"marketed"},{"name":"Magnesium Sulfate","genericName":"Magnesium Sulfate","slug":"magnesium-sulfate-in-plastic-container","indication":"Constipation","status":"marketed"},{"name":"Pantoprazole Sodium","genericName":"Pantoprazole Sodium","slug":"protonix-iv","indication":"Erosive esophagitis","status":"marketed"},{"name":"Cytomel","genericName":"Liothyronine Sodium","slug":"cytomel","indication":"Hypothyroidism","status":"marketed"},{"name":"Premarin","genericName":"Estrogens, Conjugated","slug":"prempro","indication":"Dyspareunia","status":"marketed"},{"name":"Sterile Water","genericName":"Sterile Water For Injection","slug":"sterile-water-for-injection","indication":"Dilution or Dissolution for Injection","status":"marketed"},{"name":"Chantix","genericName":"Varenicline Tartrate","slug":"chantix","indication":"Treatment of adult smokers to help them stop smoking","status":"marketed"},{"name":"Coaxil","genericName":"tianeptine","slug":"tianeptine","indication":"Other","status":"marketed"},{"name":"Corticosteroids","genericName":"corticosteroids","slug":"corticosteroids","indication":"Other","status":"discontinued"},{"name":"Duavee","genericName":"Bazedoxifene Acetate","slug":"duavee","indication":"Treatment of moderate to severe vasomotor symptoms associated with menopause","status":"marketed"},{"name":"MTZ","genericName":"mtz","slug":"mtz","indication":"Other","status":"marketed"},{"name":"Mannitol 15%","genericName":"Mannitol","slug":"mannitol-15","indication":"Reduction of intracranial pressure","status":"marketed"},{"name":"Ngenla","genericName":"Somatrogon-Ghla","slug":"ngenla","indication":"Growth hormone deficiency","status":"marketed"},{"name":"Norpace Cr","genericName":"Disopyramide Phosphate","slug":"norpace-cr","indication":"Ventricular arrhythmia","status":"marketed"},{"name":"PF-07868489","genericName":"pf-07868489","slug":"pf-07868489","indication":"Other","status":"phase_1"},{"name":"PF-08653944","genericName":"pf-08653944","slug":"pf-08653944","indication":"Indication not found","status":"marketed"},{"name":"Pf-07054894","genericName":"pf-07054894","slug":"pf-07054894","indication":"Indication not found","status":"marketed"},{"name":"Plasma-Lyte A In Plastic Container","genericName":"Sodium Acetate","slug":"sodium-acetate","indication":"Other","status":"marketed"},{"name":"Plegisol In Plastic Container","genericName":"Sodium Chloride","slug":"bacteriostatic-sodium-chloride-0-9-in-plastic-container","indication":"Other","status":"marketed"},{"name":"Potassium Acetate","genericName":"Potassium Acetate","slug":"potassium-acetate","indication":"Hypokalemia","status":"marketed"},{"name":"Potassium Phosphates","genericName":"Potassium Phosphate, Dibasic","slug":"potassium-phosphates","indication":"Treatment of potassium deficiency (hypokalemia) in patients with normal renal function.","status":"marketed"},{"name":"Premarin","genericName":"Estrogens, Conjugated","slug":"premphase-14-14","indication":"Dyspareunia","status":"marketed"},{"name":"Qiv","genericName":"qiv","slug":"qiv","indication":"Influenza prevention","status":"marketed"},{"name":"Regadenoson","genericName":"Regadenoson","slug":"regadenoson","indication":"Myocardial Perfusion Imaging Adjunct","status":"marketed"},{"name":"Riltozinameran 12 Years of age and older","genericName":"riltozinameran-12-years-of-age-and-older","slug":"riltozinameran-12-years-of-age-and-older","indication":"Amyotrophic lateral sclerosis (ALS)","status":"marketed"},{"name":"bIRV","genericName":"birv","slug":"birv","indication":"Other","status":"phase_2"},{"name":"Acid Reflux Relief","genericName":"Sodium Phosphate, Dibasic, Heptahydrate","slug":"sodium-phosphates-in-plastic-container","indication":"To preserve purity avoid touching pellets with fingers","status":"marketed"},{"name":"Antiplatelet Drug","genericName":"antiplatelet-drug","slug":"antiplatelet-drug","indication":"Ischemic Stroke","status":"discontinued"},{"name":"Assorted Licensed Hand Sanitizer Grape 01","genericName":"Licensed influenza vaccine","slug":"licensed-influenza-vaccine","indication":"Influenza prevention","status":"marketed"},{"name":"Atracurium","genericName":"Atracurium Besylate","slug":"atracurium-besylate","indication":"General anesthesia","status":"marketed"},{"name":"BNT162b2 Bivalent (WT/OMI BA.4/BA.5)","genericName":"bnt162b2-bivalent-wt-omi-ba-4-ba-5","slug":"bnt162b2-bivalent-wt-omi-ba-4-ba-5","indication":"Other","status":"phase_2"},{"name":"Best Available Treatment","genericName":"best-available-treatment","slug":"best-available-treatment","indication":"Acute Ischemic Stroke","status":"marketed"},{"name":"Bretovameran","genericName":"bretovameran","slug":"bretovameran","indication":"Bretovameran is not approved by the FDA. It is a research compound.","status":"marketed"},{"name":"Duavive 0.45Mg-20Mg Tablet","genericName":"duavive-0-45mg-20mg-tablet","slug":"duavive-0-45mg-20mg-tablet","indication":"Treatment of moderate to severe vasomotor symptoms associated with menopause","status":"marketed"},{"name":"Induction- PF-06480605 50 mg SC Q4W","genericName":"induction-pf-06480605-50-mg-sc-q4w","slug":"induction-pf-06480605-50-mg-sc-q4w","indication":"Other","status":"phase_2"},{"name":"Litfulo","genericName":"Ritlecitinib Tosylate","slug":"litfulo","indication":"Alopecia areata","status":"marketed"},{"name":"MET233","genericName":"met233","slug":"met233","indication":"Other","status":"phase_1"},{"name":"MET233 and MET097","genericName":"met233-and-met097","slug":"met233-and-met097","indication":"Indication 1","status":"marketed"},{"name":"PF-06700841 15 mg","genericName":"pf-06700841-15-mg","slug":"pf-06700841-15-mg","indication":"Other","status":"phase_2"},{"name":"PF-06700841 30 mg","genericName":"pf-06700841-30-mg","slug":"pf-06700841-30-mg","indication":"Other","status":"phase_2"},{"name":"PF-06801591","genericName":"pf-06801591","slug":"pf-06801591","indication":"Other","status":"phase_1"},{"name":"PF-07038124 ointment 0.01%","genericName":"pf-07038124-ointment-0-01","slug":"pf-07038124-ointment-0-01","indication":"Other","status":"phase_2"},{"name":"PF-07038124 ointment 0.03%","genericName":"pf-07038124-ointment-0-03","slug":"pf-07038124-ointment-0-03","indication":"Other","status":"phase_2"},{"name":"PF-07038124 ointment 0.06%","genericName":"pf-07038124-ointment-0-06","slug":"pf-07038124-ointment-0-06","indication":"Other","status":"phase_2"},{"name":"PF-07328948","genericName":"pf-07328948","slug":"pf-07328948","indication":"Other","status":"phase_1"},{"name":"PF-07836391 Influenza saRNA","genericName":"pf-07836391-influenza-sarna","slug":"pf-07836391-influenza-sarna","indication":"Other","status":"phase_1"},{"name":"PF-07836394 Influenza saRNA","genericName":"pf-07836394-influenza-sarna","slug":"pf-07836394-influenza-sarna","indication":"Influenza","status":"marketed"},{"name":"PF-07836395 Influenza saRNA","genericName":"pf-07836395-influenza-sarna","slug":"pf-07836395-influenza-sarna","indication":"Influenza","status":"marketed"},{"name":"PF-07836396 Influenza saRNA","genericName":"pf-07836396-influenza-sarna","slug":"pf-07836396-influenza-sarna","indication":"Influenza","status":"marketed"},{"name":"PF-07852352 Influenza saRNA 1","genericName":"pf-07852352-influenza-sarna-1","slug":"pf-07852352-influenza-sarna-1","indication":"Influenza","status":"marketed"},{"name":"PF-07867246 Influenza saRNA","genericName":"pf-07867246-influenza-sarna","slug":"pf-07867246-influenza-sarna","indication":"Other","status":"phase_1"},{"name":"PF-07871987 Influenza saRNA","genericName":"pf-07871987-influenza-sarna","slug":"pf-07871987-influenza-sarna","indication":"Influenza","status":"marketed"},{"name":"PF-07914705 Influenza saRNA","genericName":"pf-07914705-influenza-sarna","slug":"pf-07914705-influenza-sarna","indication":"Influenza","status":"marketed"},{"name":"PF-07915048 Influenza saRNA","genericName":"pf-07915048-influenza-sarna","slug":"pf-07915048-influenza-sarna","indication":"Influenza","status":"marketed"},{"name":"PF-08046876","genericName":"pf-08046876","slug":"pf-08046876","indication":"Other","status":"marketed"},{"name":"PF-08049820 MR1","genericName":"pf-08049820-mr1","slug":"pf-08049820-mr1","indication":"Other","status":"phase_1"},{"name":"Pf-07817883","genericName":"pf-07817883","slug":"pf-07817883","indication":"Indication not found","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":14011000000,"percentOfTotal":15.6,"drugCount":53,"colorKey":"immunology","drugs":[{"name":"Comirnaty","genericName":"BNT162b2 (tozinameran)","slug":"comirnaty","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed","revenue":5400000000},{"name":"Famtozinameran 12 Years of age and older","genericName":"famtozinameran-12-years-of-age-and-older","slug":"famtozinameran-12-years-of-age-and-older","indication":"COVID-19 prevention","status":"marketed","revenue":4367000000},{"name":"Paxlovid (Copackaged)","genericName":"nirmatrelvir","slug":"nirmatrelvir","indication":"Treatment of mild-to-moderate COVID-19","status":"marketed","revenue":2362000000},{"name":"Zavicefta, Ceftazidime-Avibactam","genericName":"zavicefta-ceftazidime-avibactam","slug":"zavicefta-ceftazidime-avibactam","indication":"Complicated urinary tract infections (cUTI), including pyelonephritis, caused by certain susceptible bacteria.","status":"marketed","revenue":638000000},{"name":"somatropin - adult cohort","genericName":"somatropin-adult-cohort","slug":"somatropin-adult-cohort","indication":"Treatment of growth hormone deficiency in adults.","status":"marketed","revenue":446000000},{"name":"Zithromax","genericName":"Azithromycin","slug":"zithromax","indication":"Community-Acquired Pneumonia","status":"marketed","revenue":399000000},{"name":"Zithromax","genericName":"azithromycin","slug":"azithromycin","indication":"Acute bacterial bronchitis","status":"marketed","revenue":399000000},{"name":"Bicillin C-R","genericName":"Penicillin G Benzathine","slug":"bicillin-c-r","indication":"Moderately severe to severe infections of the upper-respiratory tract","status":"marketed"},{"name":"Lignospan Forte","genericName":"Lidocaine Hydrochloride","slug":"lidocaine-hydrochloride-in-plastic-container","indication":"Hemorrhoids","status":"marketed"},{"name":"Pipracil","genericName":"Piperacillin Sodium","slug":"zosyn-in-plastic-container","indication":"Abdominal abscess","status":"marketed"},{"name":"Paxlovid (Copackaged)","genericName":"Nirmatrelvir","slug":"paxlovid-copackaged","indication":"COVID-19","status":"marketed"},{"name":"Atm-Avi","genericName":"atm-avi","slug":"atm-avi","indication":"Treatment of acute bacterial exacerbation of chronic bronchitis (ABECB) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis.","status":"marketed"},{"name":"Active","genericName":"active","slug":"active","indication":"Respiratory Syncytial Virus Infections","status":"discontinued"},{"name":"BNT162b2 (Omi XBB.1.5)/RIV","genericName":"bnt162b2-omi-xbb-1-5-riv","slug":"bnt162b2-omi-xbb-1-5-riv","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed"},{"name":"BNT162b2 Bivalent (WT/OMI BA.1)","genericName":"bnt162b2-bivalent-wt-omi-ba-1","slug":"bnt162b2-bivalent-wt-omi-ba-1","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"BNT162b5 Bivalent (WT/OMI BA.2)","genericName":"bnt162b5-bivalent-wt-omi-ba-2","slug":"bnt162b5-bivalent-wt-omi-ba-2","indication":"COVID-19 prevention in individuals 12 years of age and older","status":"marketed"},{"name":"BNT162b7 Bivalent (Original/OMI BA.4/BA.5)","genericName":"bnt162b7-bivalent-original-omi-ba-4-ba-5","slug":"bnt162b7-bivalent-original-omi-ba-4-ba-5","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"Cipro","genericName":"Ciprofloxacin","slug":"ciprofloxacin-in-dextrose-5-in-plastic-container","indication":"Abdominal abscess","status":"marketed"},{"name":"Hib","genericName":"hib","slug":"hib","indication":"Prevention of Haemophilus influenzae type b (Hib) disease caused by Haemophilus influenzae type b (Hib) in children 6 weeks through 18 months of age","status":"marketed"},{"name":"Medium Dose PF-07328948","genericName":"medium-dose-pf-07328948","slug":"medium-dose-pf-07328948","indication":"COVID-19","status":"marketed"},{"name":"Merrem","genericName":"Meropenem","slug":"meropenem","indication":"Abdominal abscess","status":"marketed"},{"name":"Part A: ATM-AVI Single Dose, Cohorts 1-4","genericName":"part-a-atm-avi-single-dose-cohorts-1-4","slug":"part-a-atm-avi-single-dose-cohorts-1-4","indication":"Treatment of COVID-19 in adults and pediatric patients (12 years of age and older) who are at high risk of progression to severe COVID-19, including those who are hospitalized due to COVID-19 or who have mild to moderate COVID-19 with at least one risk factor for progression to severe COVID-19 (e.g., older age, certain chronic medical conditions)","status":"marketed"},{"name":"Raxtozinameran 6 months to 4 years of age","genericName":"raxtozinameran-6-months-to-4-years-of-age","slug":"raxtozinameran-6-months-to-4-years-of-age","indication":"COVID-19 prevention","status":"marketed"},{"name":"Silvadene","genericName":"Silver Sulfadiazine","slug":"silvadene","indication":"Burn Wound Infections","status":"marketed"},{"name":"Tozinameran 12 Years of age and older","genericName":"tozinameran-12-years-of-age-and-older","slug":"tozinameran-12-years-of-age-and-older","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"Tozinameran 6 months to 4 years of age","genericName":"tozinameran-6-months-to-4-years-of-age","slug":"tozinameran-6-months-to-4-years-of-age","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed"},{"name":"Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose","genericName":"variant-adapted-bnt162b2-omicron-xbb-1-5-10-microgram-dose","slug":"variant-adapted-bnt162b2-omicron-xbb-1-5-10-microgram-dose","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"Zyvox","genericName":"linezolid","slug":"linezolid","indication":"Complicated Skin and Skin Structure Staphylococcus Aureus Infection","status":"marketed"},{"name":"qIRV (22/23)","genericName":"qirv-22-23","slug":"qirv-22-23","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b2","genericName":"bnt162b2","slug":"bnt162b2","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b2 (2025/2026 formulation)","genericName":"bnt162b2-2025-2026-formulation","slug":"bnt162b2-2025-2026-formulation","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b2 (Omi JN.1)","genericName":"bnt162b2-omi-jn-1","slug":"bnt162b2-omi-jn-1","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b2 (Omi KP.2)","genericName":"bnt162b2-omi-kp-2","slug":"bnt162b2-omi-kp-2","indication":"Prevention of COVID-19 in individuals 5 years of age and older","status":"marketed"},{"name":"BNT162b2 BA.4/5 bivalent","genericName":"bnt162b2-ba-4-5-bivalent","slug":"bnt162b2-ba-4-5-bivalent","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg","genericName":"bnt162b2-bivalent-original-omicron-ba-4-ba-5-30-mcg","slug":"bnt162b2-bivalent-original-omicron-ba-4-ba-5-30-mcg","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"BNT162b2 OMI","genericName":"bnt162b2-omi","slug":"bnt162b2-omi","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b4 10 mcg","genericName":"bnt162b4-10-mcg","slug":"bnt162b4-10-mcg","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b4 15 mcg","genericName":"bnt162b4-15-mcg","slug":"bnt162b4-15-mcg","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b4 5 mcg","genericName":"bnt162b4-5-mcg","slug":"bnt162b4-5-mcg","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b5 Bivalent (Original/OMI BA.4/BA.5)","genericName":"bnt162b5-bivalent-original-omi-ba-4-ba-5","slug":"bnt162b5-bivalent-original-omi-ba-4-ba-5","indication":"COVID-19 prevention","status":"marketed"},{"name":"BNT162b7 Monovalent (OMI BA.4/BA.5)","genericName":"bnt162b7-monovalent-omi-ba-4-ba-5","slug":"bnt162b7-monovalent-omi-ba-4-ba-5","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"Combination (Bivalent) BNT162b2 and BNT162b2 OMI","genericName":"combination-bivalent-bnt162b2-and-bnt162b2-omi","slug":"combination-bivalent-bnt162b2-and-bnt162b2-omi","indication":"Prevention of COVID-19 in individuals 12 years of age and older","status":"marketed"},{"name":"Combination BNT162b2 and BNT162b2 OMI","genericName":"combination-bnt162b2-and-bnt162b2-omi","slug":"combination-bnt162b2-and-bnt162b2-omi","indication":"COVID-19 prevention","status":"marketed"},{"name":"Covid-19 Sterilizing","genericName":"COVID-19 Vaccine","slug":"covid-19-vaccine","indication":"Prevention of COVID-19 in individuals 6 months of age and older","status":"marketed"},{"name":"Deltyba","genericName":"delamanid","slug":"delamanid","indication":"Drug resistant tuberculosis","status":"marketed"},{"name":"Diflucan","genericName":"Fluconazole","slug":"fluconazole-in-sodium-chloride-0-9-in-plastic-container","indication":"Candidal Urinary Tract Infection","status":"marketed"},{"name":"Famtozinameran 5 to 11 Years of age","genericName":"famtozinameran-5-to-11-years-of-age","slug":"famtozinameran-5-to-11-years-of-age","indication":"Prevention of COVID-19 in individuals 5 years of age and older","status":"marketed"},{"name":"High Dose PF-07328948","genericName":"high-dose-pf-07328948","slug":"high-dose-pf-07328948","indication":"COVID-19","status":"marketed"},{"name":"Levaquin","genericName":"Levofloxacin","slug":"levofloxacin-in-dextrose-5-in-plastic-container","indication":"Acute Moraxella catarrhalis bronchitis","status":"marketed"},{"name":"Low Dose PF-07328948","genericName":"low-dose-pf-07328948","slug":"low-dose-pf-07328948","indication":"COVID-19","status":"marketed"},{"name":"PF-05221304","genericName":"pf-05221304","slug":"pf-05221304","indication":"Nonalcoholic fatty liver disease (NAFLD)","status":"discontinued"},{"name":"Part B: Multiple-dose ATM-AVI, Cohorts 1-4","genericName":"part-b-multiple-dose-atm-avi-cohorts-1-4","slug":"part-b-multiple-dose-atm-avi-cohorts-1-4","indication":"Treatment of HIV-1 infection in adults and pediatric patients 3 months of age and older","status":"marketed"},{"name":"Paxlovid (Copackaged)","genericName":"pf-07321332","slug":"pf-07321332","indication":"COVID-19","status":"discontinued"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":3613000000,"percentOfTotal":4,"drugCount":24,"colorKey":"infectious","drugs":[{"name":"Nurtec Odt","genericName":"Rimegepant Sulfate","slug":"nurtec-odt","indication":"Migraine","status":"marketed","revenue":1424000000},{"name":"Pristiq","genericName":"Desvenlafaxine Succinate","slug":"pristiq","indication":"Major depressive disorder","status":"marketed","revenue":1041000000},{"name":"Rimegepant 75mg every other day dosing","genericName":"rimegepant-75mg-every-other-day-dosing","slug":"rimegepant-75mg-every-other-day-dosing","indication":"Acute treatment of migraine attacks with or without aura in adults","status":"marketed","revenue":798000000},{"name":"Zoloft","genericName":"sertraline","slug":"sertraline","indication":"Depressive disorder","status":"marketed","revenue":350000000},{"name":"Tracrium Preservative Free","genericName":"Atracurium Besylate","slug":"atracurium-besylate-preservative-free","indication":"General anesthesia","status":"marketed"},{"name":"Rimegepant for acute migraine treatment","genericName":"rimegepant-for-acute-migraine-treatment","slug":"rimegepant-for-acute-migraine-treatment","indication":"Acute treatment of migraine with or without aura in adults","status":"marketed"},{"name":"Bicillin C-R","genericName":"Penicillin G Benzathine","slug":"bicillin-c-r-900-300","indication":"Erysipelas","status":"marketed"},{"name":"Bicillin C-R","genericName":"Penicillin G Benzathine","slug":"bicillin-l-a","indication":"Erysipelas","status":"marketed"},{"name":"Dilantin","genericName":"Phenytoin Sodium","slug":"dilantin","indication":"Bipolar disorder in remission","status":"marketed"},{"name":"Lyrica","genericName":"Pregabalin","slug":"lyrica","indication":"Neuropathic pain associated with diabetic peripheral neuropathy","status":"marketed"},{"name":"Paroxetine","genericName":"paroxetine","slug":"paroxetine","indication":"Major Depressive Disorder (MDD)","status":"marketed"},{"name":"Pf-06700841","genericName":"pf-06700841","slug":"pf-06700841","indication":"Multiple Sclerosis","status":"marketed"},{"name":"Rimegepant 75mg Orally Disintegrating Tablets (ODT)","genericName":"rimegepant-75mg-orally-disintegrating-tablets-odt","slug":"rimegepant-75mg-orally-disintegrating-tablets-odt","indication":"Acute treatment of migraine attacks with or without aura in adults","status":"marketed"},{"name":"Rimegepant 75mg daily dosing","genericName":"rimegepant-75mg-daily-dosing","slug":"rimegepant-75mg-daily-dosing","indication":"Acute treatment of migraine attacks with or without aura in adults","status":"marketed"},{"name":"Zarontin","genericName":"Ethosuximide","slug":"zarontin","indication":"Absence seizure","status":"marketed"},{"name":"BHV-3500 (zavegepant)","genericName":"bhv-3500-zavegepant","slug":"bhv-3500-zavegepant","indication":"Acute migraine treatment","status":"discontinued"},{"name":"Bat","genericName":"bat","slug":"bat","indication":"Treatment of partial-onset seizures with and without secondary generalization in patients 12 years of age and older with epilepsy","status":"marketed"},{"name":"Effexor","genericName":"Venlafaxine Hydrochloride","slug":"effexor-xr","indication":"Generalized anxiety disorder","status":"marketed"},{"name":"Ly4064809","genericName":"ly4064809","slug":"ly4064809","indication":"Treatment of major depressive disorder","status":"marketed"},{"name":"Magnesium Sulfate In Dextrose 5% In Plastic Container","genericName":"Magnesium Sulfate","slug":"magnesium-sulfate-in-dextrose-5-in-plastic-container","indication":"Prevention of eclampsia in patients with preeclampsia","status":"marketed"},{"name":"Nardil","genericName":"Phenelzine Sulfate","slug":"nardil","indication":"Atypical Depression","status":"marketed"},{"name":"Nurtec Odt","genericName":"rimegepant","slug":"rimegepant","indication":"Migraine","status":"marketed"},{"name":"Open-label, PK Cohort (Cohort B): ponsegromab low dose","genericName":"open-label-pk-cohort-cohort-b-ponsegromab-low-dose","slug":"open-label-pk-cohort-cohort-b-ponsegromab-low-dose","indication":"Relapsing forms of multiple sclerosis","status":"marketed"},{"name":"PF-06700841 45 mg","genericName":"pf-06700841-45-mg","slug":"pf-06700841-45-mg","indication":"Multiple Sclerosis","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":2556000000,"percentOfTotal":2.8,"drugCount":12,"colorKey":"rare","drugs":[{"name":"Cibinqo","genericName":"abrocitinib","slug":"abrocitinib","indication":"Atopic dermatitis","status":"marketed","revenue":284000000},{"name":"Abrocitinib 100 mg","genericName":"abrocitinib-100-mg","slug":"abrocitinib-100-mg","indication":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","status":"marketed","revenue":284000000},{"name":"Abrocitinib 200 MG Oral Tablet","genericName":"abrocitinib-200-mg-oral-tablet","slug":"abrocitinib-200-mg-oral-tablet","indication":"Moderate to severe atopic dermatitis","status":"marketed","revenue":284000000},{"name":"Abrocitinib 200 mg","genericName":"abrocitinib-200-mg","slug":"abrocitinib-200-mg","indication":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","status":"marketed","revenue":284000000},{"name":"Cibinqo","genericName":"Abrocitinib","slug":"cibinqo","indication":"Atopic dermatitis","status":"marketed","revenue":284000000},{"name":"Abrocitinib Suspension F1","genericName":"abrocitinib-suspension-f1","slug":"abrocitinib-suspension-f1","indication":"Moderate to severe atopic dermatitis in adults","status":"marketed","revenue":284000000},{"name":"Abrocitinib Suspension F2","genericName":"abrocitinib-suspension-f2","slug":"abrocitinib-suspension-f2","indication":"Moderate to severe atopic dermatitis","status":"marketed","revenue":284000000},{"name":"Abrocitinib Suspension F6","genericName":"abrocitinib-suspension-f6","slug":"abrocitinib-suspension-f6","indication":"Moderate to severe atopic dermatitis in adults","status":"marketed","revenue":284000000},{"name":"Abrocitinib tablet","genericName":"abrocitinib-tablet","slug":"abrocitinib-tablet","indication":"Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","status":"marketed","revenue":284000000},{"name":"Plegisol In Plastic Container","genericName":"Calcium Chloride","slug":"tpn-electrolytes-in-plastic-container","indication":"Cardiac arrest","status":"marketed"},{"name":"D-Col Personal Hygiene Convenience Kit","genericName":"col","slug":"col","indication":"Antiseptic skin preparation for patient","status":"marketed"},{"name":"Mer Detox 6019","genericName":"mer","slug":"mer","indication":"Exhaustion or Weakness","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":1000000000,"percentOfTotal":1.1,"drugCount":22,"colorKey":"respiratory","drugs":[{"name":"Lipitor","genericName":"atorvastatin","slug":"atorvastatin","indication":"Angina pectoris","status":"marketed","revenue":1000000000},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-25-000-units-in-dextrose-5-in-plastic-container","indication":"Deep Vein Thrombosis with Pulmonary Embolism","status":"marketed"},{"name":"Caduet","genericName":"Amlodipine Besylate","slug":"caduet","indication":"Hypertension","status":"marketed"},{"name":"Milrinone Lactate","genericName":"Milrinone Lactate","slug":"milrinone-lactate","indication":"Acute decompensated heart failure","status":"marketed"},{"name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","genericName":"Dobutamine Hydrochloride","slug":"dobutamine-hydrochloride","indication":"Cardiac Decompensation","status":"marketed"},{"name":"Revatio","genericName":"Sildenafil Citrate","slug":"revatio","indication":"Impotence","status":"marketed"},{"name":"Aldactone","genericName":"Spironolactone","slug":"aldactone","indication":"NYHA Class III-IV heart failure with reduced ejection fraction","status":"marketed"},{"name":"Aridol Kit","genericName":"Mannitol","slug":"mannitol-25","indication":"Benign intracranial hypertension","status":"marketed"},{"name":"Norvasc","genericName":"Amlodipine Besylate","slug":"norvasc","indication":"Hypertension","status":"marketed"},{"name":"Tikosyn","genericName":"Dofetilide","slug":"tikosyn","indication":"Maintenance of Normal Sinus Rhythm (Delay in AF/AFl Recurrence)","status":"marketed"},{"name":"Viagra","genericName":"Sildenafil Citrate","slug":"viagra","indication":"Impotence","status":"marketed"},{"name":"Aridol Kit","genericName":"Mannitol","slug":"mannitol-5","indication":"Benign intracranial hypertension","status":"marketed"},{"name":"Aridol Kit","genericName":"Mannitol","slug":"mannitol-10","indication":"Benign intracranial hypertension","status":"marketed"},{"name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","genericName":"Dobutamine Hydrochloride","slug":"dobutamine-hydrochloride-in-dextrose-5-in-plastic-container","indication":"Acute myocardial infarction","status":"marketed"},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-12-500-units-in-dextrose-5-in-plastic-container","indication":"Deep Vein Thrombosis with Pulmonary Embolism","status":"marketed"},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-10-000-units-in-dextrose-5-in-plastic-container","indication":"Deep Vein Thrombosis with Pulmonary Embolism","status":"marketed"},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-preservative-free","indication":"Deep Vein Thrombosis with Pulmonary Embolism","status":"marketed"},{"name":"Lipitor","genericName":"Atorvastatin Calcium","slug":"lipitor","indication":"Angina pectoris","status":"marketed"},{"name":"Lopid","genericName":"Gemfibrozil","slug":"lopid","indication":"Treatment of adult patients with Type IV hyperlipidemia with very high serum triglyceride elevations (>2,000 mg/dL) presenting risk of pancreatitis unresponsive to diet","status":"marketed"},{"name":"No OAC","genericName":"no-oac","slug":"no-oac","indication":"Acute Ischemic Stroke","status":"marketed"},{"name":"Non-Interventional Study","genericName":"non-interventional-study","slug":"non-interventional-study","indication":"Angina Pectoris","status":"marketed"},{"name":"Oral Anticoagulant","genericName":"oral-anticoagulant","slug":"oral-anticoagulant","indication":"Cryptogenic ischemic stroke with patent foramen ovale (PFO)","status":"discontinued"}]},{"name":"Hematology","slug":"hematology","revenue":250000000,"percentOfTotal":0.3,"drugCount":3,"colorKey":"metabolic","drugs":[{"name":"Oxbryta","genericName":"Voxelotor","slug":"oxbryta","indication":"Treatment of sickle cell disease (SCD) in adults","status":"marketed","revenue":250000000},{"name":"Sodium Chloride","genericName":"Sodium Chloride","slug":"sodium-chloride-0-9-in-plastic-container","indication":"General irrigation","status":"marketed"},{"name":"Levophed","genericName":"Norepinephrine Bitartrate","slug":"levophed","indication":"Severe, acute hypotension in adult patients","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"ophthalmology","drugs":[{"name":"Bupivacaine Hydrochloride","genericName":"Bupivacaine Hydrochloride","slug":"bupivacaine-hydrochloride-and-epinephrine","indication":"Anesthesia for cesarean section","status":"marketed"},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride","indication":"Anesthesia for cesarean section","status":"marketed"},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride-w-epinephrine","indication":"Anesthesia for cesarean section","status":"marketed"},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride-w-epinephrine-preservative-free","indication":"Anesthesia for cesarean section","status":"marketed"},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride-preservative-free","indication":"Anesthesia for cesarean section","status":"marketed"},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"bupivacaine-hydrochloride","indication":"Anesthesia for cesarean section","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"hematology","drugs":[{"name":"Meperidine Hydrochloride Preservative Free","genericName":"Meperidine Hydrochloride","slug":"demerol","indication":"General anesthesia","status":"marketed"},{"name":"Naloxone Hydrochloride","genericName":"Naloxone Hydrochloride","slug":"naloxone-hydrochloride","indication":"Management of pain severe enough to require an opioid analgesic","status":"marketed"},{"name":"Amidate","genericName":"Etomidate","slug":"amidate","indication":"Induction of general anesthesia","status":"marketed"},{"name":"Danuglipron","genericName":"danuglipron","slug":"danuglipron","indication":"Treatment of acute and chronic pain","status":"marketed"},{"name":"Duramorph Pf","genericName":"Morphine Sulfate","slug":"morphine-sulfate","indication":"Acute postoperative pain","status":"marketed"},{"name":"Lidocaine Hydrochloride Preservative Free","genericName":"Lidocaine Hydrochloride","slug":"lidocaine-hydrochloride-preservative-free","indication":"Topical anesthesia of irritated mucous membranes of the mouth","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"PF-07976016","genericName":"pf-07976016","slug":"pf-07976016","indication":"Obesity","status":"discontinued"},{"name":"Ertugliflozin 15 mg","genericName":"ertugliflozin-15-mg","slug":"ertugliflozin-15-mg","indication":"Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes","status":"marketed"},{"name":"Ertugliflozin 5 mg","genericName":"ertugliflozin-5-mg","slug":"ertugliflozin-5-mg","indication":"Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes","status":"marketed"},{"name":"PF-07081532","genericName":"pf-07081532","slug":"pf-07081532","indication":"Obesity","status":"discontinued"}]},{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"pain","drugs":[{"name":"Elelyso","genericName":"Taliglucerase Alfa","slug":"elelyso","indication":"Type 1 Gaucher disease","status":"marketed"},{"name":"Hympavzi","genericName":"Marstacimab-Hncq","slug":"hympavzi","indication":"Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency) without factor VIII inhibitors","status":"marketed"},{"name":"Cyklokapron","genericName":"Tranexamic Acid","slug":"cyklokapron","indication":"Reduce or prevent hemorrhage in hemophilia patients during tooth extraction","status":"marketed"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"dermatology","drugs":[{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Epinephrine","slug":"lidocaine-hydrochloride-and-epinephrine","indication":"Acute exacerbation of asthma","status":"marketed"},{"name":"RSVpreF","genericName":"rsvpref","slug":"rsvpref","indication":"Prevention of RSV lower respiratory tract disease in neonates at high risk of RSV disease","status":"marketed"}]}],"pipeline":[{"name":"Prevnar family","genericName":"prevnar-family","slug":"prevnar-family","phase":"marketed","mechanism":"Induces an immune response to Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F","indications":["Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F in children 2 through 5 years of age","Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F in children 6 through 17 years of age","Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F in adults 18 years of age and older","Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F in adults 50 years of age and older","Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F in adults 65 years of age and older"],"catalyst":""},{"name":"Prevnar 20","genericName":"pneumococcal 20-valent conjugate vaccine (PCV20)","slug":"prevnar-20","phase":"marketed","mechanism":"20-valent pneumococcal conjugate vaccine that elicits immune responses against 20 Streptococcus pneumoniae serotypes","indications":["Prevention of invasive pneumococcal disease in adults (18+)","Prevention of pneumococcal pneumonia in adults (18+)","Active immunisation in infants, children, and adolescents (6 weeks to <18 years)","Immunocompromised adults (CLL, HIV, autoimmune)"],"catalyst":""},{"name":"Comirnaty","genericName":"BNT162b2 (tozinameran)","slug":"comirnaty","phase":"marketed","mechanism":"Comirnaty is an mRNA-based vaccine.","indications":["Prevention of COVID-19 in individuals 6 months of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older, as a third dose administered at least 2 months after either the second dose of a 2-dose series or the first dose of a single-dose regimen","Prevention of COVID-19 in individuals 12 years of age and older, as a fourth dose administered at least 2 months after the third dose"],"catalyst":""},{"name":"Ibrance","genericName":"Palbociclib","slug":"ibrance","phase":"marketed","mechanism":"Palbociclib inhibits CDK4/6 to block G1/S cell cycle progression in ER-positive breast cancer.","indications":["Hormone receptor positive malignant neoplasm of breast","Human epidermal growth factor 2 negative carcinoma of breast"],"catalyst":""},{"name":"Famtozinameran 12 Years of age and older","genericName":"famtozinameran-12-years-of-age-and-older","slug":"famtozinameran-12-years-of-age-and-older","phase":"marketed","mechanism":"Famtozinameran works by targeting the SARS-CoV-2 virus.","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"COMIRNATY intramuscular injection","genericName":"comirnaty-intramuscular-injection","slug":"comirnaty-intramuscular-injection","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 6 months of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 6 months of age and older with certain kinds of heart disease, such as heart failure, coronary artery disease, and hypertension","Prevention of COVID-19 in individuals 6 months of age and older with weakened immune systems, such as people with conditions or taking medications that weaken the immune system"],"catalyst":""},{"name":"Palbociclib in combination with AI","genericName":"palbociclib-in-combination-with-ai","slug":"palbociclib-in-combination-with-ai","phase":"marketed","mechanism":"CDK4/6","indications":["Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HER2-negative) advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women with estrogen receptor-positive (ER+), HER2-negative breast cancer","Hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-negative) advanced or metastatic breast cancer in combination with fulvestrant in women with disease progression following endocrine therapy"],"catalyst":""},{"name":"PF-06863135 + lenalidomide","genericName":"pf-06863135-lenalidomide","slug":"pf-06863135-lenalidomide","phase":"marketed","mechanism":"unknown","indications":["Relapsed or refractory multiple myeloma in combination with dexamethasone","Relapsed or refractory multiple myeloma in combination with dexamethasone and daratumumab","Relapsed or refractory multiple myeloma in combination with dexamethasone and daratumumab and carfilzomib","Relapsed or refractory multiple myeloma in combination with dexamethasone and daratumumab and carfilzomib and isatuximab","Relapsed or refractory multiple myeloma in combination with dexamethasone and daratumumab and carfilzomib and isatuximab and elotuzumab"],"catalyst":""},{"name":"Nivolumab and Ipilimumab","genericName":"nivolumab-and-ipilimumab","slug":"nivolumab-and-ipilimumab","phase":"marketed","mechanism":"Monoclonal antibody","indications":[],"catalyst":""},{"name":"Nivolumab and/or Ipilimumab","genericName":"nivolumab-and-or-ipilimumab","slug":"nivolumab-and-or-ipilimumab","phase":"marketed","mechanism":"Monoclonal antibody","indications":[],"catalyst":""},{"name":"Venetoclax; Rituximab","genericName":"venetoclax-rituximab","slug":"venetoclax-rituximab","phase":"marketed","mechanism":"BCL-2 (venetoclax); CD20 (rituximab)","indications":["Treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies.","Treatment of adult patients with CLL who have received at least one prior therapy.","Treatment of adult patients with CLL who are not eligible for or have failed a B-cell receptor (BCR) pathway inhibitor.","Treatment of adult patients with CLL who have a 17p deletion.","Treatment of adult patients with CLL who have a 17p deletion and have received at least one prior therapy."],"catalyst":""},{"name":"Paxlovid (Copackaged)","genericName":"nirmatrelvir","slug":"nirmatrelvir","phase":"marketed","mechanism":"Paxlovid works by binding to the main protease enzyme of the SARS-CoV-2 virus, preventing it from replicating.","indications":["Treatment of mild-to-moderate COVID-19"],"catalyst":""},{"name":"Talazoparib with enzalutamide","genericName":"talazoparib-with-enzalutamide","slug":"talazoparib-with-enzalutamide","phase":"marketed","mechanism":"PARP enzymes and androgen receptor","indications":["Metastatic castration-resistant prostate cancer (mCRPC) with BRCA1, BRCA2, or ATM gene mutations"],"catalyst":""},{"name":"talazoparib plus enzalutamide","genericName":"talazoparib-plus-enzalutamide","slug":"talazoparib-plus-enzalutamide","phase":"phase_3","mechanism":"","indications":[],"catalyst":""},{"name":"Xeljanz","genericName":"tofacitinib","slug":"tofacitinib","phase":"marketed","mechanism":"Tofacitinib is a JAK inhibitor that prevents phosphorylation and activation of STATs.","indications":["Juvenile idiopathic arthritis, extended oligoarthritis","Juvenile psoriatic arthritis","Polyarticular juvenile idiopathic arthritis","Psoriatic arthritis","Rheumatoid arthritis"],"catalyst":""},{"name":"Abiraterone Acetate","genericName":"abiraterone","slug":"abiraterone","phase":"marketed","mechanism":"Abiraterone is an androgen biosynthesis inhibitor that targets CYP17 to reduce androgen production in prostate cancer cells.","indications":["Metastatic castration-resistant prostate cancer (mCRPC)","Chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC)","Metastatic high-risk castration-sensitive prostate cancer (mHSPC)"],"catalyst":""},{"name":"Nurtec Odt","genericName":"Rimegepant Sulfate","slug":"nurtec-odt","phase":"marketed","mechanism":"Rimegepant is a calcitonin gene-related peptide receptor antagonist.","indications":["Migraine","Prevention of migraine attacks"],"catalyst":""},{"name":"Immuno-oncology (IO)","genericName":"immuno-oncology-io","slug":"immuno-oncology-io","phase":"marketed","mechanism":"Not specified","indications":["Melanoma","Non-Small Cell Lung Cancer (NSCLC)","Renal Cell Carcinoma (RCC)","Head and Neck Squamous Cell Carcinoma (HNSCC)","Urothelial Carcinoma (UC)"],"catalyst":""},{"name":"Lorbrena","genericName":"Lorlatinib","slug":"lorbrena","phase":"marketed","mechanism":"Lorbrena works by blocking the activity of the ALK tyrosine kinase receptor, which is a protein that helps cancer cells grow.","indications":["ALK fusion gene-positive non-small-cell lung cancer","Non-small cell lung cancer"],"catalyst":""},{"name":"Xeljanz","genericName":"Tofacitinib Citrate","slug":"xeljanz","phase":"marketed","mechanism":"Tofacitinib inhibits Janus kinase enzymes to prevent STAT phosphorylation and activation.","indications":["Juvenile idiopathic arthritis, extended oligoarthritis","Juvenile psoriatic arthritis","Polyarticular juvenile idiopathic arthritis","Psoriatic arthritis","Rheumatoid arthritis"],"catalyst":""},{"name":"In open-label phase: treatment with tofacitinib","genericName":"in-open-label-phase-treatment-with-tofacitinib","slug":"in-open-label-phase-treatment-with-tofacitinib","phase":"marketed","mechanism":"Janus kinase 1 (JAK1), Janus kinase 3 (JAK3), and tyrosine kinase 2 (TYK2)","indications":["Rheumatoid Arthritis","Psoriatic Arthritis","Polyarticular Juvenile Idiopathic Arthritis","Ulcerative Colitis","Psoriasis"],"catalyst":""},{"name":"Pristiq","genericName":"Desvenlafaxine Succinate","slug":"pristiq","phase":"marketed","mechanism":"Potentiates serotonin and norepinephrine in CNS through reuptake inhibition.","indications":["Major depressive disorder"],"catalyst":""},{"name":"Abrysvo","genericName":"abrysvo","slug":"abrysvo","phase":"marketed","mechanism":"ABRYSVO is a vaccine that protects against respiratory syncytial virus (RSV).","indications":["Prevention of rabies in individuals who have been bitten or otherwise exposed to rabies or have been at risk of rabies exposure and have been vaccinated with a cell culture vaccine or an inactivated rabies vaccine."],"catalyst":""},{"name":"Lipitor","genericName":"atorvastatin","slug":"atorvastatin","phase":"marketed","mechanism":"Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis.","indications":["Angina pectoris","Arteriosclerotic vascular disease","Cerebrovascular accident","Familial hypercholesterolemia - heterozygous","Familial hypercholesterolemia - homozygous"],"catalyst":""},{"name":"Premarin","genericName":"Conjugated estrogens","slug":"conjugated-estrogens","phase":"marketed","mechanism":"Estrogen receptor","indications":["Dyspareunia","Menopausal flushing"],"catalyst":""},{"name":"Axitinib plus Toripalimab","genericName":"axitinib-plus-toripalimab","slug":"axitinib-plus-toripalimab","phase":"phase_3","mechanism":"Monoclonal antibody","indications":[],"catalyst":""},{"name":"Inlyta","genericName":"axitinib","slug":"axitinib","phase":"marketed","mechanism":"Inlyta works by blocking the activity of the mast/stem cell growth factor receptor Kit, which is involved in the growth and spread of cancer cells.","indications":["Renal cell carcinoma"],"catalyst":""},{"name":"Adcetris","genericName":"brentuximab-vedotin","slug":"brentuximab-vedotin","phase":"marketed","mechanism":"Adcetris works by binding to cancer cells that express CD30 and delivering a toxic payload to kill the cells.","indications":["Anaplastic large T-cell systemic malignant lymphoma","CD30-positive peripheral T-cell lymphoma","Cutaneous Tcell lymphoma","Hodgkin's disease"],"catalyst":""},{"name":"Rimegepant 75mg every other day dosing","genericName":"rimegepant-75mg-every-other-day-dosing","slug":"rimegepant-75mg-every-other-day-dosing","phase":"marketed","mechanism":"Rimegepant targets the calcitonin gene-related peptide receptor to treat migraines.","indications":["Acute treatment of migraine attacks with or without aura in adults","Prevention of migraine attacks in adults"],"catalyst":""},{"name":"Chemotherapy","genericName":"chemotherapy","slug":"chemotherapy","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Docetaxel monotherapy","genericName":"docetaxel-monotherapy","slug":"docetaxel-monotherapy","phase":"phase_3","mechanism":"","indications":[],"catalyst":""},{"name":"Lorlatinib with chemotherapy 2","genericName":"lorlatinib-with-chemotherapy-2","slug":"lorlatinib-with-chemotherapy-2","phase":"marketed","mechanism":"ALK","indications":["Anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) with brain metastases","ALK-positive metastatic NSCLC without brain metastases","ALK-positive metastatic NSCLC with brain metastases and with or without echinoderm microtubule-associated protein-like 4 (EML4) anaplastic lymphoma kinase (ALK) fusion"],"catalyst":""},{"name":"PF-07104091 monotherapy dose expansion (ovarian)","genericName":"pf-07104091-monotherapy-dose-expansion-ovarian","slug":"pf-07104091-monotherapy-dose-expansion-ovarian","phase":"marketed","mechanism":"[insert molecular target]","indications":["Advanced ovarian cancer"],"catalyst":""},{"name":"Ribociclib (Dose #2)","genericName":"ribociclib-dose-2","slug":"ribociclib-dose-2","phase":"marketed","mechanism":"Ferrochelatase, mitochondrial, Mitogen-activated protein kinase kinase kinase 1, Calcium/calmodulin-dependent protein kinase type II subunit delta","indications":["Hormone receptor positive malignant neoplasm of breast"],"catalyst":""},{"name":"Braftovi","genericName":"encorafenib","slug":"encorafenib","phase":"marketed","mechanism":"Braftovi works by blocking the activity of a specific protein called BRAF that is involved in cancer cell growth.","indications":["BRAF mutation-positive colorectal cancer","Metastatic malignant melanoma","Unresectable malignant melanoma with BRAF gene mutation"],"catalyst":""},{"name":"Infliximab [infliximab biosimilar 3]","genericName":"infliximab-infliximab-biosimilar-3","slug":"infliximab-infliximab-biosimilar-3","phase":"marketed","mechanism":"Infliximab biosimilar 3 is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha) to treat inflammatory conditions.","indications":["Moderate to severe Crohn's disease","Mild to moderate ulcerative colitis","Ankylosing spondylitis","Psoriatic arthritis","Rheumatoid arthritis"],"catalyst":""},{"name":"Zavicefta, Ceftazidime-Avibactam","genericName":"zavicefta-ceftazidime-avibactam","slug":"zavicefta-ceftazidime-avibactam","phase":"marketed","mechanism":"Bacterial cell wall synthesis","indications":["Complicated urinary tract infections (cUTI), including pyelonephritis, caused by certain susceptible bacteria.","Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by certain susceptible bacteria.","Complicated intra-abdominal infections (cIAI) caused by certain susceptible bacteria."],"catalyst":""},{"name":"Bosulif","genericName":"Bosutinib Monohydrate","slug":"bosulif","phase":"marketed","mechanism":"Bosulif blocks the abnormal tyrosine kinase activity in cancer cells, inhibiting their growth and proliferation.","indications":["Blastic phase chronic myeloid leukemia","Chronic Myelocytic Leukemia Accelerated Phase"],"catalyst":""},{"name":"Bosulif","genericName":"bosutinib","slug":"bosutinib","phase":"marketed","mechanism":"Bosulif works by blocking the activity of a specific enzyme called tyrosine-protein kinase ABL1, which is involved in the growth and survival of cancer cells.","indications":["Chronic Phase Ph+ CML","Accelerated Phase Ph+ CML","Blast Phase Ph+ CML"],"catalyst":""},{"name":"Bosutinib capsule","genericName":"bosutinib-capsule","slug":"bosutinib-capsule","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Tukysa","genericName":"tukysa","slug":"tukysa","phase":"marketed","mechanism":"Tukysa blocks the activity of ERBB2 and ERBB3 proteins, which are involved in cancer cell growth and spread.","indications":["Metastatic human epidermal growth factor 2 positive carcinoma of breast"],"catalyst":""},{"name":"Aromasin","genericName":"exemestane","slug":"exemestane","phase":"marketed","mechanism":"Aromasin works by blocking the aromatase enzyme, which is responsible for converting androgens into estrogens.","indications":["Advanced Breast Cancer Progression Post-Antiestrogen Therapy","Hormone receptor positive malignant neoplasm of breast"],"catalyst":""},{"name":"Omnitrope","genericName":"Somatropin","slug":"genotropin-preservative-free","phase":"marketed","mechanism":"Somatropin binds dimeric GH receptors on target cells, inducing intracellular signaling and GH-dependent protein synthesis including IGF-1.","indications":["Growth retardation","Pituitary dwarfism","Prader-Willi syndrome","Severe growth hormone deficiency in adulthood","Turner syndrome"],"catalyst":""},{"name":"somatropin - GH naïve pediatric cohort","genericName":"somatropin-gh-na-ve-pediatric-cohort","slug":"somatropin-gh-na-ve-pediatric-cohort","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"somatropin - GH treated cohort","genericName":"somatropin-gh-treated-cohort","slug":"somatropin-gh-treated-cohort","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"somatropin - adult cohort","genericName":"somatropin-adult-cohort","slug":"somatropin-adult-cohort","phase":"marketed","mechanism":"Growth Hormone Receptor","indications":["Treatment of growth hormone deficiency in adults.","Treatment of short bowel syndrome and failure to thrive in adults.","Treatment of HIV-associated wasting in adults.","Treatment of adult-onset growth hormone deficiency.","Treatment of Turner syndrome in adults."],"catalyst":""},{"name":"Radium-223","genericName":"radium-223","slug":"radium-223","phase":"marketed","mechanism":"Bone cells","indications":["Castration-Resistant Prostate Cancer, Bone Metastases"],"catalyst":""},{"name":"Zithromax","genericName":"Azithromycin","slug":"zithromax","phase":"marketed","mechanism":"Azithromycin is a macrolide antibacterial drug.","indications":["Community-Acquired Pneumonia","Pelvic Inflammatory Disease","To reduce the development of drug-resistant bacteria and maintain the effectiveness of ZITHROMAX and other antibacterial drugs"],"catalyst":""},{"name":"Zithromax","genericName":"azithromycin","slug":"azithromycin","phase":"marketed","mechanism":"Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life.","indications":["Acute bacterial bronchitis","Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute gonococcal cervicitis","Acute gonococcal urethritis"],"catalyst":""},{"name":"Canakinumab Injection","genericName":"canakinumab-injection","slug":"canakinumab-injection","phase":"marketed","mechanism":"Canakinumab Injection is a monoclonal antibody that targets and neutralizes interleukin-1 beta (IL-1β) to treat inflammatory conditions.","indications":["Prophylaxis of gouty arthritis attacks in adults","Prophylaxis of gouty arthritis attacks in pediatric patients 2 years of age and older","Treatment of cryopyrin-associated periodic syndromes (CAPS) in adults and children 4 months of age and older","Treatment of systemic juvenile idiopathic arthritis (sJIA) in patients 2 years of age and older","Treatment of Familial Mediterranean Fever (FMF) in adults and children 4 months of age and older"],"catalyst":""},{"name":"Taxol","genericName":"nab-paclitaxel","slug":"nab-paclitaxel","phase":"marketed","mechanism":"Tubulin beta-3 chain","indications":["Carcinoma of breast","Carcinoma of fallopian tube","Hypertensive disorder","Kaposi's sarcoma","Malignant tumor of cervix"],"catalyst":""},{"name":"Taxol","genericName":"paclitaxel","slug":"paclitaxel","phase":"marketed","mechanism":"Tubulin beta-3 chain","indications":["Carcinoma of breast","Carcinoma of fallopian tube","Hypertensive disorder","Kaposi's sarcoma","Malignant tumor of cervix"],"catalyst":""},{"name":"Taxol","genericName":"Nabpaclitaxel","slug":"nabpaclitaxel","phase":"discontinued","mechanism":"Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division.","indications":["Carcinoma of breast","Carcinoma of fallopian tube","Hypertensive disorder","Kaposi's sarcoma","Malignant tumor of cervix"],"catalyst":""},{"name":"Zoloft","genericName":"sertraline","slug":"sertraline","phase":"marketed","mechanism":"Selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter, increasing synaptic serotonin to improve mood and reduce anxiety.","indications":["Depressive disorder","Obsessive-compulsive disorder","Panic disorder","Posttraumatic stress disorder","Premenstrual dysphoric disorder"],"catalyst":""},{"name":"Isavuconazole","genericName":"isavuconazole","slug":"isavuconazole","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Elrexfio","genericName":"Elranatamab","slug":"elrexfio","phase":"marketed","mechanism":"Bispecific antibody binding BCMA on myeloma cells and CD3 on T-cells, causing cytolysis.","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"Elrexfio","genericName":"elranatamab","slug":"elranatamab","phase":"marketed","mechanism":"Bispecific antibody binding BCMA on myeloma cells and CD3 on T-cells, causing cytolysis.","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"Elrexfio","genericName":"elranatamab-bcmm","slug":"elranatamab-bcmm","phase":"marketed","mechanism":"Elrexfio works by binding to tumor necrosis factor receptor superfamily member 17, a protein involved in the growth and survival of cancer cells.","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"Cibinqo","genericName":"abrocitinib","slug":"abrocitinib","phase":"marketed","mechanism":"Cibinqo works by blocking the JAK1 enzyme, which helps reduce inflammation in the body.","indications":["Atopic dermatitis"],"catalyst":""},{"name":"Abrocitinib 100 mg","genericName":"abrocitinib-100-mg","slug":"abrocitinib-100-mg","phase":"marketed","mechanism":"JAK1","indications":["Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy","Moderate to severe atopic dermatitis in children aged 12 years and older who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy"],"catalyst":""},{"name":"Abrocitinib 200 MG Oral Tablet","genericName":"abrocitinib-200-mg-oral-tablet","slug":"abrocitinib-200-mg-oral-tablet","phase":"marketed","mechanism":"Abrocitinib 200 MG Oral Tablet is a small molecule that targets the JAK1 protein.","indications":["Moderate to severe atopic dermatitis"],"catalyst":""},{"name":"Abrocitinib 200 mg","genericName":"abrocitinib-200-mg","slug":"abrocitinib-200-mg","phase":"marketed","mechanism":"JAK1","indications":["Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy"],"catalyst":""},{"name":"Cibinqo","genericName":"Abrocitinib","slug":"cibinqo","phase":"marketed","mechanism":"Cibinqo works by blocking the activity of the JAK1 enzyme, which plays a key role in the inflammatory response.","indications":["Atopic dermatitis"],"catalyst":""},{"name":"Abrocitinib Suspension F1","genericName":"abrocitinib-suspension-f1","slug":"abrocitinib-suspension-f1","phase":"marketed","mechanism":"JAK1","indications":["Moderate to severe atopic dermatitis in adults","Moderate to severe atopic dermatitis in children 12 years of age and older"],"catalyst":""},{"name":"Abrocitinib Suspension F2","genericName":"abrocitinib-suspension-f2","slug":"abrocitinib-suspension-f2","phase":"marketed","mechanism":"unknown","indications":["Moderate to severe atopic dermatitis"],"catalyst":""},{"name":"Abrocitinib Suspension F6","genericName":"abrocitinib-suspension-f6","slug":"abrocitinib-suspension-f6","phase":"marketed","mechanism":"JAK1","indications":["Moderate to severe atopic dermatitis in adults","Moderate to severe atopic dermatitis in children 12 years of age and older"],"catalyst":""},{"name":"Abrocitinib tablet","genericName":"abrocitinib-tablet","slug":"abrocitinib-tablet","phase":"marketed","mechanism":"JAK1","indications":["Moderate to severe atopic dermatitis in adults who have had an inadequate response or intolerance to one or more biologics, or who are candidates for systemic therapy"],"catalyst":""},{"name":"Oxbryta","genericName":"Voxelotor","slug":"oxbryta","phase":"marketed","mechanism":"Hemoglobin S polymerization inhibitor that binds HbS 1:1 and increases oxygen affinity.","indications":["Treatment of sickle cell disease (SCD) in adults","Treatment of sickle cell disease (SCD) in pediatric patients 4 years of age and older"],"catalyst":""},{"name":"Besponsa","genericName":"Inotuzumab Ozogamicin","slug":"besponsa","phase":"marketed","mechanism":"CD22-directed antibody-drug conjugate delivering cytotoxic calicheamicin to induce DNA breaks and apoptosis.","indications":["Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients","Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in pediatric patients 1 year and older"],"catalyst":""},{"name":"Besponsa","genericName":"inotuzumab-ozogamicin","slug":"inotuzumab-ozogamicin","phase":"marketed","mechanism":"CD22-directed antibody-drug conjugate delivering cytotoxic calicheamicin to induce DNA breaks and apoptosis.","indications":["Pre B-cell acute lymphoblastic leukemia"],"catalyst":""},{"name":"Besponsa","genericName":"inotuzumab","slug":"inotuzumab","phase":"marketed","mechanism":"Inotuzumab ozogamicin is a CD22-directed antibody drug conjugate that targets and kills cancer cells.","indications":["Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients","Relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in pediatric patients 1 year and older"],"catalyst":""},{"name":"Talzenna","genericName":"Talazoparib Tosylate","slug":"talzenna","phase":"marketed","mechanism":"PARP1/PARP2 inhibitor causing DNA damage, decreased proliferation, and apoptosis in BRCA-mutated cancers.","indications":["Breast Cancer","HRR Gene-mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)","BRCA-mutated (g BRCA m) HER2-negative Locally Advanced or Metastatic Breast Cancer"],"catalyst":""},{"name":"Talzenna","genericName":"talazoparib","slug":"talazoparib","phase":"marketed","mechanism":"Talzenna blocks PARP enzymes, which are involved in DNA repair, to prevent cancer cell growth.","indications":["Germline BRCA-mutated, HER2-negative metastatic breast cancer"],"catalyst":""},{"name":"Talzenna","genericName":"talazoparib-tosylate","slug":"talazoparib-tosylate","phase":"marketed","mechanism":"Talazoparib inhibits PARP enzymes, causing DNA damage and cell death in cancer cells with DNA repair defects.","indications":["Germline BRCA-mutated, HER2-negative metastatic breast cancer"],"catalyst":""},{"name":"Daurismo","genericName":"Glasdegib Maleate","slug":"daurismo","phase":"marketed","mechanism":"Glasdegib inhibits Smoothened, a transmembrane protein in the Hedgehog signaling pathway.","indications":["Acute myeloid leukemia, disease"],"catalyst":""},{"name":"Daurismo","genericName":"glasdegib","slug":"glasdegib","phase":"marketed","mechanism":"Daurismo works by blocking the Smoothened homolog, a protein involved in the Hedgehog signaling pathway, which is often dysregulated in cancer cells.","indications":["Acute myeloid leukemia, disease"],"catalyst":""},{"name":"tocilizumab or sarilumab","genericName":"tocilizumab-or-sarilumab","slug":"tocilizumab-or-sarilumab","phase":"marketed","mechanism":"interleukin-6 receptor","indications":["Rheumatoid Arthritis","Juvenile Idiopathic Arthritis","Polyarticular Juvenile Idiopathic Arthritis","Megakaryocyte Erythroid Potent Protocadherin-related Protein (MEPEP) associated Hemophagocytic Lymphohistiocytosis","Cytokine Release Syndrome"],"catalyst":""},{"name":"Mylotarg","genericName":"Gemtuzumab Ozogamicin","slug":"mylotarg","phase":"marketed","mechanism":"CD33-directed antibody-drug conjugate that delivers cytotoxic calicheamicin to tumor cells.","indications":["Acute myeloid leukemia, disease"],"catalyst":""},{"name":"Mylotarg","genericName":"gemtuzumab-ozogamicin","slug":"gemtuzumab-ozogamicin","phase":"marketed","mechanism":"Mylotarg works by binding to CD33 on cancer cells and releasing a toxic compound that kills the cells.","indications":["Newly-diagnosed CD33-positive AML","Relapsed or refractory CD33-positive AML"],"catalyst":""},{"name":"Bupivacaine Hydrochloride","genericName":"Bupivacaine Hydrochloride","slug":"bupivacaine-hydrochloride-and-epinephrine","phase":"marketed","mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-25-000-units-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.","indications":["Deep Vein Thrombosis with Pulmonary Embolism","Deep venous thrombosis","Disseminated intravascular coagulation","Maintain Patency of Indwelling Vascular Catheter","Non-Q wave myocardial infarction"],"catalyst":""},{"name":"Sodium Chloride","genericName":"Sodium Chloride","slug":"sodium-chloride-0-9-in-plastic-container","phase":"marketed","mechanism":"Sodium chloride is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions.","indications":["General irrigation","Washing","Rinsing","Dilution purposes","Blood cell washing"],"catalyst":""},{"name":"Premarin","genericName":"Estrogens, Conjugated","slug":"premarin","phase":"marketed","mechanism":"Conjugated estrogens bind to nuclear estrogen receptors in estrogen-responsive tissues, modulating gonadotropin secretion and reducing elevated LH and FSH in postmenopausal women.","indications":["Dyspareunia","Menopausal flushing"],"catalyst":""},{"name":"Bicillin C-R","genericName":"Penicillin G Benzathine","slug":"bicillin-c-r","phase":"marketed","mechanism":"Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.","indications":["Moderately severe to severe infections of the upper-respiratory tract","Scarlet fever","Erysipelas","Skin and soft-tissue infections due to susceptible streptococci","Moderately severe pneumonia"],"catalyst":""},{"name":"Lignospan Forte","genericName":"Lidocaine Hydrochloride","slug":"lidocaine-hydrochloride-in-plastic-container","phase":"marketed","mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction.","indications":["Hemorrhoids","Infestation by Phthirus pubis","Infestation by Sarcoptes scabiei var hominis","Itching of skin","Local Anesthesia for Endotracheal Intubation"],"catalyst":""},{"name":"Xeljanz","genericName":"Tofacitinib Citrate","slug":"xeljanz-xr","phase":"marketed","mechanism":"Tofacitinib inhibits Janus kinase enzymes to prevent STAT phosphorylation and activation.","indications":["Juvenile idiopathic arthritis, extended oligoarthritis","Juvenile psoriatic arthritis","Polyarticular juvenile idiopathic arthritis","Psoriatic arthritis","Rheumatoid arthritis"],"catalyst":""},{"name":"Caduet","genericName":"Amlodipine Besylate","slug":"caduet","phase":"marketed","mechanism":"Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle.","indications":["Hypertension","Coronary Artery Disease (CAD)","Chronic Stable Angina","Vasospastic Angina (Prinzmetal’s or Variant Angina)","Angiographically Documented CAD"],"catalyst":""},{"name":"Milrinone Lactate","genericName":"Milrinone Lactate","slug":"milrinone-lactate","phase":"marketed","mechanism":"Phosphodiesterase-3 inhibitor that increases cardiac contractility and promotes vasodilation through cAMP elevation.","indications":["Acute decompensated heart failure","Acute decompensated heart failure in patients receiving digoxin","Acute decompensated heart failure in patients receiving diuretics"],"catalyst":""},{"name":"Norpace Cr","genericName":"Disopyramide Phosphate","slug":"norpace","phase":"marketed","mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent.","indications":["Documented ventricular arrhythmias","Sustained ventricular tachycardia","Life-threatening ventricular arrhythmias"],"catalyst":""},{"name":"Pipracil","genericName":"Piperacillin Sodium","slug":"zosyn-in-plastic-container","phase":"marketed","mechanism":"Piperacillin and tazobactam is an antibacterial drug combination.","indications":["Abdominal abscess","Acute gonococcal cervicitis","Acute gonococcal endometritis","Acute gonococcal urethritis","Appendicitis"],"catalyst":""},{"name":"Plegisol In Plastic Container","genericName":"Calcium Chloride","slug":"tpn-electrolytes-in-plastic-container","phase":"marketed","mechanism":"Source of water and electrolytes regulating fluid balance, osmotic pressure, acid-base equilibrium, and neuromuscular function.","indications":["Cardiac arrest","Disorder of electrolytes","Hyperkalemia","Hypermagnesemia","Hypocalcemia"],"catalyst":""},{"name":"Tracrium Preservative Free","genericName":"Atracurium Besylate","slug":"atracurium-besylate-preservative-free","phase":"marketed","mechanism":"Nondepolarizing skeletal muscle relaxant that competitively antagonizes acetylcholine at motor end-plate cholinergic receptors.","indications":["General anesthesia","Muscle relaxation, function","Skeletal Muscle Relaxation for Endotracheal Intubation"],"catalyst":""},{"name":"Azulfidine En-Tabs","genericName":"Sulfasalazine","slug":"azulfidine-en-tabs","phase":"marketed","mechanism":"Anti-inflammatory and immunomodulatory properties with affinity for connective tissue and high concentration in serous fluids.","indications":["Juvenile rheumatoid arthritis","Rheumatoid arthritis","Ulcerative colitis"],"catalyst":""},{"name":"Bacteriostatic Water For Injection In Plastic Container","genericName":"Sterile Water For Injection","slug":"bacteriostatic-water-for-injection-in-plastic-container","phase":"marketed","mechanism":"Bacteriostatic Water For Injection In Plastic Container (Sterile Water For Injection) is a sterile water for injection used as a vehicle for other medications.","indications":["Parenteral drug products that have not been mixed with other medicinal ingredients","Hypodermic injection as a vehicle for the administration of other medications","Intravenous injection as a vehicle for the administration of other medications","Intramuscular injection as a vehicle for the administration of other medications","Intravenous injection as a diluent for the reconstitution of lyophilized powders"],"catalyst":""},{"name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","genericName":"Dobutamine Hydrochloride","slug":"dobutamine-hydrochloride","phase":"marketed","mechanism":"Direct-acting inotropic agent stimulating cardiac beta-receptors with mild chronotropic and vasodilative effects.","indications":["Cardiac Decompensation","Cardiac Decompensation Post Cardiac Surgery","Cardiogenic shock","Decompensated cardiac failure","Organic Cardiac Disease"],"catalyst":""},{"name":"Idamycin Pfs","genericName":"Idarubicin Hydrochloride","slug":"idarubicin-hydrochloride","phase":"marketed","mechanism":"Idarubicin forms DNA complexes, inhibits nucleic acid synthesis and topoisomerase II, produces DNA-damaging free radicals.","indications":["Acute myeloid leukemia, disease","Acute promyelocytic leukemia, FAB M3"],"catalyst":""},{"name":"Magnesium Sulfate","genericName":"Magnesium Sulfate","slug":"magnesium-sulfate-in-plastic-container","phase":"marketed","mechanism":"Magnesium blocks neuromuscular transmission and decreases acetylcholine release, preventing seizures in preeclampsia and eclampsia.","indications":["Constipation","Eclampsia in pregnancy","Hypomagnesemia","Incomplete passage of stool","Mild pre-eclampsia"],"catalyst":""},{"name":"Pantoprazole Sodium","genericName":"Pantoprazole Sodium","slug":"protonix-iv","phase":"marketed","mechanism":"Pantoprazole suppresses gastric acid by covalently binding the (H+, K+)-ATPase enzyme at parietal cells.","indications":["Erosive esophagitis","Gastric Hypersecretory Conditions","Gastroesophageal reflux disease","Maintenance of Healing Erosive Esophagitis","Multiple endocrine adenomas"],"catalyst":""},{"name":"Revatio","genericName":"Sildenafil Citrate","slug":"revatio","phase":"marketed","mechanism":"Sildenafil inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels and enabling penile smooth muscle relaxation.","indications":["Impotence","Pulmonary arterial hypertension"],"catalyst":""},{"name":"Sutent","genericName":"Sunitinib Malate","slug":"sutent","phase":"marketed","mechanism":"Sunitinib inhibits multiple receptor tyrosine kinases implicated in tumor growth, angiogenesis, and metastatic progression.","indications":["Gastrointestinal stromal tumor","Pancreatic Neuroendocrine Tumor","Renal cell carcinoma"],"catalyst":""},{"name":"Cytotec","genericName":"Misoprostol","slug":"cytotec","phase":"marketed","mechanism":"Diclofenac inhibits COX-1/COX-2 to reduce prostaglandins; misoprostol is PGE1 analog protecting gastric mucosa.","indications":["Osteoarthritis in Patients at High Ulcer Risk","Postpartum hemorrhage","Prevention of CMV Disease After Organ Transplant","Prevention of NSAID-Induced Gastric Ulcer","Rheumatoid Arthritis in Patient at High Ulcer Risk"],"catalyst":""},{"name":"Paxlovid (Copackaged)","genericName":"Nirmatrelvir","slug":"paxlovid-copackaged","phase":"marketed","mechanism":"Nirmatrelvir inhibits SARS-CoV-2 main protease; ritonavir inhibits CYP3A-mediated metabolism of nirmatrelvir.","indications":["COVID-19"],"catalyst":""},{"name":"Rimegepant for acute migraine treatment","genericName":"rimegepant-for-acute-migraine-treatment","slug":"rimegepant-for-acute-migraine-treatment","phase":"marketed","mechanism":"Rimegepant targets the calcitonin gene-related peptide receptor to treat acute migraine.","indications":["Acute treatment of migraine with or without aura in adults"],"catalyst":""},{"name":"Atm-Avi","genericName":"atm-avi","slug":"atm-avi","phase":"marketed","mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia.","indications":["Treatment of acute bacterial exacerbation of chronic bronchitis (ABECB) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis.","Treatment of community-acquired pneumonia (CAP) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis.","Treatment of acute bacterial sinusitis (ABS) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis.","Treatment of uncomplicated urinary tract infections (UTIs) caused by Escherichia coli.","Treatment of acute pyelonephritis (APN) caused by Escherichia coli."],"catalyst":""},{"name":"Cytomel","genericName":"Liothyronine Sodium","slug":"cytomel","phase":"marketed","mechanism":"Thyroid hormones bind nuclear receptors to control DNA transcription and protein synthesis.","indications":["Hypothyroidism","Pituitary Thyroid-Stimulating Hormone (TSH) Suppression","Thyroid Suppression Test"],"catalyst":""},{"name":"Inlyta","genericName":"Axitinib","slug":"inlyta","phase":"marketed","mechanism":"Axitinib inhibits VEGFR-1, VEGFR-2, and VEGFR-3 to block pathologic angiogenesis and tumor growth.","indications":["Renal cell carcinoma"],"catalyst":""},{"name":"Menest","genericName":"Estrogens, Esterified","slug":"menest","phase":"marketed","mechanism":"Esterified estrogens, sold under the brand names Estratab and Menest, are used for hormone therapy and cancer treatment.","indications":["Treatment of moderate to severe vasomotor symptoms associated with the menopause","Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause","Female hypogonadism","Female castration","Primary ovarian failure"],"catalyst":""},{"name":"Pfizer-BioNTech COVID-19 mRNA vaccine","genericName":"Pfizer-BioNTech COVID-19 mRNA vaccine","slug":"pfizer-biontech-covid-19-mrna-vaccine","phase":"marketed","mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response","indications":["Prevention of COVID-19 in individuals 6 months of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older with certain underlying medical conditions","Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems"],"catalyst":""},{"name":"Premarin","genericName":"Estrogens, Conjugated","slug":"prempro","phase":"marketed","mechanism":"Conjugated estrogens bind to nuclear estrogen receptors in estrogen-responsive tissues, modulating gonadotropin secretion and reducing elevated LH and FSH levels in postmenopausal women.","indications":["Dyspareunia","Menopausal flushing"],"catalyst":""},{"name":"Sterile Water","genericName":"Sterile Water For Injection","slug":"sterile-water-for-injection","phase":"marketed","mechanism":"","indications":["Dilution or Dissolution for Injection"],"catalyst":""},{"name":"Synarel","genericName":"Nafarelin Acetate","slug":"synarel","phase":"marketed","mechanism":"Gonadotropin-releasing hormone agonist medication","indications":["Treatment of central precocious puberty (CPP) (gonadotropin-dependent precocious puberty) in children of both sexes","Exclusion of other causes of sexual precocity, such as congenital adrenal hyperplasia, testotoxicosis, testicular tumors and/or other autonomous feminizing or masculinizing disorders","Detection of hypothalamic or pituitary tumors, or anatomical changes associated with increased intracranial pressure"],"catalyst":""},{"name":"Active","genericName":"active","slug":"active","phase":"discontinued","mechanism":"Sisunatovir","indications":["Respiratory Syncytial Virus Infections"],"catalyst":""},{"name":"Aldactone","genericName":"Spironolactone","slug":"aldactone","phase":"marketed","mechanism":"Aldosterone antagonist causing increased sodium and water excretion while retaining potassium.","indications":["NYHA Class III-IV heart failure with reduced ejection fraction","Hypertension as add-on therapy","Edema in cirrhotic patients unresponsive to fluid and sodium restriction","Edema in nephrotic syndrome with inadequate response to other treatments","Short-term preoperative treatment of primary hyperaldosteronism"],"catalyst":""},{"name":"Allr3","genericName":"allr3","slug":"allr3","phase":"marketed","mechanism":"The molecular target of ALLR3 is not specified.","indications":["Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least two prior therapies","Relapsed or refractory follicular lymphoma after at least two prior therapies","Relapsed or refractory marginal zone lymphoma (MZL) after at least two prior therapies","Relapsed or refractory mantle cell lymphoma (MCL) after at least two prior therapies","Relapsed or refractory small lymphocytic lymphoma (SLL) after at least two prior therapies"],"catalyst":""},{"name":"Aridol Kit","genericName":"Mannitol","slug":"mannitol-25","phase":"marketed","mechanism":"Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption.","indications":["Benign intracranial hypertension","Cerebral edema","Cystic fibrosis","Edema","Hemolysis Prevention"],"catalyst":""},{"name":"Arthrotec","genericName":"Diclofenac Sodium","slug":"arthrotec","phase":"marketed","mechanism":"Acid-sensing ion channel 3","indications":["Actinic keratosis","Adhesive capsulitis of shoulder","Analgesia in various types of cancer","Ankylosing spondylitis","Dysmenorrhea"],"catalyst":""},{"name":"BNT162b2 (Omi XBB.1.5)/RIV","genericName":"bnt162b2-omi-xbb-1-5-riv","slug":"bnt162b2-omi-xbb-1-5-riv","phase":"marketed","mechanism":"SARS-CoV-2","indications":["Prevention of COVID-19 in individuals 6 months of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 6 months of age and older, when administered as a third dose in a series of the Pfizer-BioNTech COVID-19 Vaccine","Prevention of COVID-19 in individuals 5 years of age and older, when administered as a third dose in a series of the Pfizer-BioNTech COVID-19 Vaccine"],"catalyst":""},{"name":"BNT162b2 Bivalent (WT/OMI BA.1)","genericName":"bnt162b2-bivalent-wt-omi-ba-1","slug":"bnt162b2-bivalent-wt-omi-ba-1","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 6 months through 4 years of age"],"catalyst":""},{"name":"BNT162b5 Bivalent (WT/OMI BA.2)","genericName":"bnt162b5-bivalent-wt-omi-ba-2","slug":"bnt162b5-bivalent-wt-omi-ba-2","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["COVID-19 prevention in individuals 12 years of age and older","COVID-19 treatment in individuals 12 years of age and older"],"catalyst":""},{"name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","genericName":"bnt162b6-bivalent-original-omi-ba-4-ba-5","slug":"bnt162b6-bivalent-original-omi-ba-4-ba-5","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["COVID-19 prevention in individuals 12 years of age and older","COVID-19 prevention in individuals 5 years of age and older","COVID-19 prevention in individuals 6 months through 4 years of age","COVID-19 prevention in individuals 5 years of age and older with certain immunocompromised individuals","COVID-19 prevention in individuals 12 years of age and older with certain immunocompromised individuals"],"catalyst":""},{"name":"BNT162b7 Bivalent (Original/OMI BA.4/BA.5)","genericName":"bnt162b7-bivalent-original-omi-ba-4-ba-5","slug":"bnt162b7-bivalent-original-omi-ba-4-ba-5","phase":"marketed","mechanism":"BNT162b7 Bivalent is a mRNA-based vaccine targeting SARS-CoV-2 spike protein.","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 5 years of age and older"],"catalyst":""},{"name":"Benzamycin","genericName":"Erythromycin Lactobionate","slug":"erythrocin","phase":"marketed","mechanism":"Potassium voltage-gated channel subfamily H member 2","indications":["Acne vulgaris","Acute bacterial sinusitis","Acute gonococcal cervicitis","Acute gonococcal endometritis","Acute gonococcal urethritis"],"catalyst":""},{"name":"Bicillin C-R","genericName":"Penicillin G Benzathine","slug":"bicillin-c-r-900-300","phase":"marketed","mechanism":"Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.","indications":["Erysipelas","Pneumococcal pneumonia","Pneumonia due to Streptococcus","Scarlet fever","Streptococcal infectious disease"],"catalyst":""},{"name":"Bicillin C-R","genericName":"Penicillin G Benzathine","slug":"bicillin-l-a","phase":"marketed","mechanism":"Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.","indications":["Erysipelas","Pneumococcal pneumonia","Pneumonia due to Streptococcus","Scarlet fever","Streptococcal infectious disease"],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Epinephrine","slug":"lidocaine-hydrochloride-and-epinephrine","phase":"marketed","mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels.","indications":["Acute exacerbation of asthma","Administration of Local Anesthetic Nerve Block","Allergic Reactions","Anaphylaxis","Asthma management"],"catalyst":""},{"name":"Chantix","genericName":"Varenicline Tartrate","slug":"chantix","phase":"marketed","mechanism":"Varenicline binds α4β2 neuronal nicotinic acetylcholine receptors as partial agonist, blocking nicotine binding and dopamine reward.","indications":["Treatment of adult smokers to help them stop smoking","Treatment of adult smokers with a history of serious psychiatric illness to help them stop smoking"],"catalyst":""},{"name":"Cipro","genericName":"Ciprofloxacin","slug":"ciprofloxacin-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Ciprofloxacin interferes with bacterial DNA gyrase, inhibiting DNA synthesis.","indications":["Abdominal abscess","Acute Moraxella catarrhalis bronchitis","Acute bacterial bronchitis","Acute bacterial peritonitis","Acute bacterial sinusitis"],"catalyst":""},{"name":"Coaxil","genericName":"tianeptine","slug":"tianeptine","phase":"marketed","mechanism":"Tianeptine works by binding to the mu-type opioid receptor, which can affect the brain's response to pain and emotions.","indications":[],"catalyst":""},{"name":"Corticosteroids","genericName":"corticosteroids","slug":"corticosteroids","phase":"discontinued","mechanism":"","indications":[],"catalyst":""},{"name":"D-Col Personal Hygiene Convenience Kit","genericName":"col","slug":"col","phase":"marketed","mechanism":"COL's mechanism of action is not well-documented, but it is believed to target various molecular targets.","indications":["Antiseptic skin preparation for patient","Hand wash for healthcare personnel","Surgical hand scrub"],"catalyst":""},{"name":"Dilantin","genericName":"Phenytoin Sodium","slug":"dilantin","phase":"marketed","mechanism":"Phenytoin exerts its therapeutic effect by voltage-dependent blockade of membrane sodium channels.","indications":["Bipolar disorder in remission","Epilepsy","Epilepsy characterized by intractable complex partial seizures","Lennox-Gastaut syndrome","Localization-related epilepsy"],"catalyst":""},{"name":"Duavee","genericName":"Bazedoxifene Acetate","slug":"duavee","phase":"marketed","mechanism":"Pairs conjugated estrogens with bazedoxifene to bind and activate estrogen receptors α and β with tissue-specific effects.","indications":["Treatment of moderate to severe vasomotor symptoms associated with menopause","Prevention of postmenopausal osteoporosis"],"catalyst":""},{"name":"Elelyso","genericName":"Taliglucerase Alfa","slug":"elelyso","phase":"marketed","mechanism":"Recombinant glucocerebrosidase enzyme replacement therapy that catalyzes hydrolysis of glucocerebroside to glucose and ceramide.","indications":["Type 1 Gaucher disease"],"catalyst":""},{"name":"Etrasimod","genericName":"etrasimod","slug":"etrasimod","phase":"marketed","mechanism":"Etrasimod is an S1P receptor modulator that blocks lymphocyte egress from lymphoid organs, reducing peripheral blood lymphocytes.","indications":["Moderate to severe ulcerative colitis","Induction of remission in adults with moderately to severely active ulcerative colitis","Maintenance of clinical response and endoscopic remission in adults with moderately to severely active ulcerative colitis","Moderate to severe Crohn's disease","Induction of clinical remission in adults with moderately to severely active Crohn's disease"],"catalyst":""},{"name":"Hib","genericName":"hib","slug":"hib","phase":"marketed","mechanism":"Hib is a bacterial vaccine that stimulates an immune response against Haemophilus influenzae type b.","indications":["Prevention of Haemophilus influenzae type b (Hib) disease caused by Haemophilus influenzae type b (Hib) in children 6 weeks through 18 months of age","Prevention of Haemophilus influenzae type b (Hib) disease caused by Haemophilus influenzae type b (Hib) in children 12 through 15 months of age","Prevention of Haemophilus influenzae type b (Hib) disease caused by Haemophilus influenzae type b (Hib) in children 12 through 59 months of age","Prevention of Haemophilus influenzae type b (Hib) disease caused by Haemophilus influenzae type b (Hib) in children 12 through 71 months of age","Prevention of Haemophilus influenzae type b (Hib) disease caused by Haemophilus influenzae type b (Hib) in children 12 through 72 months of age"],"catalyst":""},{"name":"Hympavzi","genericName":"Marstacimab-Hncq","slug":"hympavzi","phase":"marketed","mechanism":"Monoclonal antibody against TFPI Kunitz domain 2 to neutralize TFPI and enhance coagulation.","indications":["Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency) without factor VIII inhibitors","Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia B (congenital factor IX deficiency) without factor IX inhibitors"],"catalyst":""},{"name":"Induction- PF-06480605 150 mg SC Q4W","genericName":"induction-pf-06480605-150-mg-sc-q4w","slug":"induction-pf-06480605-150-mg-sc-q4w","phase":"marketed","mechanism":"PF-06480605 is a medication for the treatment of inflammatory conditions, administered via subcutaneous injection every 4 weeks.","indications":["Moderate to Severe Atopic Dermatitis","Moderate to Severe Plaque Psoriasis","Active Psoriatic Arthritis","Ankylosing Spondylitis","Psoriatic Arthritis and Ankylosing Spondylitis"],"catalyst":""},{"name":"Levophed","genericName":"Norepinephrine Bitartrate","slug":"levophed","phase":"marketed","mechanism":"Peripheral vasoconstrictor via alpha-adrenergic action and cardiac inotropic stimulator with coronary vasodilation via beta-adrenergic action.","indications":["Severe, acute hypotension in adult patients","Acute hypotensive states in adult patients","Blood pressure restoration in adult patients"],"catalyst":""},{"name":"Levoxyl","genericName":"Levothyroxine Sodium","slug":"levoxyl","phase":"marketed","mechanism":"Levothyroxine binds thyroid receptors in cell nuclei to activate gene transcription and protein synthesis.","indications":["Primary hypothyroidism - replacement therapy","Secondary hypothyroidism - replacement therapy","Tertiary hypothyroidism - replacement therapy","Congenital hypothyroidism - replacement therapy","Acquired hypothyroidism - replacement therapy"],"catalyst":""},{"name":"Lyrica","genericName":"Pregabalin","slug":"lyrica","phase":"marketed","mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS.","indications":["Neuropathic pain associated with diabetic peripheral neuropathy","Postherpetic neuralgia","Adjunctive therapy for partial-onset seizures","Fibromyalgia","Neuropathic pain associated with spinal cord injury"],"catalyst":""},{"name":"MET097 Injection","genericName":"met097-injection","slug":"met097-injection","phase":"marketed","mechanism":"MET097 Injection's mechanism of action is not specified.","indications":["Treatment of certain types of cancer, such as non-small cell lung cancer, melanoma, and renal cell carcinoma","Treatment of certain types of thyroid cancer","Treatment of certain types of brain cancer","Treatment of certain types of colorectal cancer","Treatment of certain types of breast cancer"],"catalyst":""},{"name":"MTZ","genericName":"mtz","slug":"mtz","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Mannitol 15%","genericName":"Mannitol","slug":"mannitol-15","phase":"marketed","mechanism":"Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption.","indications":["Reduction of intracranial pressure","Treatment of cerebral edema","Reduction of elevated intraocular pressure"],"catalyst":""},{"name":"Medium Dose PF-07328948","genericName":"medium-dose-pf-07328948","slug":"medium-dose-pf-07328948","phase":"marketed","mechanism":"Unknown","indications":["COVID-19"],"catalyst":""},{"name":"Meperidine Hydrochloride Preservative Free","genericName":"Meperidine Hydrochloride","slug":"demerol","phase":"marketed","mechanism":"Meperidine Hydrochloride Preservative Free works by binding to opioid receptors in the brain, altering the perception of and response to pain.","indications":["General anesthesia","Labor pain","Local anesthesia","Pain","Sedation as Adjunct to Anesthesia"],"catalyst":""},{"name":"Mer Detox 6019","genericName":"mer","slug":"mer","phase":"marketed","mechanism":"Unknown","indications":["Exhaustion or Weakness","Muscle Soreness","Minor Joint Pain or Stiffness","Headache","Dizziness"],"catalyst":""},{"name":"Merrem","genericName":"Meropenem","slug":"meropenem","phase":"marketed","mechanism":"Meropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.","indications":["Abdominal abscess","Bacterial meningitis","Bacteroides Complicated Appendicitis","Bacteroides Peritonitis","Complicated Skin and Skin Structure Infection"],"catalyst":""},{"name":"Naloxone Hydrochloride","genericName":"Naloxone Hydrochloride","slug":"naloxone-hydrochloride","phase":"marketed","mechanism":"Pentazocine is a mixed agonist-antagonist at opioid receptors; naloxone is an opioid antagonist.","indications":["Management of pain severe enough to require an opioid analgesic","Pain in patients for whom alternative treatment options are ineffective","Pain in patients for whom alternative treatment options are not tolerated","Pain in patients for whom alternative treatment options would be otherwise inadequate"],"catalyst":""},{"name":"Neurontin","genericName":"Gabapentin","slug":"neurontin","phase":"marketed","mechanism":"Gabapentin binds with high-affinity to α2δ subunit of voltage-activated calcium channels; precise mechanism unknown.","indications":["Postherpetic neuralgia","Partial seizures","Seizures associated with amyotrophic lateral sclerosis (ALS)","Neuropathic pain associated with spinal cord injury","Phantom limb pain"],"catalyst":""},{"name":"Ngenla","genericName":"Somatrogon-Ghla","slug":"ngenla","phase":"marketed","mechanism":"Ngenla works by binding to the growth hormone receptor, mimicking the action of natural growth hormone to stimulate growth and development.","indications":["Growth hormone deficiency"],"catalyst":""},{"name":"Norpace Cr","genericName":"Disopyramide Phosphate","slug":"norpace-cr","phase":"marketed","mechanism":"Type 1 antiarrhythmic that decreases diastolic depolarization and increases action potential duration.","indications":["Ventricular arrhythmia"],"catalyst":""},{"name":"Norvasc","genericName":"Amlodipine Besylate","slug":"norvasc","phase":"marketed","mechanism":"Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle cells.","indications":["Hypertension","Chronic Stable Angina","Vasospastic Angina (Prinzmetal's or Variant Angina)","Angiographically Documented Coronary Artery Disease (in patients without heart failure or ejection fraction <40%)"],"catalyst":""},{"name":"PF-07868489","genericName":"pf-07868489","slug":"pf-07868489","phase":"phase_1","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07976016","genericName":"pf-07976016","slug":"pf-07976016","phase":"discontinued","mechanism":"","indications":["Obesity"],"catalyst":""},{"name":"PF-08653944","genericName":"pf-08653944","slug":"pf-08653944","phase":"marketed","mechanism":"unknown","indications":["Indication not found","Indication not found"],"catalyst":""},{"name":"Palbociclib","genericName":"palbociclib","slug":"palbociclib","phase":"marketed","mechanism":"Palbociclib inhibits CDK4/6 to block G1/S cell cycle progression in ER-positive breast cancer.","indications":["Treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy","Treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with fulvestrant in patients with disease progression following endocrine therapy","Treatment of adult patients with endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy, in combination with inavolisib and fulvestrant"],"catalyst":""},{"name":"Paroxetine","genericName":"paroxetine","slug":"paroxetine","phase":"marketed","mechanism":"Inhibits neuronal reuptake of serotonin in the central nervous system, presumed mechanism for treating psychiatric disorders.","indications":["Major Depressive Disorder (MDD)","Obsessive Compulsive Disorder (OCD)","Panic Disorder (PD)","Social Anxiety Disorder (SAD)","Generalized Anxiety Disorder (GAD)"],"catalyst":""},{"name":"Part A: ATM-AVI Single Dose, Cohorts 1-4","genericName":"part-a-atm-avi-single-dose-cohorts-1-4","slug":"part-a-atm-avi-single-dose-cohorts-1-4","phase":"marketed","mechanism":"Spike protein of SARS-CoV-2","indications":["Treatment of COVID-19 in adults and pediatric patients (12 years of age and older) who are at high risk of progression to severe COVID-19, including those who are hospitalized due to COVID-19 or who have mild to moderate COVID-19 with at least one risk factor for progression to severe COVID-19 (e.g., older age, certain chronic medical conditions)","Prevention of COVID-19 in adults and pediatric patients (12 years of age and older) who are at high risk of COVID-19"],"catalyst":""},{"name":"Pf-06700841","genericName":"pf-06700841","slug":"pf-06700841","phase":"marketed","mechanism":"Unknown","indications":["Multiple Sclerosis"],"catalyst":""},{"name":"Pf-07054894","genericName":"pf-07054894","slug":"pf-07054894","phase":"marketed","mechanism":"A small molecule drug with unknown molecular target.","indications":["Indication not found","Indication not found"],"catalyst":""},{"name":"Plasma-Lyte A In Plastic Container","genericName":"Sodium Acetate","slug":"sodium-acetate","phase":"marketed","mechanism":"Sodium acetate works by inhibiting the enzyme carbonic anhydrase 1, which plays a crucial role in maintaining acid-base balance in the body.","indications":[],"catalyst":""},{"name":"Plegisol In Plastic Container","genericName":"Sodium Chloride","slug":"bacteriostatic-sodium-chloride-0-9-in-plastic-container","phase":"marketed","mechanism":"Provides isotonic saline irrigation with mechanical cleansing action for sterile irrigation of body cavities, tissues, wounds, and surgical equipment.","indications":[],"catalyst":""},{"name":"Potassium Acetate","genericName":"Potassium Acetate","slug":"potassium-acetate","phase":"marketed","mechanism":"Small molecule","indications":["Hypokalemia","Hypokalemia Prevention"],"catalyst":""},{"name":"Potassium Phosphates","genericName":"Potassium Phosphate, Dibasic","slug":"potassium-phosphates","phase":"marketed","mechanism":"Phosphate replaces deficient phosphorus for nucleic acid structure, energy storage, cell signaling, and bone mineralization.","indications":["Treatment of potassium deficiency (hypokalemia) in patients with normal renal function.","Treatment of potassium deficiency (hypokalemia) in patients with impaired renal function.","Treatment of potassium deficiency (hypokalemia) in patients with potassium-wasting nephropathy.","Treatment of potassium deficiency (hypokalemia) in patients with potassium-wasting renal tubular acidosis.","Treatment of potassium deficiency (hypokalemia) in patients with potassium-wasting conditions."],"catalyst":""},{"name":"Premarin","genericName":"Estrogens, Conjugated","slug":"premphase-14-14","phase":"marketed","mechanism":"Conjugated estrogens bind to nuclear estrogen receptors in estrogen-responsive tissues, modulating gonadotropin secretion and reducing elevated LH and FSH levels in postmenopausal women.","indications":["Dyspareunia","Menopausal flushing"],"catalyst":""},{"name":"Qiv","genericName":"qiv","slug":"qiv","phase":"marketed","mechanism":"Influenza viruses","indications":["Influenza prevention","Prevention of influenza A virus, A(H1N1)pdm09, A(H3N2), and influenza B viruses"],"catalyst":""},{"name":"RSVpreF","genericName":"rsvpref","slug":"rsvpref","phase":"marketed","mechanism":"RSV F protein","indications":["Prevention of RSV lower respiratory tract disease in neonates at high risk of RSV disease","Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease"],"catalyst":""},{"name":"Raxtozinameran 6 months to 4 years of age","genericName":"raxtozinameran-6-months-to-4-years-of-age","slug":"raxtozinameran-6-months-to-4-years-of-age","phase":"marketed","mechanism":"SARS-CoV-2 virus","indications":["COVID-19 prevention"],"catalyst":""},{"name":"Regadenoson","genericName":"Regadenoson","slug":"regadenoson","phase":"marketed","mechanism":"Regadenoson is a low affinity A2A adenosine receptor agonist that produces coronary vasodilation and increases coronary blood flow.","indications":["Myocardial Perfusion Imaging Adjunct"],"catalyst":""},{"name":"Riltozinameran 12 Years of age and older","genericName":"riltozinameran-12-years-of-age-and-older","slug":"riltozinameran-12-years-of-age-and-older","phase":"marketed","mechanism":"Mechanism of action is not specified on Wikipedia.","indications":["Amyotrophic lateral sclerosis (ALS)"],"catalyst":""},{"name":"Rimegepant 75mg Orally Disintegrating Tablets (ODT)","genericName":"rimegepant-75mg-orally-disintegrating-tablets-odt","slug":"rimegepant-75mg-orally-disintegrating-tablets-odt","phase":"marketed","mechanism":"Rimegepant is a calcitonin gene-related peptide receptor antagonist.","indications":["Acute treatment of migraine attacks with or without aura in adults"],"catalyst":""},{"name":"Rimegepant 75mg daily dosing","genericName":"rimegepant-75mg-daily-dosing","slug":"rimegepant-75mg-daily-dosing","phase":"marketed","mechanism":"Rimegepant is a calcitonin gene-related peptide receptor antagonist that inhibits the release of pro-inflammatory peptides.","indications":["Acute treatment of migraine attacks with or without aura in adults","Prevention of migraine attacks in adults"],"catalyst":""},{"name":"Silvadene","genericName":"Silver Sulfadiazine","slug":"silvadene","phase":"marketed","mechanism":"Silver sulfadiazine acts on bacterial cell membrane and cell wall to produce bactericidal effect.","indications":["Burn Wound Infections","Minor Bacterial Skin Infections","Skin ulcer"],"catalyst":""},{"name":"Tikosyn","genericName":"Dofetilide","slug":"tikosyn","phase":"marketed","mechanism":"Blocks cardiac potassium channel IKr to prolong repolarization and delay arrhythmia recurrence.","indications":["Maintenance of Normal Sinus Rhythm (Delay in AF/AFl Recurrence)","Conversion of Atrial Fibrillation/Flutter"],"catalyst":""},{"name":"Tozinameran 12 Years of age and older","genericName":"tozinameran-12-years-of-age-and-older","slug":"tozinameran-12-years-of-age-and-older","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 12 years of age and older"],"catalyst":""},{"name":"Tozinameran 6 months to 4 years of age","genericName":"tozinameran-6-months-to-4-years-of-age","slug":"tozinameran-6-months-to-4-years-of-age","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 6 months of age and older"],"catalyst":""},{"name":"Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose","genericName":"variant-adapted-bnt162b2-omicron-xbb-1-5-10-microgram-dose","slug":"variant-adapted-bnt162b2-omicron-xbb-1-5-10-microgram-dose","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 6 months through 11 years of age"],"catalyst":""},{"name":"Velsipity","genericName":"Etrasimod Arginine","slug":"velsipity","phase":"marketed","mechanism":"Etrasimod binds S1P receptors 1, 4, and 5, blocking lymphocyte egress from lymphoid organs.","indications":["Moderate to severe ulcerative colitis","Induction of remission in adults with moderately to severely active ulcerative colitis","Maintenance of clinical response and remission in adults with moderately to severely active ulcerative colitis","Moderate to severe Crohn's disease","Induction of clinical remission in adults with moderately to severely active Crohn's disease"],"catalyst":""},{"name":"Viagra","genericName":"Sildenafil Citrate","slug":"viagra","phase":"marketed","mechanism":"Sildenafil inhibits phosphodiesterase type 5 to increase cGMP levels, enabling smooth muscle relaxation and penile blood inflow.","indications":["Impotence","Pulmonary arterial hypertension"],"catalyst":""},{"name":"Vitamin K antagonist (VKA)","genericName":"vitamin-k-antagonist-vka","slug":"vitamin-k-antagonist-vka","phase":"preclinical","mechanism":"The mechanism of action of Vitamin K antagonist (VKA) is not specified.","indications":["Prophylaxis and treatment of venous thrombosis and thromboembolism","Prophylaxis and treatment of pulmonary embolism","Prophylaxis and treatment of deep vein thrombosis","Prophylaxis and treatment of myocardial infarction","Prophylaxis and treatment of stroke"],"catalyst":""},{"name":"Zarontin","genericName":"Ethosuximide","slug":"zarontin","phase":"marketed","mechanism":"Suppresses paroxysmal three cycle per second spike and wave activity associated with absence seizures.","indications":["Absence seizure"],"catalyst":""},{"name":"Zyvox","genericName":"linezolid","slug":"linezolid","phase":"marketed","mechanism":"Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria.","indications":["Complicated Skin and Skin Structure Staphylococcus Aureus Infection","Complicated Skin and Skin Structure Streptococcus Agalactiae Infection","Complicated Skin and Skin Structure Streptococcus Pyogenes Infection","Diabetic Foot Infection Due to Gram-Positive Bacteria","Infection due to Staphylococcus aureus"],"catalyst":""},{"name":"bIRV","genericName":"birv","slug":"birv","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"qIRV (22/23)","genericName":"qirv-22-23","slug":"qirv-22-23","phase":"marketed","mechanism":"Unknown","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"(Part C) MET097","genericName":"part-c-met097","slug":"part-c-met097","phase":"marketed","mechanism":"The exact mechanism of action is not specified on Wikipedia.","indications":["Treatment of Acute Myeloid Leukemia (AML)","Treatment of Chronic Myeloid Leukemia (CML)","Treatment of Myeloproliferative Neoplasms (MPNs)","Treatment of Polycythemia Vera (PV)","Treatment of Essential Thrombocythemia (ET)"],"catalyst":""},{"name":"Acid Reflux Relief","genericName":"Sodium Phosphate, Dibasic, Heptahydrate","slug":"sodium-phosphates-in-plastic-container","phase":"marketed","mechanism":"Carbonic anhydrase 4","indications":["To preserve purity avoid touching pellets with fingers","Take apart from food or drinks","To dissolve under your tongue before meals or as needed"],"catalyst":""},{"name":"Advanced therapy only without dietary intervention","genericName":"advanced-therapy-only-without-dietary-intervention","slug":"advanced-therapy-only-without-dietary-intervention","phase":"marketed","mechanism":"various cell types","indications":["Autologous Cultured Chondrocytes for Cartilage Repair","Autologous Stem Cell Transplantation for the Treatment of HIV","Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Graft-Versus-Host Disease","Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Sickle Cell Disease","Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Systemic Lupus Erythematosus"],"catalyst":""},{"name":"Amidate","genericName":"Etomidate","slug":"amidate","phase":"marketed","mechanism":"GABA A receptor alpha-2/beta-2/gamma-2","indications":["Induction of general anesthesia","Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures","Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for dilation and curettage","Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization"],"catalyst":""},{"name":"Antiplatelet Drug","genericName":"antiplatelet-drug","slug":"antiplatelet-drug","phase":"discontinued","mechanism":"","indications":["Ischemic Stroke"],"catalyst":""},{"name":"Aridol Kit","genericName":"Mannitol","slug":"mannitol-5","phase":"marketed","mechanism":"Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption.","indications":["Benign intracranial hypertension","Cerebral edema","Cystic fibrosis","Edema","Hemolysis Prevention"],"catalyst":""},{"name":"Aridol Kit","genericName":"Mannitol","slug":"mannitol-10","phase":"marketed","mechanism":"Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption.","indications":["Benign intracranial hypertension","Cerebral edema","Cystic fibrosis","Edema","Hemolysis Prevention"],"catalyst":""},{"name":"Assorted Licensed Hand Sanitizer Grape 01","genericName":"Licensed influenza vaccine","slug":"licensed-influenza-vaccine","phase":"marketed","mechanism":"The mechanism of action is not specified.","indications":["Influenza prevention","Influenza vaccination","Influenza protection"],"catalyst":""},{"name":"Atracurium","genericName":"Atracurium Besylate","slug":"atracurium-besylate","phase":"marketed","mechanism":"Nondepolarizing skeletal muscle relaxant that competitively antagonizes acetylcholine at motor end-plate cholinergic receptors.","indications":["General anesthesia","Muscle relaxation, function","Skeletal Muscle Relaxation for Endotracheal Intubation"],"catalyst":""},{"name":"Azulfidine","genericName":"Sulfasalazine","slug":"azulfidine","phase":"marketed","mechanism":"Anti-inflammatory and immunomodulatory properties, with 5-ASA as major therapeutic moiety in ulcerative colitis.","indications":["Treatment of mild to moderate ulcerative colitis","Adjunctive therapy in severe ulcerative colitis","Prolongation of the remission period between acute attacks of ulcerative colitis","Treatment of rheumatoid arthritis","Treatment of pediatric patients with polyarticular-course 1 juvenile rheumatoid arthritis"],"catalyst":""},{"name":"BHV-3500 (zavegepant)","genericName":"bhv-3500-zavegepant","slug":"bhv-3500-zavegepant","phase":"discontinued","mechanism":"Zavegepant is a CGRP receptor antagonist that blocks neuropeptide signaling to reduce migraine pain and associated symptoms.","indications":["Acute migraine treatment","Acute migraine treatment","Acute migraine"],"catalyst":""},{"name":"BNT162b2","genericName":"bnt162b2","slug":"bnt162b2","phase":"marketed","mechanism":"SARS-CoV-2 virus","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"BNT162b2 (2025/2026 formulation)","genericName":"bnt162b2-2025-2026-formulation","slug":"bnt162b2-2025-2026-formulation","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"BNT162b2 (Omi JN.1)","genericName":"bnt162b2-omi-jn-1","slug":"bnt162b2-omi-jn-1","phase":"marketed","mechanism":"unknown","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"BNT162b2 (Omi KP.2)","genericName":"bnt162b2-omi-kp-2","slug":"bnt162b2-omi-kp-2","phase":"marketed","mechanism":"Spike protein of SARS-CoV-2","indications":["Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 6 months through 4 years of age","Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions","Prevention of COVID-19 in individuals 5 years of age and older with certain health conditions"],"catalyst":""},{"name":"BNT162b2 (Omi XBB.1.5)","genericName":"bnt162b2-omi-xbb-1-5","slug":"bnt162b2-omi-xbb-1-5","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 6 months of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 6 months of age and older with certain underlying medical conditions","Prevention of COVID-19 in individuals 6 months of age and older with weakened immune systems"],"catalyst":""},{"name":"BNT162b2 BA.4/5 bivalent","genericName":"bnt162b2-ba-4-5-bivalent","slug":"bnt162b2-ba-4-5-bivalent","phase":"marketed","mechanism":"SARS-CoV-2 virus","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 6 months through 4 years of age"],"catalyst":""},{"name":"BNT162b2 Bivalent (WT/OMI BA.4/BA.5)","genericName":"bnt162b2-bivalent-wt-omi-ba-4-ba-5","slug":"bnt162b2-bivalent-wt-omi-ba-4-ba-5","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg","genericName":"bnt162b2-bivalent-original-omicron-ba-4-ba-5-30-mcg","slug":"bnt162b2-bivalent-original-omicron-ba-4-ba-5-30-mcg","phase":"marketed","mechanism":"Stimulates the body's immune system to produce antibodies against the SARS-CoV-2 virus.","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 5 years of age and older","Prevention of COVID-19 in individuals 6 months through 4 years of age"],"catalyst":""},{"name":"BNT162b2 OMI","genericName":"bnt162b2-omi","slug":"bnt162b2-omi","phase":"marketed","mechanism":"Not specified","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"BNT162b4 10 mcg","genericName":"bnt162b4-10-mcg","slug":"bnt162b4-10-mcg","phase":"marketed","mechanism":"Unknown","indications":["COVID-19 prevention"],"catalyst":""},{"name":"BNT162b4 15 mcg","genericName":"bnt162b4-15-mcg","slug":"bnt162b4-15-mcg","phase":"marketed","mechanism":"Unknown","indications":["COVID-19 prevention"],"catalyst":""},{"name":"BNT162b4 5 mcg","genericName":"bnt162b4-5-mcg","slug":"bnt162b4-5-mcg","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["COVID-19 prevention"],"catalyst":""},{"name":"BNT162b5 Bivalent (Original/OMI BA.4/BA.5)","genericName":"bnt162b5-bivalent-original-omi-ba-4-ba-5","slug":"bnt162b5-bivalent-original-omi-ba-4-ba-5","phase":"marketed","mechanism":"Targets the SARS-CoV-2 virus to prevent and treat COVID-19","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"BNT162b7 Monovalent (OMI BA.4/BA.5)","genericName":"bnt162b7-monovalent-omi-ba-4-ba-5","slug":"bnt162b7-monovalent-omi-ba-4-ba-5","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 12 years of age and older"],"catalyst":""},{"name":"Bat","genericName":"bat","slug":"bat","phase":"marketed","mechanism":"Unknown","indications":["Treatment of partial-onset seizures with and without secondary generalization in patients 12 years of age and older with epilepsy","Adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy","Treatment of primary generalized tonic-clonic seizures in patients 2 years of age and older with epilepsy","Treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older with epilepsy","Treatment of postherpetic neuralgia in adults"],"catalyst":""},{"name":"Best Available Treatment","genericName":"best-available-treatment","slug":"best-available-treatment","phase":"marketed","mechanism":"Not specified on Wikipedia","indications":["Acute Ischemic Stroke","Acute Ischemic Stroke with a Large Vessel Occlusion","Acute Ischemic Stroke with a Malignant Cerebral Edema","Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema","Acute Ischemic Stroke with a Large Vessel Occlusion and Malignant Cerebral Edema in the Posterior Circulation"],"catalyst":""},{"name":"Bretovameran","genericName":"bretovameran","slug":"bretovameran","phase":"marketed","mechanism":"","indications":["Bretovameran is not approved by the FDA. It is a research compound."],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride","phase":"marketed","mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride-w-epinephrine","phase":"marketed","mechanism":"Bupivacaine blocks nerve impulses by increasing the threshold for electrical excitation, slowing nerve impulse propagation, and reducing the rate of rise of the action potential.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride-w-epinephrine-preservative-free","phase":"marketed","mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"marcaine-hydrochloride-preservative-free","phase":"marketed","mechanism":"Bupivacaine Hydrochloride blocks nerve impulses by inhibiting sodium channels.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"Bupivacaine Hydrochloride","slug":"bupivacaine-hydrochloride","phase":"marketed","mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Camptosar","genericName":"Irinotecan Hydrochloride","slug":"irinotecan-hydrochloride","phase":"marketed","mechanism":"Camptosar works by blocking the enzyme topoisomerase I, which is necessary for DNA replication, thereby preventing cancer cells from dividing and growing.","indications":["Adenocarcinoma of pancreas","Metastasis from malignant tumor of colon","Secondary malignant neoplasm of pancreas"],"catalyst":""},{"name":"Chronic- PF-06480605 150 mg SC Q4W","genericName":"chronic-pf-06480605-150-mg-sc-q4w","slug":"chronic-pf-06480605-150-mg-sc-q4w","phase":"marketed","mechanism":"JAK1 and JAK2 enzymes","indications":["Moderate to severe atopic dermatitis","Moderate to severe plaque psoriasis","Active psoriatic arthritis","Moderate to severe hidradenitis suppurativa","Moderate to severe Crohn's disease"],"catalyst":""},{"name":"Chronic- PF-06480605 450 mg SC Q4W","genericName":"chronic-pf-06480605-450-mg-sc-q4w","slug":"chronic-pf-06480605-450-mg-sc-q4w","phase":"marketed","mechanism":"IL-4 receptor alpha subunit","indications":["Moderate to severe atopic dermatitis","Moderate to severe plaque psoriasis","Moderate to severe hidradenitis suppurativa","Moderate to severe erythromelalgia","Moderate to severe prurigo nodularis"],"catalyst":""},{"name":"Chronic- PF-06480605 50 mg SC Q4W","genericName":"chronic-pf-06480605-50-mg-sc-q4w","slug":"chronic-pf-06480605-50-mg-sc-q4w","phase":"marketed","mechanism":"JAK pathway","indications":["Moderate to severe atopic dermatitis","Moderate to severe plaque psoriasis","Active psoriatic arthritis","Moderate to severe hidradenitis suppurativa","Moderate to severe Crohn's disease"],"catalyst":""},{"name":"Combination (Bivalent) BNT162b2 and BNT162b2 OMI","genericName":"combination-bivalent-bnt162b2-and-bnt162b2-omi","slug":"combination-bivalent-bnt162b2-and-bnt162b2-omi","phase":"marketed","mechanism":"SARS-CoV-2 virus","indications":["Prevention of COVID-19 in individuals 12 years of age and older","Prevention of COVID-19 in individuals 5 years of age and older"],"catalyst":""},{"name":"Combination BNT162b2 and BNT162b2 OMI","genericName":"combination-bnt162b2-and-bnt162b2-omi","slug":"combination-bnt162b2-and-bnt162b2-omi","phase":"marketed","mechanism":"A combination of two mRNA-based vaccines that work together to prevent and treat COVID-19.","indications":["COVID-19 prevention","COVID-19 treatment"],"catalyst":""},{"name":"Covid-19 Sterilizing","genericName":"COVID-19 Vaccine","slug":"covid-19-vaccine","phase":"marketed","mechanism":"SARS-CoV-2","indications":["Prevention of COVID-19 in individuals 6 months of age and older","Prevention of COVID-19 in individuals 5 years of age and older for the Pfizer-BioNTech COVID-19 Vaccine","Prevention of COVID-19 in individuals 6 months of age and older for the Moderna COVID-19 Vaccine","Prevention of COVID-19 in individuals 6 months of age and older for the Novavax COVID-19 Vaccine","Prevention of COVID-19 in individuals 12 years of age and older for the Janssen COVID-19 Vaccine"],"catalyst":""},{"name":"Cyklokapron","genericName":"Tranexamic Acid","slug":"cyklokapron","phase":"marketed","mechanism":"Tranexamic acid occupies lysine receptor binding sites on plasmin, preventing fibrin dissolution.","indications":["Reduce or prevent hemorrhage in hemophilia patients during tooth extraction","Reduce or prevent hemorrhage in hemophilia patients following tooth extraction","Reduce need for replacement therapy in hemophilia patients during tooth extraction","Reduce need for replacement therapy in hemophilia patients following tooth extraction"],"catalyst":""},{"name":"Danuglipron","genericName":"danuglipron","slug":"danuglipron","phase":"marketed","mechanism":"Danuglipron is a small-molecule GLP-1 receptor agonist.","indications":["Treatment of acute and chronic pain"],"catalyst":""},{"name":"Deltyba","genericName":"delamanid","slug":"delamanid","phase":"marketed","mechanism":"","indications":["Drug resistant tuberculosis"],"catalyst":""},{"name":"Diflucan","genericName":"Fluconazole","slug":"fluconazole-in-sodium-chloride-0-9-in-plastic-container","phase":"marketed","mechanism":"Cytochrome P450 3A4","indications":["Candidal Urinary Tract Infection","Candidal septicemia","Candidal vulvovaginitis","Candidemia","Candidiasis of mouth"],"catalyst":""},{"name":"Disitamab vedotin","genericName":"disitamab-vedotin","slug":"disitamab-vedotin","phase":"marketed","mechanism":"human epidermal growth factor receptor 2 (HER2)","indications":["Locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma","Locally advanced or metastatic esophageal squamous cell carcinoma"],"catalyst":""},{"name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","genericName":"Dobutamine Hydrochloride","slug":"dobutamine-hydrochloride-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Beta-2 adrenergic receptor","indications":["Acute myocardial infarction","Cardiogenic shock","Heart failure","Low cardiac output syndrome","Postcardiotomy low output syndrome"],"catalyst":""},{"name":"Doxorubicin Hydrochloride","genericName":"Doxorubicin Hydrochloride","slug":"doxorubicin-hydrochloride","phase":"marketed","mechanism":"Doxorubicin intercalates nucleotide bases and interacts with topoisomerase II to form DNA-cleavable complexes, inhibiting DNA/RNA replication.","indications":["Adjuvant chemotherapy for women with axillary lymph node involvement following resection of primary breast cancer","Acute lymphoblastic leukemia","Acute myeloblastic leukemia","Hodgkin lymphoma","Non-Hodgkin lymphoma"],"catalyst":""},{"name":"Duavive 0.45Mg-20Mg Tablet","genericName":"duavive-0-45mg-20mg-tablet","slug":"duavive-0-45mg-20mg-tablet","phase":"marketed","mechanism":"estrogen receptors","indications":["Treatment of moderate to severe vasomotor symptoms associated with menopause"],"catalyst":""},{"name":"Duramorph Pf","genericName":"Morphine Sulfate","slug":"morphine-sulfate","phase":"marketed","mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body.","indications":["Acute postoperative pain","Chronic Pain with Opioid Tolerance","Chronic pain","Diarrhea","General anesthesia"],"catalyst":""},{"name":"Effexor","genericName":"Venlafaxine Hydrochloride","slug":"effexor-xr","phase":"marketed","mechanism":"Potentiates serotonin and norepinephrine in CNS through reuptake inhibition.","indications":["Generalized anxiety disorder","Major depressive disorder","Panic disorder","Social phobia"],"catalyst":""},{"name":"Ertugliflozin 15 mg","genericName":"ertugliflozin-15-mg","slug":"ertugliflozin-15-mg","phase":"marketed","mechanism":"SGLT2","indications":["Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes"],"catalyst":""},{"name":"Ertugliflozin 5 mg","genericName":"ertugliflozin-5-mg","slug":"ertugliflozin-5-mg","phase":"marketed","mechanism":"SGLT2","indications":["Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes"],"catalyst":""},{"name":"Estring","genericName":"Estradiol","slug":"estring","phase":"marketed","mechanism":"Prevents pregnancy primarily by suppressing ovulation.","indications":["Acne vulgaris","Advanced Prostatic Carcinoma","Atrophic vaginitis","Atrophic vulva","Contraception"],"catalyst":""},{"name":"Famtozinameran 5 to 11 Years of age","genericName":"famtozinameran-5-to-11-years-of-age","slug":"famtozinameran-5-to-11-years-of-age","phase":"marketed","mechanism":"SARS-CoV-2 spike protein","indications":["Prevention of COVID-19 in individuals 5 years of age and older"],"catalyst":""},{"name":"Fragmin","genericName":"Dalteparin Sodium","slug":"fragmin","phase":"marketed","mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin.","indications":["Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave MI","Prophylaxis of DVT in Abdominal Surgery","Prophylaxis of DVT in Hip Replacement Surgery","Prophylaxis of DVT in Medical Patients with Restricted Mobility","Extended Treatment of Symptomatic VTE in Adult Patients with Cancer"],"catalyst":""},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-12-500-units-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Heparin enhances Antithrombin III's activity to inhibit coagulation factors Xa and IIa, preventing clot formation.","indications":["Deep Vein Thrombosis with Pulmonary Embolism","Deep venous thrombosis","Disseminated intravascular coagulation","Maintain Patency of Indwelling Vascular Catheter","Non-Q wave myocardial infarction"],"catalyst":""},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-10-000-units-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.","indications":["Deep Vein Thrombosis with Pulmonary Embolism","Deep venous thrombosis","Disseminated intravascular coagulation","Maintain Patency of Indwelling Vascular Catheter","Non-Q wave myocardial infarction"],"catalyst":""},{"name":"Heparin Sodium In Plastic Container","genericName":"Heparin Sodium","slug":"heparin-sodium-preservative-free","phase":"marketed","mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.","indications":["Deep Vein Thrombosis with Pulmonary Embolism","Deep venous thrombosis","Disseminated intravascular coagulation","Maintain Patency of Indwelling Vascular Catheter","Non-Q wave myocardial infarction"],"catalyst":""},{"name":"High Dose PF-07328948","genericName":"high-dose-pf-07328948","slug":"high-dose-pf-07328948","phase":"marketed","mechanism":"Not specified","indications":["COVID-19"],"catalyst":""},{"name":"Hospital-Based Vaccination Pathway","genericName":"hospital-based-vaccination-pathway","slug":"hospital-based-vaccination-pathway","phase":"marketed","mechanism":"various pathogens","indications":["Pneumococcal disease","Influenza","Meningococcal disease","Tetanus, diphtheria, and pertussis (Tdap)","Varicella (chickenpox)"],"catalyst":""},{"name":"Idamycin Pfs","genericName":"Idarubicin Hydrochloride","slug":"idamycin-pfs","phase":"marketed","mechanism":"Idarubicin forms DNA complexes, inhibits nucleic acid synthesis and topoisomerase II, produces DNA-damaging free radicals.","indications":["Acute myeloid leukemia, disease","Acute promyelocytic leukemia, FAB M3"],"catalyst":""},{"name":"Induction- PF-06480605 450 mg SC Q4W","genericName":"induction-pf-06480605-450-mg-sc-q4w","slug":"induction-pf-06480605-450-mg-sc-q4w","phase":"marketed","mechanism":"PF-06480605 is a small molecule that targets the IL-17 pathway to treat inflammatory conditions.","indications":["Moderate to severe plaque psoriasis","Active psoriatic arthritis","Active ankylosing spondylitis","Moderate to severe atopic dermatitis","Moderate to severe hidradenitis suppurativa"],"catalyst":""},{"name":"Induction- PF-06480605 50 mg SC Q4W","genericName":"induction-pf-06480605-50-mg-sc-q4w","slug":"induction-pf-06480605-50-mg-sc-q4w","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"Intra-articular corticosteroid injections","genericName":"intra-articular-corticosteroid-injections","slug":"intra-articular-corticosteroid-injections","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Osteoarthritis of the knee","Osteoarthritis of the hip","Rheumatoid arthritis","Tendinitis (e.g., Achilles, rotator cuff)","Bursitis (e.g., olecranon, prepatellar)"],"catalyst":""},{"name":"Levaquin","genericName":"Levofloxacin","slug":"levofloxacin-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Levaquin works by inhibiting bacterial DNA replication and transcription by binding to the enzyme DNA gyrase.","indications":["Acute Moraxella catarrhalis bronchitis","Acute bacterial bronchitis","Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute maxillary sinusitis"],"catalyst":""},{"name":"Lidocaine Hydrochloride Preservative Free","genericName":"Lidocaine Hydrochloride","slug":"lidocaine-hydrochloride-preservative-free","phase":"marketed","mechanism":"Voltage-gated sodium channels (Nav)","indications":["Topical anesthesia of irritated mucous membranes of the mouth","Topical anesthesia of inflamed mucous membranes of the mouth","Topical anesthesia of irritated mucous membranes of the pharynx","Topical anesthesia of inflamed mucous membranes of the pharynx","Reducing gagging during X-ray picture taking"],"catalyst":""},{"name":"Lipitor","genericName":"Atorvastatin Calcium","slug":"lipitor","phase":"marketed","mechanism":"Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis.","indications":["Angina pectoris","Arteriosclerotic vascular disease","Cerebrovascular accident","Familial hypercholesterolemia - heterozygous","Familial hypercholesterolemia - homozygous"],"catalyst":""},{"name":"Litfulo","genericName":"Ritlecitinib Tosylate","slug":"litfulo","phase":"marketed","mechanism":"Ritlecitinib irreversibly inhibits JAK3 and TEC kinase family by blocking ATP binding site.","indications":["Alopecia areata"],"catalyst":""},{"name":"Lopid","genericName":"Gemfibrozil","slug":"lopid","phase":"marketed","mechanism":"PPAR-alpha (Peroxisome Proliferator-Activated Receptor Alpha)","indications":["Treatment of adult patients with Type IV hyperlipidemia with very high serum triglyceride elevations (>2,000 mg/dL) presenting risk of pancreatitis unresponsive to diet","Treatment of adult patients with Type V hyperlipidemia with very high serum triglyceride elevations (>2,000 mg/dL) presenting risk of pancreatitis unresponsive to diet","Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis","Reducing risk of developing coronary heart disease in Type IIb patients without history or symptoms of existing coronary heart disease with low HDL-cholesterol, elevated LDL-cholesterol, and elevated triglycerides unresponsive to weight loss, diet, exercise, and other pharmacologic agents"],"catalyst":""},{"name":"Low Dose PF-07328948","genericName":"low-dose-pf-07328948","slug":"low-dose-pf-07328948","phase":"marketed","mechanism":"SARS-CoV-2 virus","indications":["COVID-19"],"catalyst":""},{"name":"Ly4064809","genericName":"ly4064809","slug":"ly4064809","phase":"marketed","mechanism":"Not specified on Wikipedia","indications":["Treatment of major depressive disorder"],"catalyst":""},{"name":"MET233","genericName":"met233","slug":"met233","phase":"phase_1","mechanism":"","indications":[],"catalyst":""},{"name":"MET233 and MET097","genericName":"met233-and-met097","slug":"met233-and-met097","phase":"marketed","mechanism":"Not specified","indications":["Indication 1","Indication 2"],"catalyst":""},{"name":"Magnesium Sulfate In Dextrose 5% In Plastic Container","genericName":"Magnesium Sulfate","slug":"magnesium-sulfate-in-dextrose-5-in-plastic-container","phase":"marketed","mechanism":"Magnesium Sulfate blocks neuromuscular transmission and decreases acetylcholine levels, leading to vasodilation and a depressant effect on the central nervous system.","indications":["Prevention of eclampsia in patients with preeclampsia","Treatment of seizures","Prevention of recurrent seizures in patients with eclampsia"],"catalyst":""},{"name":"Met097","genericName":"met097","slug":"met097","phase":"marketed","mechanism":"Not specified","indications":["Treatment of adult patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation","Treatment of adult patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation","Treatment of adult patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation","Treatment of adult patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation","Treatment of adult patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation"],"catalyst":""},{"name":"Nardil","genericName":"Phenelzine Sulfate","slug":"nardil","phase":"marketed","mechanism":"Amine oxidase [flavin-containing] B","indications":["Atypical Depression","Mixed Anxiety and Depression","Severe Depression with Endogenous Features"],"catalyst":""},{"name":"Nipent","genericName":"Pentostatin","slug":"nipent","phase":"marketed","mechanism":"Adenosine deaminase (ADA)","indications":["Untreated hairy cell leukemia with active disease","Alpha-interferon-refractory hairy cell leukemia with active disease","Hairy cell leukemia patients with clinically significant anemia","Hairy cell leukemia patients with neutropenia","Hairy cell leukemia patients with thrombocytopenia"],"catalyst":""},{"name":"No OAC","genericName":"no-oac","slug":"no-oac","phase":"marketed","mechanism":"Factor Xa","indications":["Acute Ischemic Stroke","Atrial Fibrillation or Flutter with a High Risk of Stroke","Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke","Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF"],"catalyst":""},{"name":"Non-Interventional Study","genericName":"non-interventional-study","slug":"non-interventional-study","phase":"marketed","mechanism":"Vitamin K epoxide reductase","indications":["Angina Pectoris","Atrial Fibrillation","Atrial Flutter","Atrial Tachycardia","Cardiac Arrest"],"catalyst":""},{"name":"Nurtec Odt","genericName":"rimegepant","slug":"rimegepant","phase":"marketed","mechanism":"Rimegepant blocks the calcitonin gene-related peptide receptor.","indications":["Migraine","Prevention of migraine attacks"],"catalyst":""},{"name":"Oncovin","genericName":"vincristine","slug":"vincristine","phase":"marketed","mechanism":"Canalicular multispecific organic anion transporter 1","indications":["Acute lymphoid leukemia","Burkitt's lymphoma","Diffuse non-Hodgkin's lymphoma, large cell","Follicular non-Hodgkin's lymphoma","Hodgkin's disease"],"catalyst":""},{"name":"Oncovin","genericName":"Vincristine Sulfate","slug":"vincristine-sulfate-pfs","phase":"marketed","mechanism":"Canalicular multispecific organic anion transporter 1","indications":["Acute leukemia","Hodgkin's disease","Non-Hodgkin's malignant lymphomas","Rhabdomyosarcoma","Neuroblastoma"],"catalyst":""},{"name":"Open-label, PK Cohort (Cohort B): ponsegromab low dose","genericName":"open-label-pk-cohort-cohort-b-ponsegromab-low-dose","slug":"open-label-pk-cohort-cohort-b-ponsegromab-low-dose","phase":"marketed","mechanism":"The mechanism of ponsegromab low dose is not specified on Wikipedia.","indications":["Relapsing forms of multiple sclerosis","Active secondary progressive multiple sclerosis"],"catalyst":""},{"name":"Oral Anticoagulant","genericName":"oral-anticoagulant","slug":"oral-anticoagulant","phase":"discontinued","mechanism":"Inhibits Factor Xa to block the intrinsic and extrinsic coagulation pathways, preventing thrombin generation and clot formation.","indications":["Cryptogenic ischemic stroke with patent foramen ovale (PFO)","Polycythemia vera and essential thrombocythemia (thromboembolism prevention)","Left ventricular thrombus","Mechanical heart valve thrombosis prevention","Secondary stroke prevention in older adults"],"catalyst":""},{"name":"PF-05221304","genericName":"pf-05221304","slug":"pf-05221304","phase":"discontinued","mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation.","indications":["Nonalcoholic fatty liver disease (NAFLD)","Nonalcoholic steatohepatitis (NASH)","NASH with fibrosis","NAFLD/NASH (combination therapy with DGAT2i)"],"catalyst":""},{"name":"PF-06700841 15 mg","genericName":"pf-06700841-15-mg","slug":"pf-06700841-15-mg","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"PF-06700841 30 mg","genericName":"pf-06700841-30-mg","slug":"pf-06700841-30-mg","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"PF-06700841 45 mg","genericName":"pf-06700841-45-mg","slug":"pf-06700841-45-mg","phase":"marketed","mechanism":"Unknown mechanism of action","indications":["Multiple Sclerosis"],"catalyst":""},{"name":"PF-06801591","genericName":"pf-06801591","slug":"pf-06801591","phase":"phase_1","mechanism":"Monoclonal antibody","indications":[],"catalyst":""},{"name":"PF-06882961 (Cohort 3)","genericName":"pf-06882961-cohort-3","slug":"pf-06882961-cohort-3","phase":"marketed","mechanism":"Not specified","indications":["Non-small cell lung cancer"],"catalyst":""},{"name":"PF-06882961 (Cohorts 1 and 2)","genericName":"pf-06882961-cohorts-1-and-2","slug":"pf-06882961-cohorts-1-and-2","phase":"marketed","mechanism":"PF-06882961 is a small molecule with a molecular target.","indications":["Treatment of follicular lymphoma","Treatment of follicular lymphoma","Treatment of follicular lymphoma","Treatment of follicular lymphoma","Treatment of follicular lymphoma"],"catalyst":""},{"name":"PF-07038124","genericName":"pf-07038124","slug":"pf-07038124","phase":"discontinued","mechanism":"PF-07038124 is a topical PDE4 inhibitor that blocks phosphodiesterase-4 to reduce inflammatory cytokine production in skin immune cells.","indications":["Atopic Dermatitis","Plaque Psoriasis","Vitiligo","Seborrheic Dermatitis","Papulopustular Rosacea"],"catalyst":""},{"name":"PF-07038124 ointment 0.01%","genericName":"pf-07038124-ointment-0-01","slug":"pf-07038124-ointment-0-01","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07038124 ointment 0.03%","genericName":"pf-07038124-ointment-0-03","slug":"pf-07038124-ointment-0-03","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07038124 ointment 0.06%","genericName":"pf-07038124-ointment-0-06","slug":"pf-07038124-ointment-0-06","phase":"phase_2","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07081532","genericName":"pf-07081532","slug":"pf-07081532","phase":"discontinued","mechanism":"Peptide","indications":["Obesity"],"catalyst":""},{"name":"PF-07328948","genericName":"pf-07328948","slug":"pf-07328948","phase":"phase_1","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07836391 Influenza saRNA","genericName":"pf-07836391-influenza-sarna","slug":"pf-07836391-influenza-sarna","phase":"phase_1","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07836394 Influenza saRNA","genericName":"pf-07836394-influenza-sarna","slug":"pf-07836394-influenza-sarna","phase":"marketed","mechanism":"unknown","indications":["Influenza"],"catalyst":""},{"name":"PF-07836395 Influenza saRNA","genericName":"pf-07836395-influenza-sarna","slug":"pf-07836395-influenza-sarna","phase":"marketed","mechanism":"Unknown","indications":["Influenza"],"catalyst":""},{"name":"PF-07836396 Influenza saRNA","genericName":"pf-07836396-influenza-sarna","slug":"pf-07836396-influenza-sarna","phase":"marketed","mechanism":"Not specified","indications":["Influenza"],"catalyst":""},{"name":"PF-07852352 Influenza saRNA 1","genericName":"pf-07852352-influenza-sarna-1","slug":"pf-07852352-influenza-sarna-1","phase":"marketed","mechanism":"influenza virus","indications":["Influenza"],"catalyst":""},{"name":"PF-07867246 Influenza saRNA","genericName":"pf-07867246-influenza-sarna","slug":"pf-07867246-influenza-sarna","phase":"phase_1","mechanism":"","indications":[],"catalyst":""},{"name":"PF-07871987 Influenza saRNA","genericName":"pf-07871987-influenza-sarna","slug":"pf-07871987-influenza-sarna","phase":"marketed","mechanism":"influenza virus","indications":["Influenza"],"catalyst":""},{"name":"PF-07914705 Influenza saRNA","genericName":"pf-07914705-influenza-sarna","slug":"pf-07914705-influenza-sarna","phase":"marketed","mechanism":"influenza virus","indications":["Influenza"],"catalyst":""},{"name":"PF-07915048 Influenza saRNA","genericName":"pf-07915048-influenza-sarna","slug":"pf-07915048-influenza-sarna","phase":"marketed","mechanism":"influenza virus","indications":["Influenza"],"catalyst":""},{"name":"PF-08046876","genericName":"pf-08046876","slug":"pf-08046876","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"PF-08049820 MR1","genericName":"pf-08049820-mr1","slug":"pf-08049820-mr1","phase":"phase_1","mechanism":"","indications":[],"catalyst":""},{"name":"Part B: Multiple-dose ATM-AVI, Cohorts 1-4","genericName":"part-b-multiple-dose-atm-avi-cohorts-1-4","slug":"part-b-multiple-dose-atm-avi-cohorts-1-4","phase":"marketed","mechanism":"The mechanism of part-b-multiple-dose-atm-avi-cohorts-1-4 is not specified.","indications":["Treatment of HIV-1 infection in adults and pediatric patients 3 months of age and older","Treatment of HIV-1 infection in adults and pediatric patients 3 months of age and older without antiretroviral treatment options","Treatment of HIV-1 infection in adults and pediatric patients 3 months of age and older without antiretroviral treatment options or for whom it is not feasible to use antiretroviral therapy","Treatment of HIV-1 infection in adults and pediatric patients 3 months of age and older without antiretroviral treatment options or for whom it is not feasible to use antiretroviral therapy in certain resource-limited settings","Treatment of HIV-1 infection in adults and pediatric patients 3 months of age and older without antiretroviral treatment options or for whom it is not feasible to use antiretroviral therapy in certain resource-limited settings"],"catalyst":""},{"name":"Paxlovid (Copackaged)","genericName":"pf-07321332","slug":"pf-07321332","phase":"discontinued","mechanism":"Paxlovid works by inhibiting the activity of an enzyme that the SARS-CoV-2 virus needs to replicate.","indications":["COVID-19"],"catalyst":""},{"name":"Pf-04171327","genericName":"pf-04171327","slug":"pf-04171327","phase":"marketed","mechanism":"PF-04171327 is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM).","indications":["Multiple Myeloma","Relapsed or Refractory Multiple Myeloma","Relapsed or Refractory Multiple Myeloma after at least 2 prior lines of therapy","Relapsed or Refractory Multiple Myeloma after at least 3 prior lines of therapy","Relapsed or Refractory Multiple Myeloma after at least 4 prior lines of therapy"],"catalyst":""},{"name":"Pf-06823859","genericName":"pf-06823859","slug":"pf-06823859","phase":"marketed","mechanism":"PD-1/PD-L1","indications":["Non-Small Cell Lung Cancer (NSCLC) with high PD-L1 expression (Tumor Proportion Score (TPS) ≥ 50%) as monotherapy (pembrolizumab in combination with pemetrexed and platinum (pemetrexed + platinum) in patients with a PD-L1 TPS ≥ 1% as determined by an FDA-approved test.","Squamous Cell Carcinoma of the Head and Neck (SCCHN) with disease progression on or after platinum-containing chemotherapy.","Locally Advanced or Metastatic Urothelial Carcinoma (UC) with disease progression during or following platinum-containing chemotherapy or within 12 months of receiving neoadjuvant or adjuvant platinum-containing chemotherapy.","Locally Advanced or Metastatic Urothelial Carcinoma (UC) with disease progression during or following platinum-containing chemotherapy or within 12 months of receiving neoadjuvant or adjuvant platinum-containing chemotherapy in patients who are not eligible for platinum-containing chemotherapy.","Locally Advanced or Metastatic Urothelial Carcinoma (UC) with disease progression during or following platinum-containing chemotherapy or within 12 months of receiving neoadjuvant or adjuvant platinum-containing chemotherapy in patients who are not eligible for platinum-containing chemotherapy and have a PD-L1 combined positive score (CPS) ≥ 10 as determined by an FDA-approved test."],"catalyst":""},{"name":"Pf-06865571","genericName":"pf-06865571","slug":"pf-06865571","phase":"marketed","mechanism":"PD-1/PD-L1 pathway","indications":["Non-Small Cell Lung Cancer (NSCLC) with high PD-L1 expression (≥ 50%) as a monotherapy in adults","Non-Small Cell Lung Cancer (NSCLC) with high PD-L1 expression (≥ 50%) as a monotherapy in adults and in combination with pembrolizumab in adults","Urothelial Carcinoma (UC) in adults","Urothelial Carcinoma (UC) in adults in combination with pembrolizumab","Head and Neck Squamous Cell Carcinoma (HNSCC) in adults"],"catalyst":""},{"name":"Pf-06882961","genericName":"pf-06882961","slug":"pf-06882961","phase":"marketed","mechanism":"Not specified","indications":["Non-small cell lung cancer","Urothelial carcinoma"],"catalyst":""},{"name":"Pf-07264660","genericName":"pf-07264660","slug":"pf-07264660","phase":"marketed","mechanism":"The mechanism of action of PF-07264660 is not specified.","indications":["Multiple Myeloma","Relapsed or Refractory Multiple Myeloma"],"catalyst":""},{"name":"Pf-07817883","genericName":"pf-07817883","slug":"pf-07817883","phase":"marketed","mechanism":"SARS-CoV-2 main protease","indications":["Indication not found","Indication not found"],"catalyst":""}],"recentEvents":[{"date":"2023-06-07","type":"regulatory","headline":"Pfizer's COVID-19 Vaccine, Comirnaty, Receives EUA in the US","summary":"The US FDA granted Emergency Use Authorization (EUA) to Pfizer's COVID-19 vaccine, Comirnaty, for individuals 12 years and older.","drugName":"Comirnaty","sentiment":"positive"},{"date":"2022-12-09","type":"earnings","headline":"Pfizer Reports Strong Q3 2022 Earnings","summary":"Pfizer reported strong Q3 2022 earnings, driven by the success of its COVID-19 vaccine and other products.","drugName":"","sentiment":"positive"},{"date":"2022-08-26","type":"deal","headline":"Pfizer to Acquire Seagen for $43 Billion","summary":"Pfizer agreed to acquire Seagen, a biotechnology company, for $43 billion to expand its oncology portfolio.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPVmhFLU0ydWdRaGJDWmFfSmNxR2pnX2R3M2ctTnE5X25ENUlFOUs1QnhnZ0VzWVhJTno4cy1sdXRhUWlNZ2RwMk1HMDZZYVVXUWJGeG5IUFhXYklFV3NRcms4Ry1tc1JqMGd2ZktqMjZKaW9mX2VuazJVVlFqRGpJRlJCeF9iQlJDcVdlTGFtTEVfdzdoR3pRRW0xOHY?oc=5","date":"2026-04-01","type":"pipeline","source":"Investopedia","summary":"Top Pfizer Shareholders - Investopedia","headline":"Top Pfizer Shareholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNNS1lS3JkZkdOQkN2ZWZVaGFPSW44Yi0zSTZ4NXptU2NDMGpKUWQwMWd6TUVzSWN3MWNpMTFFRkJ2T2hXYW13d3J3ZjkyMkd2dnRieHMxRjdjLWpJZGxzOHROOF9zN1Jya2twNnhheEVQUmVOSHl3SzNLWXhOS2dVQS1SZnZZR2pNemc?oc=5","date":"2026-03-31","type":"pipeline","source":"TradingKey","summary":"Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement - TradingKey","headline":"Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPdnFtbnpQZ3pzRG9vdEx2UnhRaEM1SEZ0dHE1cm9pazhJSk1FQnN0MF90d3lOdnMweU9PeU1FSC1Gb21xSEVvY3l4cGlacXktcVYwUlhFOHlCT2RwaWNfek9qcFN1SFplODIwTnRRaUdPNkRwOEV6Y0Z5OVNnSnZSMW0yMzc4ckVDNzRrWWpWMWh2dw?oc=5","date":"2026-03-27","type":"deal","source":"The Acquirer's Multiple","summary":"Pfizer Inc (PFE): Our Calculation of Intrinsic Value - The Acquirer's Multiple","headline":"Pfizer Inc (PFE): Our Calculation of Intrinsic Value - The Acquirer's Multiple","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPbWhkWVl6cmFMRnlFOE5QMEJxM0NHd0x3SzhCNGEzZU9DTVRzcURhYkZLTlJVa3U4ck1yZE16ZFhDR2Q4NEZTendhVW1UcERZa0xfd1VzMm1mbERyMzFld1NtRDdONkRuYkpZXzVIeXRpZm56cDE5d1RzaERLampzQWVR?oc=5","date":"2026-03-01","type":"trial","source":"Yahoo Finance","summary":"Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM - Yahoo Finance","headline":"Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBJXzd5VXR6cTZZdnJQXzZaRlpIZmE5Z0YwY2JNWDV0bXo1S0p3aUhuTnhrdHFOY2hlakpYN1pYNG93UnBvbGhrTVk2eWVRMjR2dlc4OU5zazd6R3lrUXdzYXBOMlVaQlhIMFlWTXp3?oc=5","date":"2026-02-19","type":"pipeline","source":"Finviz","summary":"Where is Pfizer Inc. (PFE) Headed? - Finviz","headline":"Where is Pfizer Inc. (PFE) Headed?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE8wV2o4dFVmTHhxOFpreXd1TF85OXRUUURTZkE4dE5yOW5Ja2ZHMGZZRVRwSGhGeHFlZElvX1BBbmRqY0dKTzdTeUVzSWVfVE5sV21EaktVNjM1cmMwQ2o1RkM1ODN5RTFHNXpSV1h3RS1zZw?oc=5","date":"2026-02-04","type":"pipeline","source":"Finviz","summary":"Pfizer Inc. (PFE): A Bull Case Theory - Finviz","headline":"Pfizer Inc. (PFE): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQLTVxZzdueEJFcWJCN1ZTWmp1bGNicHVqWF9nOVhvdDh5RndlVnhrX0l2Z01ZUF9rU3FyRXdJXzczNVBPb2FYVlU0OVBhUFBBMTlFSTNWem5saFRtRlZ6TTF5RzVHSTNSWGxSZGlvUFFZeUxyNmhDcnc5bGNvYTJSVE03Y1NuLXAyVDlmdFYzaw?oc=5","date":"2026-01-29","type":"pipeline","source":"Seeking Alpha","summary":"Pfizer: A High-Yield Pharma At A Turning Point (NYSE:PFE) - Seeking Alpha","headline":"Pfizer: A High-Yield Pharma At A Turning Point (NYSE:PFE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5TR0lRSjNVNDJWdFNGX2FLeDVmUllOWmNuNG8wUzJUcnJLcW03a0VjSWxSZzRscTRMNkxGR1VTY0dCRTZXelFndXAwdUVFbzNPMkZNdEUxTWtPalVzYm1ZVEJRSjh6MV9yQ0FwZXUxMko?oc=5","date":"2025-12-04","type":"deal","source":"Investor's Business Daily","summary":"Is Pfizer Stock A Buy In December 2025 After It Clinches The $10 Billion Takeover Of Metsera? - Investor's Business Daily","headline":"Is Pfizer Stock A Buy In December 2025 After It Clinches The $10 Billion Takeover Of Metsera? - Investor's Business Dail","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQNVZXZ3dzSjNieVNjSjhpZmsyMllpS0s5NU5aOGlQUnRWUW1LeXA0RTJ1RThtQmVIVHV2WTFZd3JsMi02eTRFak1ISjlaNjFHNFNLRWFoR2MtaXp1NGNiV1JqUDdZckR4NzBkT0tJTldMOGNDM1lISTBfN0p1cFJ0YlNoUHVmOU5NaTUzeXA5VjBiQl9Rc3QtdElNNXRlM0tyYXJXaQ?oc=5","date":"2025-11-30","type":"deal","source":"Seeking Alpha","summary":"Pfizer: The Pharma Giant To Buy Right Now (NYSE:PFE) - Seeking Alpha","headline":"Pfizer: The Pharma Giant To Buy Right Now (NYSE:PFE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxObXotSk1KcmlFOU5oVVU4emdhMUo4S2ZDU2x3dXJheWVycC1sNHprNTFzVEJmWW9Pc3ZjeEg1d1hqcW5oazI4XzRBU1RoSzRHZWVoT1liMk40eVBXSkNTRG9XcWd1LVVxdXlXMVdfNFhtN09PTWEtZmQ3eGh6ZGNLeDNhX1NWQzdmZTdlWg?oc=5","date":"2025-11-19","type":"pipeline","source":"Seeking Alpha","summary":"Pfizer: Is This Pharma Giant Finally A Bargain (NYSE:PFE) - Seeking Alpha","headline":"Pfizer: Is This Pharma Giant Finally A Bargain (NYSE:PFE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQeDBXc0YwR3RCZjRDVnZXajN4TU9VVjluUUc5Qkp6S09EWEhkTmVtMGFUWnlsckxBRUk1b1I4dTRleVYyZnZ3X1Qwd1otMXU0RnRha2R1NkJlVVVxWVpReXYyTjA0X2FQeFd4VExoeklaUnpWWFE0emc1eVpTcVFCcm1B?oc=5","date":"2025-10-26","type":"trial","source":"Yahoo Finance","summary":"Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study - Yahoo Finance","headline":"Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQWjVQblJZOHlpSW9sRWozUjZ1SFdPOWdUbWVFc3NPUHRGSTRaYmI2UWU5Nkx5clloT1Job2hkUXlvZXNtVVF2T2NydE1HQ1BjcFByd0c0M19zSERGRGluT0phYWI5OU9hUHhaWEtTcDZpbDdZTF9ZU01DZGZTZUtmRE93?oc=5","date":"2025-09-07","type":"regulatory","source":"Yahoo Finance","summary":"Pfizer Inc (PFE) Announces New Trial Collaboration With Olema Pharmaceuticals - Yahoo Finance","headline":"Pfizer Inc (PFE) Announces New Trial Collaboration With Olema Pharmaceuticals","sentiment":"neutral"}],"patents":[{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"8367734","type":"Formulation","expiryDate":"2026-01-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9278182","type":"Formulation","expiryDate":"2026-02-01","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"8268348","type":"Method of Use","expiryDate":"2026-02-21","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9101543","type":"Method of Use","expiryDate":"2026-02-21","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"7758891","type":"Method of Use","expiryDate":"2026-02-21","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8926594","type":"Formulation","expiryDate":"2026-03-31","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"7731686","type":"Formulation","expiryDate":"2026-06-01","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10960155","type":"Formulation","expiryDate":"2026-06-25","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"8034375","type":"Method of Use","expiryDate":"2026-08-13","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"8268348*PED","type":"Compound","expiryDate":"2026-08-21","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"7758891*PED","type":"Compound","expiryDate":"2026-08-21","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9101543*PED","type":"Compound","expiryDate":"2026-08-21","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Lyrica","drugSlug":"lyrica","patentNumber":"10022447","type":"Method of Use","expiryDate":"2026-11-02","territory":"US","genericFilings":[]},{"drugName":"Lyrica","drugSlug":"lyrica","patentNumber":"8945620","type":"Formulation","expiryDate":"2026-11-02","territory":"US","genericFilings":[]},{"drugName":"Lyrica","drugSlug":"lyrica","patentNumber":"9144559","type":"Formulation","expiryDate":"2026-11-02","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11590286","type":"Formulation","expiryDate":"2026-12-12","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11590286","type":"Formulation","expiryDate":"2026-12-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"8329213","type":"Compound","expiryDate":"2027-01-06","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"8034375*PED","type":"Compound","expiryDate":"2027-02-13","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9238108","type":"Formulation","expiryDate":"2027-02-20","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"8206360","type":"Formulation","expiryDate":"2027-02-27","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8206360","type":"Formulation","expiryDate":"2027-02-27","territory":"US","genericFilings":[]},{"drugName":"Lyrica","drugSlug":"lyrica","patentNumber":"9144559*PED","type":"Compound","expiryDate":"2027-05-02","territory":"US","genericFilings":[]},{"drugName":"Lyrica","drugSlug":"lyrica","patentNumber":"10022447*PED","type":"Compound","expiryDate":"2027-05-02","territory":"US","genericFilings":[]},{"drugName":"Lyrica","drugSlug":"lyrica","patentNumber":"8945620*PED","type":"Compound","expiryDate":"2027-05-02","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9724471","type":"Formulation","expiryDate":"2027-05-23","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"7947017","type":"Formulation","expiryDate":"2028-03-12","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"7947017","type":"Formulation","expiryDate":"2028-03-12","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"9730900","type":"Method of Use","expiryDate":"2028-07-10","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"9833419","type":"Formulation","expiryDate":"2028-07-10","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"9724310","type":"Compound","expiryDate":"2028-07-10","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"7955619","type":"Formulation","expiryDate":"2028-08-12","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"10314788","type":"Formulation","expiryDate":"2028-08-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"8147867","type":"Compound","expiryDate":"2028-08-29","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"7749194","type":"Formulation","expiryDate":"2028-10-30","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"8231573","type":"Formulation","expiryDate":"2028-11-25","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8231573","type":"Formulation","expiryDate":"2028-11-25","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"8226610","type":"Formulation","expiryDate":"2029-04-10","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8226610","type":"Formulation","expiryDate":"2029-04-10","territory":"US","genericFilings":[]},{"drugName":"Ibrance","drugSlug":"palbociclib","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":2500000000},{"drugName":"Xeljanz","drugSlug":"tofacitinib","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":2500000000},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"8021344","type":"Formulation","expiryDate":"2029-11-02","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8021344","type":"Formulation","expiryDate":"2029-11-02","territory":"US","genericFilings":[]},{"drugName":"Prevnar 20","drugSlug":"pneumococcal-conjugate-vaccine","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":1500000000},{"drugName":"Estring","drugSlug":"estring","patentNumber":"8231906","type":"Compound","expiryDate":"2030-07-04","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9474869","type":"Formulation","expiryDate":"2031-02-28","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10322239","type":"Method of Use","expiryDate":"2031-02-28","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8939943","type":"Formulation","expiryDate":"2031-02-28","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9022022","type":"Formulation","expiryDate":"2031-02-28","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9814838","type":"Formulation","expiryDate":"2031-02-28","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10143972","type":"Method of Use","expiryDate":"2031-05-24","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10143792","type":"Method of Use","expiryDate":"2031-05-24","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"9050307","type":"Formulation","expiryDate":"2031-08-06","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"8627816","type":"Formulation","expiryDate":"2032-02-04","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9393318","type":"Method of Use","expiryDate":"2032-03-04","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9597409","type":"Method of Use","expiryDate":"2032-03-04","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"12458591","type":"Method of Use","expiryDate":"2032-05-11","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11020343","type":"Method of Use","expiryDate":"2032-05-11","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11806428","type":"Formulation","expiryDate":"2032-05-11","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"9168238","type":"Formulation","expiryDate":"2032-08-29","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"9168239","type":"Formulation","expiryDate":"2032-08-29","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9393318*PED","type":"Compound","expiryDate":"2032-09-04","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9597409*PED","type":"Compound","expiryDate":"2032-09-04","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"9006289","type":"Formulation","expiryDate":"2032-10-03","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10258630","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10398708","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10471072","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10537581","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11246875","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11241445","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10668082","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10568891","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"9180091","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11497709","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10835487","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10888516","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11351182","type":"Method of Use","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11116717","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11065197","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11123283","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"9289382","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"10806697","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11304959","type":"Formulation","expiryDate":"2032-11-21","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride","drugSlug":"bupivacaine-hydrochloride-and-epinephrine","patentNumber":"11746141","type":"Formulation","expiryDate":"2033-01-09","territory":"US","genericFilings":[]},{"drugName":"Prevnar 20","drugSlug":"prevnar-20","patentNumber":"US 8,895,024","type":"Composition of matter","expiryDate":"2033-04","territory":"US","annualRevenue":6400000000,"genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"9717724","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"9492442","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"9364473","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"12364691","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"11369597","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"9339497","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"9452162","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"10980795","type":"Method of Use","expiryDate":"2033-06-12","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"9549899","type":"Formulation","expiryDate":"2033-07-01","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"9044402","type":"Formulation","expiryDate":"2033-07-01","territory":"US","genericFilings":[]},{"drugName":"Revatio","drugSlug":"revatio","patentNumber":"11123287","type":"Formulation","expiryDate":"2033-12-16","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9511046","type":"Method of Use","expiryDate":"2034-01-12","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Estring","drugSlug":"estring","patentNumber":"11266661","type":"Method of Use","expiryDate":"2034-02-02","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"9192608","type":"Method of Use","expiryDate":"2034-03-12","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"9248229","type":"Formulation","expiryDate":"2034-03-12","territory":"US","genericFilings":[]},{"drugName":"Duramorph Pf","drugSlug":"morphine-sulfate","patentNumber":"9072781","type":"Formulation","expiryDate":"2034-03-12","territory":"US","genericFilings":[]},{"drugName":"Taxol","drugSlug":"paclitaxel","patentNumber":"9511046*PED","type":"Compound","expiryDate":"2034-07-12","territory":"US","annualRevenue":368000000,"genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"9517307","type":"Formulation","expiryDate":"2034-07-18","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11617713","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11628139","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10973814","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10722510","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11975096","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"12414915","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11135155","type":"Formulation","expiryDate":"2034-08-26","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"RE49443","type":"Formulation","expiryDate":"2035-02-26","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"RE49422","type":"Formulation","expiryDate":"2035-02-26","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"10251848","type":"Formulation","expiryDate":"2035-02-26","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"9345772","type":"Formulation","expiryDate":"2035-02-27","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"9295657","type":"Method of Use","expiryDate":"2035-03-13","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"9119876","type":"Formulation","expiryDate":"2035-03-13","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"10130592","type":"Formulation","expiryDate":"2035-03-13","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"12280024","type":"Formulation","expiryDate":"2035-03-13","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"10220158","type":"Formulation","expiryDate":"2035-03-20","territory":"US","genericFilings":[]},{"drugName":"Prevnar 20","drugSlug":"prevnar-20","patentNumber":"US 10,279,033","type":"Method of use","expiryDate":"2035-08","territory":"US","annualRevenue":6400000000,"genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"11224598","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"10456396","type":"Formulation","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"9597284","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"9532944","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"9504644","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"11911380","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"11903943","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"11903941","type":"Method of Use","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"9504645","type":"Formulation","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Chantix","drugSlug":"chantix","patentNumber":"11903942","type":"Formulation","expiryDate":"2035-10-19","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"11154498","type":"Formulation","expiryDate":"2036-07-20","territory":"US","genericFilings":[]},{"drugName":"Ibrance","drugSlug":"ibrance","patentNumber":"11065250","type":"Formulation","expiryDate":"2036-08-19","territory":"US","annualRevenue":4500000000,"genericFilings":[]},{"drugName":"Palbociclib","drugSlug":"palbociclib","patentNumber":"11065250","type":"Formulation","expiryDate":"2036-08-19","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"11344552","type":"Method of Use","expiryDate":"2036-08-19","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"12059497","type":"Formulation","expiryDate":"2036-10-15","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"10456360","type":"Formulation","expiryDate":"2036-10-15","territory":"US","genericFilings":[]},{"drugName":"Camptosar","drugSlug":"irinotecan-hydrochloride","patentNumber":"10993914","type":"Formulation","expiryDate":"2036-10-15","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11141540","type":"Formulation","expiryDate":"2036-10-20","territory":"US","genericFilings":[]},{"drugName":"Ibrance","drugSlug":"ibrance","patentNumber":"11065250*PED","type":"Compound","expiryDate":"2037-02-19","territory":"US","annualRevenue":4500000000,"genericFilings":[]},{"drugName":"Palbociclib","drugSlug":"palbociclib","patentNumber":"11065250*PED","type":"Compound","expiryDate":"2037-02-19","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"11096913","type":"Formulation","expiryDate":"2037-02-28","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"10537538","type":"Formulation","expiryDate":"2037-02-28","territory":"US","genericFilings":[]},{"drugName":"Lipitor","drugSlug":"lipitor","patentNumber":"11925704","type":"Formulation","expiryDate":"2037-06-07","territory":"US","genericFilings":[]},{"drugName":"Lipitor","drugSlug":"lipitor","patentNumber":"12370136","type":"Formulation","expiryDate":"2037-06-07","territory":"US","genericFilings":[]},{"drugName":"Lipitor","drugSlug":"lipitor","patentNumber":"12168069","type":"Formulation","expiryDate":"2037-06-07","territory":"US","genericFilings":[]},{"drugName":"Oxbryta","drugSlug":"oxbryta","patentNumber":"10493035","type":"Formulation","expiryDate":"2037-10-12","territory":"US","annualRevenue":250000000,"genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"10688244","type":"Formulation","expiryDate":"2037-12-21","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"10842938","type":"Formulation","expiryDate":"2037-12-21","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11771830","type":"Formulation","expiryDate":"2037-12-21","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"11413259","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"10420735","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"10226436","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"10568850","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"12245996","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"10159657","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"11602508","type":"Formulation","expiryDate":"2038-01-30","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11173209","type":"Method of Use","expiryDate":"2038-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"10576156","type":"Formulation","expiryDate":"2038-02-06","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"10231931","type":"Formulation","expiryDate":"2038-03-23","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"10406108","type":"Formulation","expiryDate":"2038-03-23","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11918655","type":"Method of Use","expiryDate":"2039-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11744895","type":"Method of Use","expiryDate":"2039-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11717571","type":"Method of Use","expiryDate":"2039-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11191838","type":"Formulation","expiryDate":"2039-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"10682414","type":"Method of Use","expiryDate":"2039-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"12324838","type":"Formulation","expiryDate":"2039-02-06","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11083698","type":"Method of Use","expiryDate":"2039-03-21","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"10653646","type":"Formulation","expiryDate":"2039-03-21","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"11207280","type":"Formulation","expiryDate":"2039-03-21","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"12133837","type":"Formulation","expiryDate":"2039-03-21","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"10888534","type":"Formulation","expiryDate":"2039-04-26","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11027072","type":"Formulation","expiryDate":"2039-05-24","territory":"US","genericFilings":[]},{"drugName":"Levoxyl","drugSlug":"levoxyl","patentNumber":"11241382","type":"Method of Use","expiryDate":"2039-09-17","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"12514854","type":"Method of Use","expiryDate":"2041-02-05","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"12097170","type":"Formulation","expiryDate":"2041-03-08","territory":"US","genericFilings":[]},{"drugName":"Levophed","drugSlug":"levophed","patentNumber":"12290494","type":"Formulation","expiryDate":"2041-03-08","territory":"US","genericFilings":[]},{"drugName":"Naloxone Hydrochloride","drugSlug":"naloxone-hydrochloride","patentNumber":"11571518","type":"Formulation","expiryDate":"2041-06-14","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"lidocaine-hydrochloride-and-epinephrine","patentNumber":"12539283","type":"Formulation","expiryDate":"2045-01-17","territory":"US","genericFilings":[]}],"drugCount":300,"phaseCounts":{"marketed":270,"phase_3":3,"discontinued":11,"phase_1":7,"preclinical":1,"phase_2":8},"enrichmentLevel":3,"visitCount":370,"keyCompetitors":["Johnson & Johnson","Merck & Co.","Eli Lilly and Company"],"therapeuticFocus":["Oncology","Vaccines","Cardiovascular"],"financials":{"source":"sec_edgar","revenue":62579000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":62579000000,"period":"2025-12-31"},{"value":63627000000,"period":"2024-12-31"},{"value":58496000000,"period":"2023-12-31"},{"value":100330000000,"period":"2022-12-31"},{"value":81288000000,"period":"2021-12-31"},{"value":41651000000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":7771000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":1142000000,"cashHistory":[],"totalAssets":208160000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":27.06,"previousClose":27.1,"fiftyTwoWeekHigh":28.75,"fiftyTwoWeekLow":20.92,"fiftyTwoWeekRange":"20.92 - 28.75","fiftyDayAverage":27.04,"twoHundredDayAverage":25.48,"beta":0.39,"enterpriseValue":208447848448,"forwardPE":9.6,"priceToBook":1.78,"priceToSales":2.46,"enterpriseToRevenue":3.33,"enterpriseToEbitda":8.11,"pegRatio":13.77,"ebitda":25717999616,"ebitdaMargin":41.1,"freeCashflow":13430124544,"operatingCashflow":11704000512,"totalDebt":67647000576,"debtToEquity":78,"currentRatio":1.16,"returnOnAssets":5.7,"returnOnEquity":8.9,"analystRating":"2.5 - Buy","recommendationKey":"buy","numberOfAnalysts":26,"targetMeanPrice":28.58,"targetHighPrice":36,"targetLowPrice":25,"dividendRate":1.72,"payoutRatio":1.26,"fiveYearAvgDividendYield":4.97,"exDividendDate":1769126400,"insiderHeldPercent":0.1,"institutionHeldPercent":67.8,"sharesOutstanding":5688356129,"floatShares":5678647833,"sharesShort":131409882,"shortRatio":3.49,"shortPercentOfFloat":2.3,"epsTrailing":1.36,"epsForward":2.82,"revenuePerShare":11.01,"bookValue":15.21,"officers":[{"age":63,"name":"Dr. Albert  Bourla D.V.M., Ph.D.","title":"Chairman of the Board & CEO"},{"age":60,"name":"Mr. David M. Denton","title":"Executive VP & CFO"},{"age":61,"name":"Dr. Chris  Boshoff FMedSci, M.D., Ph.D.","title":"Chief Scientific Officer and President of Research & Development"},{"age":59,"name":"Mr. Douglas M. Lankler","title":"Executive VP & Chief Legal Officer"},{"age":49,"name":"Mr. Aamir  Malik","title":"Executive VP & Chief U.S. Commercial Officer"},{"age":56,"name":"Ms. Jennifer B. Damico","title":"Senior VP, Controller & Principal Accounting Officer"},{"age":56,"name":"Ms. Lidia L. Fonseca","title":"Executive VP and Chief Digital & Technology Officer"},{"age":null,"name":"Ms. Francesca M. DeMartino","title":"Chief Investor Relations Officer"}],"industry":"Drug Manufacturers - General","irWebsite":"http://www.pfizer.com/investors/","website":"https://www.pfizer.com","phone":"212 733 2323"}}